id,title,link
0,A European Academy of Neurology guideline on medical management issues in dementia,https://pureadmin.qub.ac.uk/ws/portalfiles/portal/248089949/ene.14412.pdf
1,Allergie présumée aux pénicillines – Évaluation des risques pour un usage optimal et sécuritaire des bêta-lactamines,https://www.infectiologie.com/UserFiles/File/jni/2024/com/jni2024-sg2-02-chopin.pdf
2,Détection de l’entérocoque résistant à la vancomycine (ERV),https://professionals.wrha.mb.ca/old/extranet/ipc/files/manuals/bilingual/Bilingual_5_VRE_Test.pdf
3,Diagnostik und Therapie der Vitiligo. S2k-LL (DDG),https://register.awmf.org/assets/guidelines/013-093l_S1_Diagnostik-Therapie-Vitiligo_2021-04.pdf
4,Diagnostik und Therapie von Gedächtnisstörungen bei neurologischen Erkrankungen. S2e-LL (DGN),https://register.awmf.org/assets/guidelines/030-124l_S2e_Diagnostik_Therapie_Ged%C3%A4chtnisst%C3%B6rungen_2025-03-abgelaufen.pdf
5,"EAN guideline on palliative care of people with severe, progressive multiple sclerosis",
6,Empfehlungen für die strukturellen Voraussetzungen der pädiatrisch onkologischen und hämatologischen Versorgung. S2k-LL (GPOH),https://register.awmf.org/assets/guidelines/025-038l_S3k_Strukturelle-Voraussetzungen-paediatrische-onkologische-haematologische-Versorgung__2024-08.pdf
7,European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO‐NMD),
8,European Academy of Neurology and European Federation of Neurorehabilitation Societies guideline on pharmacological support in early motor rehabilitation after acute ischaemic stroke,https://medandlife.org/wp-content/uploads/JMedLife-14-295.pdf
9,European guideline and expert statements on the management of narcolepsy in adults and children,
10,Guía de Práctica Clínica de Intervenciones Psicosociales en el Trastorno Mental Grave. Revisión,https://portal.guiasalud.es/wp-content/uploads/2018/12/GPC_453_TMG_ICS_resum.pdf
11,Guidelines for clinical application of Chinese patent medicine in the treatment of influenza in children (2024),https://www1.hkexnews.hk/app/sehk/2025/107680/a125569/sehk25091500322.pdf
12,Guidelines for Management of Latent Tuberculosis Infection in Patients Requiring Immunosuppressive Agents,https://publications.ersnet.org/content/erj/53/1/1802077.full.pdf
13,"Konservative, operative und rehabilitative Versorgung bei Bandscheibenvorfällen mit radikulärer Symptomatik. S2k-LL (DGOU)",
14,"Maladie pulmonaire obstructive chronique : repérage, diagnostic, usage optimal des médicaments et des dispositifs d’inhalation, et prise en charge globale",https://sicleo.org/wp-content/uploads/2025/01/Lafond-Pierre-Alexandre_MPOC-.pdf
15,Orthotic Management of Adolescent Idiopathic Scoliosis,https://eprints.staffs.ac.uk/2422/1/eprints2422.pdf
16,"Prostatakarzinom. S3-LL (Leitlinienprogramm Onkologie von AWMF, DKG und DKH)",https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Prostatatkarzinom/Prostata_4_0/LL_Prostata_Langversion_4.0.pdf
17,"S3-Leitlinie zu bevölkerungsorientierten Strategien des Öffentlichen Zahngesundheitsdienstes zur zahnmedizinischen Prävention, Gesundheitsförderung und Stärkung der Mundgesundheitskompetenz (LL Zähne). S3-LL (DGZMK)",
18,Sexuell übertragbare Infektionen mit Mykoplasmen und Ureaplasmen. S3-LL (DSTIG),https://www.dstig.de/DSTIG-Leitfaden_Auflage_04_2023-2024.pdf
19,Standardisierte Ersteinschätzung zur Steuerung in der Notfall– und Akutversorgung an Krankenhausstandorten und integrierten Notfallstrukturen (DIRECT). S3-LL (DGINA),
20,中国高血压合并蛋白尿临床实践指南,https://www.scdc.sh.cn/shjk/shjk/upload/202105/0513_125537_187.pdf
21,中成药治疗轻度认知障碍临床实践指南,https://pdf.hanspub.org/tcm_2272778.pdf
22,胃内镜黏膜下剥离术围术期指南,http://medi-guide.meditool.cn/ymtpdf/284BAFCA-6E95-95D2-9380-4C6532FC54AA.pdf
23,'La pelle al sole con cautela' - prevenzione del melanoma,https://www.enpam.it/wp-content/uploads/prevenzioneBENEVENTO2017.pdf
24,'L´ABC del diabete' - Raccomandazioni sul diabete mellito,https://www.siditalia.it/pdf/LG_379_diabete_ed2022_feb2023.pdf
25,2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the Respiratory Society (ERS),
26,2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes,http://www.amcar.ma/ressources/att/assises/2019/Bennis_25092019.pdf
27,2019 ESC Guidelines for the management of patients with supraventricular tachycardia,http://smurbmpm.fr/wp-content/uploads/2019/10/1.pdf
28,2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk,https://www.portailvasculaire.fr/sites/default/files/docs/2019_esc-eas_dyslipidemie_guidelines.pdf
29,"2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD",https://www.portailvasculaire.fr/sites/default/files/docs/2019_esc_easd_diabete_guidelines.pdf
30,"2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (3rd edition)",https://www.sonographers.org/publicassets/eb20c998-1389-ea11-90fb-0050568796d8/arf_rhd_guidelines_3rd_edition_final-asa-compressed.pdf
31,2022 Saudi Guideline for Low Back Pain,https://www.orthopt.org/uploads/content_files/files/jospt.2021.0304.pdf
32,2023 Canadian Acne Guidelines,
33,2023中国克罗恩病诊治指南,
34,2023中国溃疡性结肠炎诊治指南,http://hncis.hnwsjk.cn/xiaohua/upload/files/2024/12/405c238312cfd31b.pdf
35,2024 Saudi Guideline for Community acquired pneumonia,https://sdiopr.s3.ap-south-1.amazonaws.com/2024/Apr/4-Apr-24/2024_AJMPCP_114295/Ms_AJMPCP_114295.pdf
36,2025 international consensus guidelines for cognitive assessment of people with cerebral palsy,https://www.cureus.com/articles/378180-cognitive-improvement-in-children-with-cerebral-palsy-following-combined-scalp-acupuncture-and-high-frequency-repetitive-transcranial-magnetic-stimulation-rtms-a-prospective-observational-study.pdf
37,A Clinical Practice Guideline for the Use of Ankle-Foot Orthoses and Functional Electrical Stimulation Post-Stroke,
38,A comparison of palliative care outcome measures used in Residential Aged Care Facilities (Best Practice 14(5)),
39,A guideline developers' handbook (SIGN CPG 50),https://dec.gov.ua/wp-content/uploads/2019/11/sign50.pdf
40,A handbook for patients and carer representatives (SIGN CPG 100),https://www.sign.ac.uk/assets/sign100.pdf
41,A national clinical practice guideline on the management of localised prostate cancer,https://kce.fgov.be/sites/default/files/2021-11/KCE_194C_prostate_cancer_0.pdf
42,A National Guideline for the Assessment and Diagnosis of Autism Spectrum Disorders in Australia,
43,A National Guideline for the prevention of pressure ulcers,https://images.skintghent.be/20184995654130_belgian-pu-prevention-guidelines.pdf
44,A national guideline for the treatment of pressure ulcers,https://images.skintghent.be/2018499572652_belgian-pu-treatment-guidelines.pdf
45,A Proactive Approach to Bladder and Bowel Management in Adults,https://rnao.ca/sites/rnao-ca/files/bpg/Bladder_and_Bowel_Management_FINAL_WEB.pdf
46,A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force,
47,AAN-EFNS guidelines on trigeminal neuralgia management,http://www.24hmb.com/voimages/web_image/upload/file/20140717/59191405569242025.pdf
48,Aanpak van slaapklachten en insomnie bij volwassenen in de eerste lijn (Richtlijn),https://www.huisartsnu.be/sites/default/files/h47-06-05_Slaapklachten-en-insomnie.pdf
49,AAOS Appropriate Use Criteria Anterior Cruciate Ligament Injuries: Prevention Programs,https://www.aaos.org/globalassets/quality-and-practice-resources/auc-acl-injury-prevention-programs.pdf
50,AAOS Appropriate Use Criteria for Limb Salvage or Early Amputation,https://www.aaos.org/globalassets/quality-and-practice-resources/dod/limb-salvage-or-early-amputation-1-16-20.pdf
51,AAOS Appropriate Use Criteria for Management of Developmental Dysplasia of the Hip in Infants up to Six Months of Age: Intended for Use by Orthopaedic Specialists,https://www.aaos.org/globalassets/quality-and-practice-resources/pddh/ddh-auc_specialist-2022-reissue.pdf
52,AAOS Appropriate Use Criteria for Management of Osteochondritis Dissecans of the Femoral Condyle,
53,"AAOS Appropriate Use Criteria for Pharmacologic, Physical, and Cognitive Pain Alleviation for Musculoskeletal Extremity/Pelvis Surgery",https://www.aaos.org/globalassets/quality-and-practice-resources/dod/painalleviationauc.pdf
54,AAOS Appropriate Use Criteria for Shoulder OA with Intact Rotator Cuff and Severe Glenoid Retroversion,
55,AAOS Appropriate Use Criteria for the Early Screening for Psychosocial Risk and Protective Factors,https://www.aaos.org/globalassets/quality-and-practice-resources/methodology/auc-methodology_v3.pdf
56,AAOS Appropriate Use Criteria for the Management of Carpal Tunnel Syndrome,https://www.aaos.org/globalassets/quality-and-practice-resources/carpal-tunnel/management-of-carpal-tunnel-syndrome-7-31-19.pdf
57,AAOS Appropriate Use Criteria for the Management of Developmental Dysplasia of the Hip in Infants up to Six Months of Age: Intended for Use by General Pediatricians and Referring Physicians,https://www.aaos.org/globalassets/quality-and-practice-resources/pddh/ddh-auc_generalist_3.5.18.pdf
58,AAOS Appropriate Use Criteria for the Management of Osteoarthritis of the Hip,https://www.aaos.org/globalassets/quality-and-practice-resources/osteoarthritis-of-the-hip/oah-cpg.pdf
59,AAOS Appropriate Use Criteria for the Management of Osteoarthritis of the Knee (Non-Arthroplasty),https://www.aaos.org/globalassets/quality-and-practice-resources/osteoarthritis-of-the-knee/oak3cpg.pdf
60,AAOS Appropriate Use Criteria for the Management of Pediatric Supracondylar Humerus Fractures,https://upload.orthobullets.com/journalclub/free_pdf/26735703_Management_of_Pediatric_Supracondylar_Humerus.8.pdf
61,AAOS Appropriate Use Criteria for the Management of Pediatric Supracondylar Humerus Fractures with Vascular Injury,https://upload.orthobullets.com/journalclub/free_pdf/26735703_Management_of_Pediatric_Supracondylar_Humerus.8.pdf
62,AAOS Appropriate Use Criteria for the Management of Rotator Cuff Pathology,https://www.aaos.org/globalassets/quality-and-practice-resources/rotator-cuff/management-of-rotator-cuff-injuries-2.pdf
63,AAOS Appropriate Use Criteria for the Prevention of Orthopaedic Infection in Patients Undergoing Dental Procedures,https://www.aaos.org/globalassets/quality-and-practice-resources/dental/pudp_guideline.pdf
64,AAOS Appropriate Use Criteria for the Surgical Management of Osteoarthritis of the Knee,https://upload.orthobullets.com/journalclub/free_pdf/27355286_Surgical_Management_of_Osteoarthritis_of_the_Knee_.13.pdf
65,AAOS Appropriate Use Criteria for the Treatment of Distal Radius Fractures (2021),
66,AAOS Appropriate Use Criteria for Treatment of Distal Radius Fractures,https://escholarship.org/content/qt0415b468/qt0415b468.pdf
67,AAOS Appropriate Use Criteria Pediatric Developmental Dysplasia of the Hip in Infants up to Six Months of Age: General Pediatricians and Referring Physicians,https://www.aaos.org/globalassets/quality-and-practice-resources/pddh/ddh-auc_generalist-2022-reissue.pdf
68,AAOS Appropriate Use Criteria: Hip Fractures in Older Adults: Acute Treatment,https://www.aaos.org/globalassets/quality-and-practice-resources/hip-fractures-in-the-elderly/hip-fx-auc_hardcopy-treatment_3.31.161.pdf
69,AAOS Appropriate Use Criteria: Humeral Component Design During Primary Anatomic Total Shoulder Arthroplasty,
70,AAOS Appropriate Use Criteria: Postoperative Rehabilitation of Low Energy Hip Fractures in Older Adults,https://www.aaos.org/globalassets/quality-and-practice-resources/hip-fractures-in-the-elderly/hip-fx-rehab-auc_reapproval.pdf
71,AAOS Appropriate Use Criteria: Prevention of Secondary Hip Fracture and/or Fragility Fracture,https://www.aaos.org/globalassets/quality-and-practice-resources/hip-fractures-in-the-elderly/prev.-secondary-fx-auc--.pdf
72,AAOS Appropriate Use Criteria: Return to Play to Pre-Injury Level Following Anterior Cruciate Ligament Injury,https://www.aaos.org/globalassets/quality-and-practice-resources/anterior-cruciate-ligament-injuries/acl-return-to-play-auc.pdf
73,AAOS Appropriate Use Criteria: Treatment for Shoulder OA with Intact Rotator Cuff and Severe Glenoid Retroversion,
74,AAOS AUC: Mgmt. of Development of Developmental Dysplasia of the Hip in Infants up to 6 months: Ortho Specialists,https://www.aaos.org/globalassets/quality-and-practice-resources/pddh/ddh-auc_generalist_3.5.18.pdf
75,AAOS CLINICAL PRACTICE GUIDELINE FOR EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING RECOVERY FROM ADULT ORTHOPAEDIC TRAUMA,https://cme.lww.com/ovidfiles/00124635-202202010-00010.pdf
76,"AAOS Clinical Practice Guideline for Pharmacologic, Physical, and Cognitive Pain Alleviation for Musculoskeletal Extremity/Pelvis Surgery",https://www.aaos.org/globalassets/quality-and-practice-resources/dod/pain-alleviation-review-report.pdf
77,AAOS Clinical Practice Guideline for the Management of Acute Isolated Meniscal Pathology,https://www.aaos.org/globalassets/quality-and-practice-resources/acute-meniscal-pathology/amp-cpg.pdf
78,AAOS Clinical Practice Guideline for the Management of Anterior Cruciate Ligament Injuries,https://www.aaos.org/globalassets/quality-and-practice-resources/anterior-cruciate-ligament-injuries/anterior-cruciate-ligament-injuries-grand-rounds-ppt.pdf
79,AAOS Clinical Practice Guideline for the Management of Carpal Tunnel Syndrome,https://www.aaos.org/globalassets/quality-and-practice-resources/carpal-tunnel/management-of-carpal-tunnel-syndrome-7-31-19.pdf
80,AAOS Clinical Practice Guideline for the Management of Hip Fractures in Older Adults,https://orthoinfo.aaos.org/globalassets/pdfs/plain-language-summary_hip-fractures-2024.pdf
81,AAOS Clinical Practice Guideline for the Management of Osteoarthritis of the Knee (Non-Arthroplasty) (3rd Edition),
82,AAOS Clinical Practice Guideline for the Management of Rotator Cuff Injuries,https://new.aaos.org/globalassets/quality-and-practice-resources/rotator-cuff/rotator-cuff-2025/rotator-cuff-cpg.pdf
83,AAOS Clinical Practice Guideline for the Management of Surgical Site Infections,https://www.aaos.org/globalassets/quality-and-practice-resources/surgical-site-infections/management-of-surgical-site-infections-8-13-19a.pdf
84,AAOS Clinical Practice Guideline on the Management of Osteoarthritis of the Hip,https://www.aaos.org/globalassets/quality-and-practice-resources/osteoarthritis-of-the-hip/oah-cpg.pdf
85,AAOS Diagnosis and Prevention of Periprosthetic Joint Infections Clinical Practice Guideline,https://www.aaos.org/globalassets/quality-and-practice-resources/pji/diagnosisandpreventionofperiprostheticjointinfections-7-24-19.pdf
86,AAOS Evidence-Based Clinical Practice Guideline for the Surgical Management of Osteoarthritis of the Knee,
87,AAOS Evidence-Based Clinical Practice Guideline for the Treatment of Clavicle Fractures,https://www.aaos.org/globalassets/quality-and-practice-resources/clavicle-fractures/clavicle-fractures-cpg.pdf
88,AAOS Evidence-Based Clinical Practice Guideline on Diagnosis and Treatment of Osteochondritis Dissecans,
89,AAOS Evidence-Based Clinical Practice Guideline on Treatment of Distal Radius Fracture,https://www.aaos.org/globalassets/quality-and-practice-resources/distal-radius/distal-radius-fractures-10-13-2020.pdf
90,AAOS Evidence-Based Clinical Practice Guideline on Treatment of Pediatric Diaphyseal Femur Fractures,
91,AAOS Evidence-Based Clinical Practice Guideline on Treatment of Pediatric Supracondylar Humerus Fractures,https://orthoinfo.aaos.org/globalassets/pdfs/pediatric-supracondylar-humerus-fractures-cpg_pls.pdf
92,AAOS Management of Glenohumeral Joint Osteoarthritis Evidence-Based Clinical Practice Guideline,http://rearmyourself.com/assets/lib/files/Clinical%20Practice%20Guidelines%20Regarding%20Shoulder%20Osteoarthritis.pdf
93,AAOS Systematic Literature Review on the Management of Surgical Site Infections,https://www.aaos.org/globalassets/quality-and-practice-resources/surgical-site-infections/management-of-surgical-site-infections-8-13-19a.pdf
94,AAOS/AAHKS The Prevention of Total Hip and Knee Arthroplasty Periprosthetic Joint Infection in Patients Undergoing Dental Procedures,
95,AAOS/ASSH Management of Distal Radius Fractures Evidence-Based Clinical Practice Guideline,https://www.aaos.org/globalassets/quality-and-practice-resources/distal-radius/distal-radius-fractures-10-13-2020.pdf
96,AAOS/METRC Clinical Practice Guideline for the Evaluation of Psychosocial Factors Influencing Recovery From Adult Orthopaedic Trauma,
97,AAOS/METRC Clinical Practice Guideline on Management of Acute Compartment Syndrome,https://www.aaos.org/globalassets/quality-and-practice-resources/dod/management-of-acute-compartment-syndrome-1-16-20.pdf
98,AAOS/METRC Prevention of Surgical Site Infections After Major Extremity Trauma Appropriate Use Criteria,
99,Abdominal aortic aneurysm: diagnosis and management (NG156),https://www.ncbi.nlm.nih.gov/books/NBK556917/bin/niceng156er6-apph-et1.pdf
100,Abdominelles Aortenaneurysma. S3-LL (DGG),https://www.degum.de/fileadmin/dokumente/Aktivitaeten/Leitlinien/PDF-Verlinkungen/004-014m__S3_Bauchaortenaneurysma_2018-08_-_Leitlinienreport.pdf
101,"Abklärung der Mikro-Hämaturie bei Kindern und jungen Erwachsenen zur Früherkennung von Nierenerkrankungen. S3-LL (DGfN, GPN)",https://www.aerzteblatt.de/pdf/122/6/m1021.pdf
102,Abklärung einer Zyanose im Kindes- und Jugendalter. S2k-LL (DGPK),https://www.dgpk.org/wp-content/uploads/2025_06_25_Leitlinie-Zyanose_final.pdf
103,Abklärung eines Herzgeräusches im Kindes- und Jugendalter. S2k-LL (DGPK),https://www.dgpk.org/wp-content/uploads/LL-Herzgeraeusch-HAAS_finaleVersionAS16_01_18.pdf
104,Ablaufschema für die Erstellung und Koordinierung von Leitlinien,https://www.dgn.org/cms-content/DGN_LL_Leitfaden_V4_07_2025_1753176547047.pdf
105,Abordaje integrado intra y exrahospitalario de los trastornos de conducta en la adolescencia (Informe nº: Osteba D-10-01),https://www.osakidetza.euskadi.eus/contenidos/informacion/2010_osteba_publicacion/es_def/adjuntos/d_10_01_aborda_adoles.pdf
106,Abordajes de los trastornos de la personalidad en la red de salud mental del País Vasco (Informe nº: Osteba D-08-01),
107,Abortion care (NG140),https://ranzcog.edu.au/wp-content/uploads/Clinical-Guideline-Abortion-Care.pdf
108,Abortion care guideline,https://ranzcog.edu.au/wp-content/uploads/Clinical-Guideline-Abortion-Care.pdf
109,Academy of Nutrition and Dietetics Evidence Analysis Manual,https://www.andeal.org/files/Docs/2012_Jan_EA_Manual.pdf
110,Accident vasculaire cérébral: méthodes de rééducation de la fonction motrice chez l'adulte. Recommandation pour la pratique clinique,
111,Achtergronddocument (blauwdruk kanker en werk). National evidence-based guideline,https://nvab-online.nl/app/uploads/2024/10/ADOC_Kanker_en_werk_2019.pdf
112,Acné (guide de pratique clinique),https://orbi.uliege.be/bitstream/2268/167590/1/COMMENT...ACNE.pdf
113,Acne (M15),https://link.springer.com/content/pdf/10.1007/978-90-313-6614-9_51.pdf
114,Acne (Richtlijn),https://www.pcds.org.uk/files/general/Acne-Pathway-2024-final-proof.pdf
115,Acne vulgaris: management (NG198),https://www.ncbi.nlm.nih.gov/books/NBK573048/bin/niceng198er1_bm1.pdf
116,Active Surveillance for the Management of Localized Prostate Cancer,https://pureadmin.qub.ac.uk/ws/files/134674864/ActSur.pdf
117,Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement,
118,Actualisation de la revue de la littérature d'une recommandation en santé publique sur la 'Détection précoce du mélanome cutané'. Rapport d'orientation: Facteurs de retard au diagnostic du mélanome cutané. Recommandation en santé publique.,https://apimed-pl.org/contenu/uploads/2019/10/Dossier-documentaire-melanome.pdf
119,Actualisation des recommandations cliniques pour le cancer de l’oesophage et de l’estomac,https://kce.fgov.be/sites/default/files/2021-11/KCE_179B_actualisation_cancer_oesophage_et_estomac.pdf
120,Actualización de Guías de Práctica Clínica en el Sistema Nacional de Salud. Manual Metodológico,https://diprece.minsal.cl/wrdprss_minsal/wp-content/uploads/2016/03/Manual-metodologico-GPC-151014.pdf
121,Actualización del Sistema de Trabajo Compartido para Revisiones Sistemáticas de la Evidencia Científica y Lectura Crítica (Informe nº: Osteba E-17-09),
122,Acute Cholecystitis,http://koraytopgul.com/wp-content/uploads/2021/05/535596749803130453.pdf
123,Acute Coronary Syndrome,https://www.aafp.org/pubs/afp/issues/2017/0215/p232.pdf
124,Acute coronary syndromes (NG185),https://www.ncbi.nlm.nih.gov/books/NBK565355/bin/niceng185er3_bm2.pdf
125,Acute coronary syndromes (SIGN CPG 148),https://www.sign.ac.uk/assets/sign148.pdf
126,Acute diarree (M34),https://link.springer.com/content/pdf/10.1007/BF03085090.pdf
127,Acute heart failure (CG187),https://www.ncbi.nlm.nih.gov/books/NBK575857/bin/nicecg187guid_pathway1.pdf
128,Acute keelpijn (M11),https://link.springer.com/content/pdf/10.1007/978-90-313-6614-9_60.pdf
129,Acute keelpijn (Richtlijn),https://dev.domusmedica.be/sites/default/files/Richtlijn%20Acute%20Keelpijn_0.pdf
130,"Acute kidney injury: prevention, detection and management (NG148)",https://www.alderhey.nhs.uk/wp-content/uploads/2023/06/Prevention-and-Management-of-Acute-Kidney-Injury-Guideline.pdf
131,Acute leukemia. National consensus-based nutrition guideline,https://research.rug.nl/files/133864548/Adherence_to_guidelines_on_nutrition_support_during_intensive_treatment_of_acute_myeloid_leukemia_patients_A_nationwide_comparison.pdf
132,Acute Myeloid Leukemia,https://www.cancer.va.gov/assets/pdf/clinical-pathways/aml.pdf
133,Acute rhinosinusitis (M33),https://academic.oup.com/fampra/article-pdf/29/6/706/1236117/cms022.pdf
134,Acute rinosinusitis (Richtlijn),https://www.chp.gov.hk/files/pdf/guidance_notes_acute_rhinosinusitis_full.pdf
135,Acute stroke treatment in Europe: a questionnaire-based survey on behalf of the EFNS Task Force on acute neurological stroke care,
136,Acute upper GI bleeding (CG141),https://iguana-quillfish-73n3.squarespace.com/s/A-Stanley-2019-review-UGIB.pdf
137,Acutely ill patients in hospital (CG50),http://www.dickyricky.com/Medicine/Guidelines/NICE/CG050%20Acutely%20ill%20patients%20in%20hospital%20-%20Quick%20reference%20guide.pdf
138,Acuut coronair syndroom (M80),
139,Acuut hoesten (M78),https://richtlijnen.nhg.org/files/2020-01/acuut_hoesten_m78.pdf
140,Adaptación y evaluación de un programa de formación on-line en lectura crítica dirigido a profesionales de enfermería (Informe nº: Osteba E-14-01),https://www.osakidetza.euskadi.eus/contenidos/informacion/2014_osteba_publicacion/es_def/adjuntos/formacion_online.pdf
141,Adenoide Vegetationen. S2k-LL (DGHNO),https://register.awmf.org/assets/guidelines/017-021l_S2k_Adenoide-Vegetationen_2023-02.pdf
142,ADHD (aktiivisuuden ja tarkkaavuuden häiriö),https://www.theseus.fi/bitstream/10024/874810/4/Hetekorpi_Kervinen.pdf
143,ADHD bij kinderen (M104),https://www.henw.org/system/files/download/hw5711-584.pdf
144,"ADHS bei Kindern, Jugendlichen und Erwachsenen. S3-LL (DGKJP,  DGPPN, DGSPJ)",https://www.dgppn.de/_Resources/Persistent/6f514fd31d75221054f1d880bda9637728e2b92d/Langfassung%20ADHS%20Leitlinie_080618.pdf
145,Adipositas und Schwangerschaft. S3-LL (DGGG),http://www.ggg-b.de/vortraege/56.pdf
146,Adjuvant and Salvage Radiotherapy After Prostatectomy: American Society of Clinical Oncology Clinical Practice Guideline Endorsement,
147,Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non-Small Cell Lung Cancer,https://www.cancercareontario.ca/sites/ccocancercare/files/guidelines/full/JCO_Z4401FINAL.pdf
148,Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update,
149,Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update,
150,Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline,https://www.gicancer.or.kr/content/event/pdf/18sp/20.pdf
151,Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline,https://www.clinicsinoncology.com/open-access/new-insights-into-the-adjuvant-treatment-of-stage-ii-colon-8783.pdf
152,"Adjuvante systemische Antibiotikagabe bei subgingivaler Instrumentierung im Rahmen der systematischen Parodontitistherapie. S3-LL (DG Paro, DGZMK)",
153,"Adoleszente Idiopathische Skoliose. S2k-LL (DWG, DGOU)",https://www.aerzteblatt.de/pdf/120/19/a884.pdf
154,Adrenal insufficiency: identification and management (NG243),https://www.ncbi.nlm.nih.gov/books/NBK609100/bin/niceng243er12-appb-et1.pdf
155,Adult Asthma Care: Promoting Control of Asthma,https://rnao.ca/sites/rnao-ca/files/bpg/Adult_Asthma_FINAL_WEB.pdf
156,Adult Weight Management (AWM). Evidence Based Nutrition Practice Guideline,https://www.andeal.org/vault/pqnew176.pdf
157,"Adulte Weichgewebesarkome. S3-LL (Leitlinienprogramm Onkologie der AWMF, DKG und DKH)",https://register.awmf.org/assets/guidelines/032-044OLp1_S3_Adulte_Weichgewebesarkome_2025-01.pdf
158,Advanced breast cancer: diagnosis and treatment (CG81),https://www.health-ni.gov.uk/sites/default/files/publications/dhssps/hsc-sqsd-nice-cg81-27-14.pdf
159,Advocacy services for adults with health and social care needs (NG227),https://www.ncbi.nlm.nih.gov/books/NBK588852/bin/niceng227er3-appf-et1.pdf
160,Age-related macular degeneration (NG82),https://www.rcophth.ac.uk/wp-content/uploads/2021/08/AMD-Services-Commissioning-Guidance-Recommendtions.pdf
161,Ahdistuneisuushäiriöt,https://www.kaypahoito.fi/xmedia/khp/khp00127.pdf
162,Aide-mémoire sur les trousses de chlorhydrate de naloxone — Stabilité et conservation,https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Usage_optimal/Trousses_naloxone_conservation_GN_INESSS.pdf
163,Aikuisen kohonnut verenpaine: omahoitoon sitoutumisen tukeminen,https://hotus.fi/wp-content/uploads/2025/05/suositus-verenpaine-web.pdf
164,Aikuispotilaan normotermian ylläpito perioperatiivisen hoitoprosessin aikana,
165,Aikuisten kotisyntyinen bakteerikeuhkokuume,https://www.kaypahoito.fi/xmedia/khp/khp00110.pdf
166,Air pollution: outdoor air quality and health (NG70),
167,Aivoinfarkti ja TIA,https://fasoco.fi/wp-content/uploads/2020/02/12-2-Aivoinfarkti-ja-TIA-2020.pdf
168,Aivovammat,https://www.kaypahoito.fi/xmedia/hoi/hoi18020c.pdf
169,Aivoverenkiertohäiriön sairastaneen omahoidon ohjauksen sisällöt,https://hotus.fi/wp-content/uploads/2025/12/avh2-nak1-tiedontarpeet.pdf
170,Aivoverenkiertohäiriöpotilaan nielemisen seulonta akuuttivaiheessa – hoitosuositus sairaanhoitajille,https://www.hotus.fi/wp-content/uploads/2021/12/avh-hoitosuositus.pdf
171,Ajustement des antidépresseurs pour le suivi d’un trouble dépressif caractérisé (majeur) ou d’un trouble anxieux,https://www.ciusss-capitalenationale.gouv.qc.ca/sites/d8/files/docs/ProfSante/OrdonnancesCollectives/GMF/DSI_INESSS-Protocole-medical-antidepresseurs.pdf
172,Ajustement des hypolipémiants (statines et ézétimibe) dans la prise en charge du risque cardiovasculaire,https://www.santeestrie.qc.ca/clients/SanteEstrie/Professionnels/Ordonnances_collectives/Ordonnances-collectives-regionales/628005_INESSS_PMN_hypolipemiants2022-03-22.pdf
173,"Aktinische Keratose und Plattenepithelkarzinom der Haut. S3-LL (Leitlinienprogramm Onkologie der AWMF, DKG und DKH)",https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/LL_Aktinische_Keratose_und_PEK_Langversion_2.01.pdf
174,Akute Beratungsanlässe pädiatrischer Patient*innen in der hausärztlichen Praxis; General Practice GUIDEline for acute pediatric conditions in general practice (GPGUIDE-Kids). S3-LL (DEGAM),
175,Akute Herzinsuffizienz und mechanische Kreislaufunterstützung. S2k-LL (DGPK),https://www.dgpk.org/wp-content/uploads/LL.AHI_2020-final.pdf
176,"Akute infektiöse Gastroenteritis im Säuglings-, Kindes- und Jugendalter. S2k-LL (GPGE)",https://www.thieme-connect.com/products/ejournals/pdf/10.1055/a-0981-6906.pdf
177,Akute Otitis media. S2k-LL (DGHNO-KHC),https://thehub.utoronto.ca/family/wp-content/uploads/2016/12/Acute-Otitis-Media.pdf
178,Akute und chronische exogene Osteomyelitis langer Röhrenknochen des Erwachsenen. S2k-LL (DGU),https://www.dgpraec.de/wp-content/uploads/2021/04/012-033l_S2k_Osteomyelitis_2018-01_1.pdf
179,"Akuter und chronischer Husten, Diagnostik und Therapie von Kindern und Jugendlichen. S2k-LL (GPP)",https://register.awmf.org/assets/guidelines/020-003l_S2k_Fachaerztliche-Diagnostik-Therapie-erwachsene-Patienten-Husten__2025-02_1.pdf
180,Akuter und chronischer Husten. S3-LL (DEGAM),
181,Akutes rheumatisches Fieber und Poststreptokokken reaktive Arthritis. S2k-LL (DGPK),https://register.awmf.org/assets/guidelines/023-027l_S2k_Akutes-rheumatisches-Fieber-Poststreptokokken-reaktive-Arthritis_2024-04.pdf
182,"Akutes, nicht obstruktives Lungenversagen im Kindesalter (pädiatrisches ARDS, PARDS). S2k-LL (GNPI)",https://register.awmf.org/assets/guidelines/024-017m_S2k_Akutes_nicht_obstruktives_Lungenversagen_ARDS_2021-08.pdf
183,Akuttherapie des ischämischen Hirninfarktes. S2e-LL (DGN),
184,Akuttherapie und Management der Anaphylaxie. S2k-LL (DGAKI),https://archiv.dgaki.de/wp-content/uploads/2010/05/065-025_AWMF_S2k_Akuttherapie_anaphylaktischer_Reaktionen_2013-12-Allergo-J-Int-2014.pdf
185,Alahengitystieinfektiot (lapset),https://www.kaypahoito.fi/xmedia/khp/khp00108.pdf
186,Alaraajojen laskimovajaatoiminta,https://www.kaypahoito.fi/xmedia/khp/khp00043.pdf
187,Alaraajojen tukkiva valtimotauti,https://www.theseus.fi/bitstream/10024/870507/2/Gruner_Hamalainen.pdf
188,Alaselkäkipu,https://www.kaypahoito.fi/xmedia/khp/khp00002.pdf
189,Alcohol dependence and harmful alcohol use (CG115),
190,Alcohol interventions in secondary and further education (NG135),
191,Alcohol-use disorders - preventing harmful drinking  (PH24),https://www.drugsandalcohol.ie/13588/1/NICE_alcohol-use-disorders-prevention.pdf
192,Alcohol-use disorders: physical complications (CG100),https://www.health-ni.gov.uk/sites/default/files/publications/dhssps/hsc-sqsd-nice-03-11.pdf
193,Algemene inleiding richtlijnen palliatieve zorg. National consensus-based guideline,https://palliatievezorgvlaanderen.be/wp-content/uploads/2025/03/Pallialine-richtlijn-palliatieve-zorg-voor-patienten-met-hartfalen-december-2024.pdf
194,Algemene principes van palliatieve zorg,https://www.hospicededuinschehoeve.nl/wp-content/uploads/2022/08/62-5.pdf
195,Algorithme de prise en charge de la lombalgie avec ou sans douleur radiculaire,https://www.amub-ulb.be/system/files/rmb/old/e098f552f99cced7aebe57ff7d6e3700.pdf
196,Algorithme de traitement de la leucémie myéloïde aiguë,https://dam.esmo.org/image/upload/FR-LAM-Guide-pour-les-Patients.pdf
197,Alkaptonurie (AKU). S2k-LL (DGKJ),https://akusociety.org/wp-content/uploads/2023/07/AnIntroductiontoAlkaptonuriaAKU-children27sbooklet.pdf
198,Alkoholiongelmat,https://www.kaypahoito.fi/xmedia/khp/khp00049.pdf
199,All users of indoor tanning beds.,https://www.asds.net/Portals/0/PDF/asdsa/asdsa-position-statement-indoor-tanning.pdf
200,Allergen-Immuntherapie bei IgE-vermittelten allergischen Erkrankungen.  S2k-LL (DGAKI),https://kinderpneumologie.ch/wp-content/uploads/2018/11/leitlinie-immuntherapie-awmf.pdf
201,"Allergieprävention. S3-LL (DGAKI, DGKJ)",
202,Allergische en niet-allergische rinitis (M48),https://link.springer.com/content/pdf/10.1007/BF03084741.pdf
203,Allergische Rhinitis. S3-LL (DGAKI),https://archiv.dgaki.de/wp-content/uploads/2022/11/als2303Kopp.pdf
204,Allergologische Diagnostik von Überempfindlichkeitsreaktionen auf Arzneimittel. S2k-LL (DGAKI),https://archiv.dgaki.de/wp-content/uploads/2010/05/061-021_AWMF_S2k_LL_Allergologische_Diagnostik_von_Ueberempfindlichkeitsreaktionen_auf_Arzneimittel_AJ_2015.pdf
205,Alternativas a la hospitalización psiquiátrica de corta estancia. Programas de seguimiento intensivo ambulatorio (Informe nº: Osteba D-13-04),https://www.euskadi.eus/contenidos/informacion/2013_osteba_publicacion/es_def/adjuntos/D_13_04%20alternativas%20a%20la%20hospitalizacion.pdf
206,"Alternatives à l’acide valproïque chez les filles, adolescentes, femmes en âge de procréer et femmes enceintes ayant un trouble bipolaire ou une épilepsie",https://static.cnsf.asso.fr/wp-content/uploads/2018/06/fiche_memo_alternatives_acide_valproique_2015-12-08_15-24-53_177.pdf
207,Ambulant erworbene bakterielle Meningoenzephalitis im Erwachsenenalter. S2k-LL (DGN),https://www.dgn.org/wp-content/uploads/2015/10/030-089l_S2k_Ambulant_erworbene_Meningoenzephalitis_2016-08-verlaengert_01.pdf
208,Amenorroe (M58),https://link.springer.com/content/pdf/10.1007/978-90-313-6614-9_31.pdf
209,American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline,https://www.melbournebreastcancersurgery.com.au/wp-content/themes/ypo-theme/pdf/acs-asco-breast-survivorship-slides.pdf
210,American Cancer Society: Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update.,
211,American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Chemotherapy Sensitivity and Resistance Assays,https://www.bcbstx.com/docs/provider/tx/standards/clinical-pay-coding/lab-mgmt/2026/cpcplab030-1-3-2026.pdf
212,American Society of Clinical Oncology Endorsement: Guideline for the Management of Fever and Neutropenia in Children with Cancer and or Undergoing Hematopoietic Stem Cell Transplantation,
213,American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism,
214,American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia,https://www.hematology.org/-/media/hematology/files/clinicians/guidelines/vte/2018ash_clinical_practice_guidelinesvte_heparin-induced-snapshot.pdf
215,American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy,https://www.hematology.org/-/media/hematology/files/clinicians/guidelines/vte/2018ash_clinical_practice_guidelinesvte_snapshotanticoagulation.pdf
216,American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients,https://www.hematology.org/-/media/hematology/files/clinicians/guidelines/vte/ash-teaching-slide-setvteprophylaxismedpdffinal71923.pdf
217,American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism,https://cancer-networks.com/wp-content/uploads/2024/04/g-2.pdf
218,American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy,https://www.hematology.org/-/media/hematology/files/clinicians/guidelines/vte/ashslideset-pregnancy5-17.pdf
219,American Society of Hematology 2019 guidelines for immune thrombocytopenia,https://ce.mayo.edu/sites/default/files/ITP%20ASH%20and%20ICR%20Guidelines%20Leave%20Behind.pdf
220,American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients,https://www.hematology.org/-/media/hematology/files/clinicians/guidelines/vte/2019ash_clinical_practice_guidelines_vte_snapshot_surgical.pdf
221,American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease,https://www.hscsnhealthplan.org/sites/default/files/SCD%20-%20ASH%20Guidelines%20%20-%20Cardiopulm%20%26%20Kidney%20Dz.pdf
222,American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism,https://www.hematology.org/-/media/hematology/files/clinicians/guidelines/vte/ash-vte-treatment_pdf.pdf
223,American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain,
224,"American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults",
225,American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support,https://www.hematology.org/-/media/hematology/files/clinicians/guidelines/guidelines-update-08_2023/ash-scd-guidelines_transfusion-snapshot_june-2023.pdf
226,American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults,https://www.hematology.org/-/media/hematology/files/clinicians/guidelines/aml-in-older-adults-update-public-comment-supplementary-file-1.pdf
227,American Society of Hematology 2021 Guidelines for Management of Venous Thromboembolism: Prevention and Treatment in Patients with Cancer.,https://www.hematology.org/-/media/hematology/files/clinicians/guidelines/ash-guidelines-update-2025/vte-guideline-snapshot_prevention-and-treatment-in-patients-with-cancer.pdf
228,American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19,
229,American Society of Hematology 2023 Guidelines for Management of Venous Thromboembolism: Thrombophilia Testing,https://www.portailvasculaire.fr/sites/default/files/docs/2023_ash_guidelines_thrombophilie.pdf
230,American Society of Hematology Guidelines on Acute Lymphoblastic Leukemia in Adolescents and Young Adults,
231,American Society of Hematology guidelines on Amyloidosis,https://www.hematology.org/-/media/hematology/files/clinicians/guidelines/20240603-amyloidosis-dx-public-comment-updated--june-6.pdf
232,Amyotrofische laterale sclerose (ALS). National consensus-based guideline,https://www.med.unc.edu/neurology/wp-content/uploads/sites/716/2018/05/ALS.pdf
233,Anale Dysplasien und Analkarzinom-Screening bei Menschen mit HIV. S2k-LL (DAIG),
234,Analfissur. S3-LL (DGK),https://link.springer.com/content/pdf/10.1007/s00053-020-00448-7.pdf
235,"Analgesie, Sedierung und Delirmanagement in der Intensivmedizin (DAS-Leitlinie). S3-LL (DGAI, DIVI)",https://register.awmf.org/assets/guidelines/001-012m_S3_Analgesie-Sedierung-Delirmanagement-in-der-Intensivmedizin-DAS_2021-08.pdf
236,Análisis coste efectividad de la terapia tópica de presión negativa para el tratamiento de las úlceras venosas de pierna (Informe nº: Osteba E-15-06),https://www.aes.es/Jornadas2015/pdf/posters/economia_2015_59_1.pdf
237,Análisis coste-efectividad de los tratamientos del síndrome de la apnea del sueño en la comunidad autónoma del País Vasco (Informe nº: Osteba D-01-01),https://www.euskadi.eus/contenidos/informacion/2001_osteba_publicacion/es_def/adjuntos/2001/d_01-01_apnea_sueno.pdf
238,Análisis coste-efectividad de una experiencia de telemonitorización en pacientes con insuficiencia cardiaca y enfermedad pulmonar obstructiva crónica (Informe nº: Osteba E12/04),https://www.ivap.euskadi.eus/contenidos/informacion/2012_osteba_publicacion/es_def/adjuntos/Analisis_coste-efectividad_de_una_experiencia.pdf
239,Análisis coste-efectividad del recambio valvular aórtico mediante prótesis valvular percutánea frente al tratamiento quirúrgico habitual (Informe nº: Osteba E-14-19),https://www.scielo.cl/pdf/rchcardiol/v34n1/art01.pdf
240,Análisis de impacto presupuestario de un procedimiento de telemedicina en programas de aseguramiento de la calidad de las espirometrías en pacientes con EPOC (Informe nº: Osteba I12-02),https://www.euskadi.eus/contenidos/informacion/2012_osteba_publicacion/es_def/adjuntos/eku_12_02_espir_infor.pdf
241,Análisis de la adecuación de las admisiones hospitalarias desde urgencias (Informe nº: Osteba D-01-06),https://www.euskadi.eus/contenidos/informacion/2001_osteba_publicacion/es_def/adjuntos/2001/d_01-06_admisiones_hospitalarias.pdf
242,Análisis de la efectividad y eficiencia de distintos abordajes diagnósticos y terapéuticos de la úlcera duodenal no complicada. Recomendaciones (Informe nº: Osteba D-00-01),https://www.euskadi.eus/contenidos/informacion/2000_osteba_publicacion/es_def/adjuntos/2000/d_00_01_ulcera_duodenal.pdf
243,"Análisis de la eficacia, seguridad y eficiencia de la estabilización de los discos intervertebrales mediante Discogel® (Informe nº: Osteba E-17-08)",
244,Análisis de la evidencia científica sobre la efectividad y eficiencia de los diferentes tipos de prótesis de cadera. Recomendaciones (Informe nº: Osteba D-00-07),https://www.euskadi.eus/contenidos/informacion/2000_osteba_publicacion/es_def/adjuntos/2000/d_00_07_protesis_cadera.pdf
245,"Análisis de la evolución de las principales causas de mortalidad en personas mayores de 65 años, de la Comunidad Autónoma del País Vasco (1986-2001) (Informe nº: Osteba D-05-05)",https://www.euskadi.eus/contenidos/informacion/2005_osteba_publicacion/es_def/adjuntos/2005/d_05-05_mortalidad_mayores_65.pdf
246,Análisis de la introducción de la Telemedicina en la gestión-coordinación de atención primaria-especializada. Evaluación de resultados y costes de experiencias preexistentes (teleoftalmología) (Informe nº: Osteba E-08-07),https://www.euskadi.eus/contenidos/informacion/2008_osteba_publicacion/es_def/adjuntos/e_08_07_teleoftalmol.pdf
247,Análisis de la profilaxis antibiótica quirúrgica (Informe nº: Osteba D-01-02),https://www.euskadi.eus/contenidos/informacion/2001_osteba_publicacion/es_def/adjuntos/2001/d_01-02_profilaxis_antibiotica_quirurgica.pdf
248,Análisis de la utilización de protocolos clínicos para el control de enfermos crónicos en la atención primaria (Informe nº: Osteba D-00-10),https://www.euskadi.eus/contenidos/informacion/2000_osteba_publicacion/es_def/adjuntos/2000/d_00_10_protocolos_cronicos.pdf
249,Análisis de las técnicas de aislamiento y profilaxis de la tuberculosis a nivel hospitalario (Informe nº: Osteba D-01-07),
250,"Análisis de situación, revisión sistemática y validación de un algoritmo diagnóstico del tromboembolismo pulmonar (TEP) en los servicios de urgencias hospitalarias del Servicio Vasco de Salud (Informe nº: Osteba D-13-12)",https://www.euskadi.eus/contenidos/informacion/2013_osteba_publicacion/es_def/adjuntos/Informe%20D-13-12%20Tromboembolismo.pdf
251,"Análisis del uso de la radiología simple de cráneo, tórax y abdomen en los servicios de urgencia hospitalarios (Informe nº: Osteba D-01-04)",https://www.euskadi.eus/contenidos/informacion/2001_osteba_publicacion/es_def/adjuntos/2001/d_01-04_radiologia_simple.pdf
252,Análisis económico de los catéteres venosos centrales de inserción periférica (PICC) insertados por personal de enfermería en pacientes oncológicos y hematológicos (Informe nº: Osteba E-16-03),
253,Análisis epidemiológico de la información recogida por los registros hospitalarios del cáncer en la CAPV. Identificación de posibles mejoras en cuanto a la retroinformación y a la difusión de los resultados (Informe nº: Osteba D-08-02),https://www.euskadi.eus/contenidos/informacion/2008_osteba_publicacion/es_def/adjuntos/D_08_02_regishospi_canc.pdf
254,Análisis y desarrollo del plan de actividades preventivas de atención primaria. Revisión de la oferta preferente y del programa informático de soporte (Informe n° D-11-01),https://www.sanidad.gob.es/areas/calidadAsistencial/estrategias/atencionPrimaria/docs/Manual_de_evaluacion_y_seguimiento_del_PAPYC2025-2027.pdf
255,Análisis y revisión de los protocolos y stándares de calidad en el proceso de diagnóstico de la prevención del cáncer cervical (Informe nº: Osteba D-01-05),https://www.euskadi.eus/contenidos/informacion/2001_osteba_publicacion/es_def/adjuntos/2001/d_01-05_cancer_cervical.pdf
256,"Analkarzinom (Diagnostik, Therapie und Nachsorge von Analkanal- und Analrandkarzinomen). S3-LL (Leitlinienprogramm Onkologie der AWMF, DKG und DKH)",https://www.aerzteblatt.de/pdf/118/13/m217.pdf
257,"Analyse critique d'une recommandation élaborée par un organisme professionnel : recommandation de bonne pratique, fiche mémo ou fiche pertinence",https://www.has-sante.fr/upload/docs/application/pdf/2016-04/guide_methodologique_fiche_memo_fiche_pertinence.pdf
258,Anaphylaxis (CG134),http://dickyricky.com/Medicine/Guidelines/NICE/CG134%20Anaphylaxis.pdf
259,Anemie (M76),https://link.springer.com/content/pdf/10.1007/978-90-313-6614-9_82.pdf
260,"Angeborene primäre Hypothyreose: Diagnostik, Therapie und Verlaufskontrolle. S2k-LL (DGKJ, DGE)",https://dgpp.de/cms/media/download_gallery/S2k-Leitlinie_Primaere_angeborene_Hypothyreose.pdf
261,Angioplastie immédiate ou dissociée de l’acte de coronarographie diagnostique dans la maladie coronaire stable,https://orbi.uliege.be/bitstream/2268/194717/1/Angioplastie%20ou%20chirurgie%20Rev%20du%20Praticien.pdf
262,Angst (M62),https://mcclimburg-noord.nl/system/ckeditor_assets/attachments/264/20210313_Referenties_Psychiatrie_V2_1_.pdf
263,Angst. National consensus-based guideline,https://www.vkgl.nl/images/links/Richtlijnen_en_protocollen/Dutch_national_consensus-based_guideline_for_the_disclosure_of_incidental_findings_during_clinical_genetic_diagnostic_testing_.pdf
264,"Anhaltende Trauerstörung. S3-LL (DEGAM, DGPJ, DGP, DGPPN, DKPM)",https://www.dgppn.de/_Resources/Persistent/dab39effff92b9c5630fc1d8ba43e0d18a99ce93/S3-LL-Guideline%20Psychosocial%20Interventions_short.pdf
265,Ankle sprain: diagnosis and therapy,https://www.andrewssportsmedicine.com/storage/wysiwyg/89-_ankle_sprain.pdf
266,Ankylose und Unterkieferhypomobilität. S2k-LL (DGMKG),https://register.awmf.org/assets/guidelines/007-064k_S3_Ankylose_Unterkieferhypomobilit%C3%A4t_2016-07-abgelaufen.pdf
267,Anorexie en gewichtsverlies,
268,Antenatal and postnatal mental health (CG192),https://elearning.rcgp.org.uk/pluginfile.php/175878/mod_book/chapter/606/Perinatalmentalhealth2023.pdf
269,Antenatal care (NG201),https://www.ncbi.nlm.nih.gov/books/NBK573782/bin/niceng201er5-appd-et1.pdf
270,"Antenatal, Intrapartum and Postnatal Care in Low Risk Pregnancy",https://www.canada.ca/content/dam/hc-sc/documents/services/publications/healthy-living/maternity-newborn-care-guidelines-chapter-3/maternity-newborn-care-guidelines-chapter-3-en.pdf
271,Antiagrégants plaquettaires: prise en compte des risques thrombotique et hémorragique en cas de geste endoscopique chez le coronarien. Recommandation de bonne pratique,https://www.sfed.org/wp-content/uploads/2021/10/Antiagregplaqendo_argum-3c7.pdf
272,Antibioprophylaxie de l’endocardite  infectieuse,https://swissheart.ch/assets/content/shop/Brosch%C3%BCren/PDF_1.001-1.999/1.414_Endokarditisausweis_Ewachsene_FR_2023.pdf
273,Antibioprophylaxie lors de chirurgies du  tractus digestif et de la paroi abdominale,https://sofia.medicalistes.fr/spip/IMG/pdf/Antibioprophylaxie_en_chirurgie_digestive_en_2010.pdf
274,Antibiotic Prophylaxis in Oral Surgery for Prevention of Surgical Site Infection (2nd Edition),https://www.moh.gov.my/moh/resources/Penerbitan/CPG/Dental%20&%20Oral/QR_ABX.pdf
275,Antibiotic Stewardship ambulant. S3-LL (DEGAM),https://register.awmf.org/assets/guidelines/020-020l_S3_Behandlung-von-erwachsenen-Patienten-mit-ambulant-erworbener-Pneumonie__2021-05.pdf
276,Antibiotic surgical prophylaxis of patients colonised by multidrug-resistant bacteria,http://revistamedicinamilitara.ro/wp-content/uploads/2022/10/2022_10_31_Review_Article_Individualized.pdf
277,Antibiotic surgical prophylaxis regimens among patients colonised by MDR-GNB and MDR-GPB,
278,Antibiotikatherapie bei HNO-Infektionen. S2-LL (DGHNO),https://www.kvsh.de/fileadmin/user_upload/dokumente/Praxis/Verordnungen/Arzneimittel/AM_A_Z/Antibiotika_Leitlinien_2025_Oktober.pdf
279,Antibiotikatherapie bei multiresistenten Erregern. S3-LL (DGHM),https://www.p-e-g.org/files/content/Service/Empfehlungen-Leitlinien/PEG-S2k-Leitlinie-Update-2018.pdf
280,Anticonceptie (M02),https://www.anticonceptie-online.nl/NHG-Standaard-M02.pdf
281,Anticonvulsant Prophylaxis and Steroid Use in Adults With Metastatic Brain Tumors: ASCO and SNO Endorsement of the Congress of Neurological Surgeons Guidelines,
282,Antiemetics: ASCO Guideline Update,https://janetabrahm.com/wp-content/uploads/2023/04/ASCO-Anbtiemetic-guideline-202071.pdf
283,Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update,https://padovaid.com/Talpitz.pdf
284,Antimicrobial stewardship - changing risk-related behaviours in the general population (NG63),https://docs.bvsalud.org/biblioref/2021/05/1179837/antimicrobial-stewardship-changing-riskrelated-behaviours-in-t_Hwwsv8X.pdf
285,Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use (NG15),https://docs.bvsalud.org/biblioref/2021/05/1223975/antimicrobial-stewardship-systems-and-processes-for-effective-_bskczjR.pdf
286,Antiresorptiva-assoziierte Kiefernekrose (AR-ONJ). S3-LL (DGMKG),https://www.endodontologie-hagen.de/fileadmin/editorial/gemeinschaftspraxis/downloads/_S3_Antiresorptiva-assoziierte-Kiefernekrosen-AR-ONJ_2018-12.pdf
287,Antisocial behaviour and conduct disorders in children and young people: recognition and management (CG158),
288,Antisocial personality disorder (CG77),https://www.researchgate.net/profile/Birgit-Voellm/publication/44681586_Psychological_interventions_for_antisocial_personality_disorder/links/5a78da590f7e9b41dbd4405a/Psychological-interventions-for-antisocial-personality-disorder.pdf
289,Antithrombotics: indications and management (SIGN CPG 129),https://www.sign.ac.uk/media/1067/sign129.pdf
290,Anuscarcinoom National Consensus- based guidline,https://www.analcancerfoundation.org/wp-content/uploads/2015/04/NCCN-guidelines.pdf
291,Aortenisthmusstenose im Kindes- und Jugendalter. S2k-LL (DGPK),https://register.awmf.org/assets/guidelines/023-010m_S2k_Aortenisthmusstenose_Kinder_Jugendliche_2018-07-abgelaufen.pdf
292,Aortenklappeninsuffizienz und Aortenklappenersatz im Kindes- und Jugendalter. S2k-LL (DGPK),https://www.dgpk.org/wp-content/uploads/LL-AI-AKE_April-2024_final_clean.pdf
293,Aphasie und Sprechapraxie: Diagnostik und Therapie. S2k-LL (DGN),https://www.dgppn.de/_Resources/Persistent/1f641e4edaf5c5d5a5114ee69146ba459a7da6b3/S3-Leitlinie+Demenzen_Langversion_2023_11_28_Final+%28003%29.pdf
294,Aplasies utéro-vaginales. Guide ALD,https://crsls.sls.org/wp-content/uploads/2014/11/13-00045.pdf
295,Aplicación de las Recomendaciones de las Guías de Práctica Clínica a la Toma de Decisiones Compartida. Manual Metodológico,
296,Aplicación del sistema GRADE en la GPC sobre asma infantil (Informe nº: Osteba E-15-04),https://www.enfermeriacomunitaria.org/web/attachments/article/1330/GPC.%20Asma%20Infantil.pdf
297,Appendizitis im Kindes- und Jugendalter. S2k-LL (DGKCH),https://register.awmf.org/assets/guidelines/166-004l_S2k_Harnwegsinfektionen_im_Kindesalter_2021-08_1.pdf
298,Approach to fever assessment in ambulatory cancer patients receiving chemotherapy,https://www.urology.wiki/Guidelines/Cancers/Chemotherapy/%E9%97%A8%E8%AF%8A%E6%8E%A5%E5%8F%97%E5%8C%96%E7%96%97%E7%9A%84%E8%82%BF%E7%98%A4%E6%82%A3%E8%80%85%E5%8F%91%E7%83%AD%E7%9A%84%E8%AF%84%E4%BC%B0%E6%96%B9%E6%B3%95%E4%B8%B4%E5%BA%8A%E5%AE%9E%E8%B7%B5%E6%8C%87%E5%8D%97.pdf
299,Approche syndromique : traitement pharmacologique,https://publications.msss.gouv.qc.ca/msss/fichiers/2014/14-829-07W.pdf
300,Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update,
301,Appropriate Use Criteria: Anterior Cruciate Ligament Injuries: Prevention Programs,https://www.aaos.org/globalassets/quality-and-practice-resources/auc-acl-injury-prevention-programs.pdf
302,Appropriate Use of High-Flow Nasal Oxygen in Hospitalized Patients for Initial or Postextubation Management of Acute Respiratory Failure: A Clinical Guideline From the American College of Physicians,http://medi-guide.meditool.cn/ymtpdf/8AD5F019-5445-8986-AB31-6EEFBD8E2B61.pdf
303,Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emergency Department or Inpatient Settings: A Clinical Guideline From the American College of Physicians,https://emergencymed.org.il/wp-content/uploads/2024/03/Appropriate_Use_of_Point_of_Care_Ultraso.pdf
304,Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians,https://dason.medicine.duke.edu/sites/default/files/appropriate_use_of_short-course_antibiotics_in_common_infections-_best_practice_advice_from_the_american_college_of_physicians_-_annals_intern_med_2021.pdf
305,Arbeit unter Einwirkung von Infrarotstrahlung (Wärmestrahlung) - Gefährdungen und Schädigungen von Augen und Haut. S2e-LL (DGAUM),https://register.awmf.org/assets/guidelines/002-010m_S2e_Arbeit-unter-Einwirkung-von-Infrarotstrahlung-Waermestrahlung_2015-12..pdf
306,Arbeiten unter klimatischen Belastungen. S2k-LL (DGAUM),https://register.awmf.org/assets/guidelines/002-045m_S2k_Arbeiten-unter-klimatischen-Belastungen_2022-07.pdf
307,Arbeitsmedizinische Eignungsuntersuchung für Arbeitnehmer auf Offshore-Windenergieanlagen und anderen Offshore-Installationen. S2k-LL (DGAUM),https://register.awmf.org/assets/guidelines/002-043l_S2k_Arbeitsmedizinische-Eignungsuntersuchung-Arbeitnehmer-Offshore-Windenergieanlagen-anderen-Offshore-Installationen_2021-09.pdf
308,Arbeitsplatzbezogener Inhalationstest (AIT) - specific inhalation challenge (SIC). S2k-LL (DGAUM),https://register.awmf.org/assets/guidelines/002-026m_S2k_Arbeitsplatzbezogener-Inhalationstest-AIT_2021-07.pdf
309,Arrêt des benzodiazépines et médicaments apparentés : démarche du médecin traitant en ambulatoire,https://www.has-sante.fr/upload/docs/application/pdf/2015-06/fiche_memo_arret_benzodiazepines_pour_mel_2015_06_16.pdf
310,Arterielle Hypertonie im Kindes- und Jugendalter. S2k-LL (DGPK),https://register.awmf.org/assets/guidelines/023-040l_S2k_Arterielle_Hypertonie-Kinder-Jugendliche_2024-08.pdf
311,Arteriosklerotische Erkrankungen der Nierenarterie. S2k-LL (DGG),https://register.awmf.org/assets/guidelines/004-008l_S2k_Arteriosklerotische_Erkrankungen-der-Nierenarterie_2025-06.pdf
312,Artritis (M90),https://link.springer.com/content/pdf/10.1007/bf03085727.pdf
313,Artroscopia con lavado articular en el tratamiento de la artrosis de rodilla (Informe nº: Osteba E-15-08),
314,"Arvelig mammacancer - Henvisningskriterier til genetisk rådgivning, indikation for tilbud om surveillance og profylaktisk kirurgi",
315,Arzneimitteltherapie bei Multimorbidität - Living Guideline. S2k-LL (DGIM),https://link.springer.com/content/pdf/10.1007/s00108-023-01500-6.pdf
316,"Ärztliche Begutachtung von Menschen mit chronischen Schmerzen. S2k-LL (DGOU, DGPM)",https://register.awmf.org/assets/guidelines/187-006l_S2k_Aerztliche-Begutachtung-chronische-Schmerzen_2023-08_2.pdf
317,"Ärztliche, pflegerische und therapeutische Versorgung von Personen mit außerklinischem Intensivpflegebedarf aufgrund von Erkrankungen des Nervensystems oder der Muskulatur",https://maik-online.org/wp-content/uploads/2025/11/2025_MAIK_Kongress_Vortrag_GROSS.pdf
318,Ascites. National consensus-based guideline,https://cdn.ncpodcast.net/file/NCPodcast/allegati/nc34_LG_britanniche_ascite_2020.pdf
319,ASCO Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males with Germ Cell Tumors,https://www.bcbsil.com/docs/provider/il/standards/cpcp/cpcplab/2026/cpcplab037-1-1-2026.pdf
320,ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease,https://www1.wfh.org/publications/files/pdf-1858.pdf
321,ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease,https://www1.wfh.org/publications/files/pdf-1858.pdf
322,"ASH, ABHH, ACHO, Grupo CAHT, Grupo  CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, and SVH 2021 guidelines for management of venous thromboembolism in Latin America",https://www.sochihem.cl/site/docs/ASHVTE.pdf
323,"ASH, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, Sociedad Peruana de Hematología, and SVH 2022 guidelines for prevention of venous thromboembolism in Latin America",https://www.sochihem.cl/site/docs/ASHVTE.pdf
324,"ASH, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, SVH, 2022 Guidelines for diagnosis of Venous Thromboembolism and management in Special Populations in Latin America",https://www.sochihem.cl/site/docs/ASHVTE.pdf
325,Asia-Pacific Guidelines for Long-Acting Growth Hormone Therapy,http://e-apem.org/upload/pdf/apem-2448202-101.pdf
326,Asian Consensus on Diagnostic Pathways for Invasive Pulmonary Fungal Diseases in High-burden Countries,
327,Aspecifieke lagerugpijn (M54),https://richtlijnen.nhg.org/files/2018-10/aspecifieke_lagerugpijn_m54_totstandkoming_en_methoden_.pdf
328,Assessment & Management of Acute Cholecystitis,https://www.surgeryscience.com/articles/433/4-1-136-357.pdf
329,Assessment & Management of Acute Coronary Syndrome in Adults,https://media.neliti.com/media/publications/584250-managing-acute-coronary-syndrome-protoco-45e56ce1.pdf
330,ASSESSMENT & MANAGEMENT OF ACUTE DIARRHOEA IN CHILDREN,https://www.wiredhealthresources.net/presentations/11-A2/story_content/external_files/2.Management_Acute_Diarrhea_Children.pdf
331,Assessment & Management of Common Anaemias In Adults,https://www.isbtweb.org/static/f69e633c-ae47-4512-bef3cec2b9e2aaca/The-Assessment-and-Management-of-Common-Anaemias-In-Adults-1.pdf
332,Assessment & Management of Stable Angina,https://www.accp.com/docs/bookstore/psap/p5b01samplemod3.pdf
333,Assessment and Care of Adults at Risk for Suicidal Ideation and Behaviour,https://rnao.ca/sites/rnao-ca/files/Assessment_and_Care_of_Adults_at_Risk_for_Suicidal_Ideation_and_Behaviour_0.pdf
334,"Assessment and Interventions for Perinatal Depression, Second Edition",https://rnao.ca/sites/rnao-ca/files/bpg/Perinatal_Depression_FINAL_web.pdf
335,Assessment and Management of Dysphagia in Children with Neurological Impairments (Best Practice 13(1)),https://core.ac.uk/download/pdf/60541408.pdf
336,"Assessment and Management of Foot Ulcers for People with Diabetes, Second Edition",https://rnao.ca/sites/rnao-ca/files/Assessment_and_Management_of_Foot_Ulcers_for_People_with_Diabetes_Second_Edition1.pdf
337,"Assessment and Management of Pain, Third Edition",https://rnao.ca/sites/rnao-ca/files/AssessAndManagementOfPain2014.pdf
338,"Assessment and Management of Pressure Injuries for the Interprofessional Team, Third Edition",https://rnao.ca/sites/rnao-ca/files/PI_BPG_FINAL_WEB_June_10_2016.pdf
339,Assessment and Management of Venous Leg Ulcers,https://rnao.ca/sites/rnao-ca/files/Assessment_and_Mangement_of_Venous_Leg_Ulcers.pdf
340,Assessment of Adult Women with Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline,https://www.fasgo.org.ar/images/Assessment_of_Adult_Women_With_Ovarian_Masses.pdf
341,"Assessment, diagnosis and interventions for autism spectrum disorders (SIGN CPG 145)",https://www.sign.ac.uk/assets/sign145.pdf
342,"Assessment, diagnosis, care and support for people with dementia and their carers (SIGN CPG 168)",https://eprints.gla.ac.uk/328241/1/328241.pdf
343,Assisting caregivers to support people with dementia (Best Practice 14(9)),https://www.cdc.gov/healthy-aging/media/pdfs/2024/06/promoting-caregiving-across-the-full-community-202012-508.pdf
344,Asthma  optimising long-term management with inhaled corticosteroid,https://isomer-user-content.by.gov.sg/68/9af0e4c2-d0ba-4a2a-b428-ce01c25e338f/asthma-management-(nov-2020).pdf
345,Asthma in adults: diagnosis and surveillance in primary health care,https://hcp.lunghealth.ca/wp-content/uploads/2020/02/Asthma-Diagnosis-and-Management-Algorithm.pdf
346,"Asthma pathway (BTS, NICE, SIGN) (NG244)",https://scionpublishing.com/wp-content/uploads/2025/01/General-Medicine-and-Surgery_6th-reprint-PDF_p132-133.pdf
347,Asthma – Nationale VersorgungsLeitlinie (NVL),https://register.awmf.org/assets/guidelines/nvl-002l_S3_Asthma_2024-08.pdf
348,Asthma – PatientenLeitlinie zur Nationalen VersorgungsLeitlinie,http://www.asconet.net/html/fuerpatienten/literatur/asthma-patientenleitlinie.pdf
349,"Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) (NG245)",https://www.myastrazeneca.co.uk/content/dam/intelligentcontent/portals/hcp/gb/en/pdfs/symbicort/references/Banner-3-References-and-Abbreviations.pdf
350,Astma,https://www.mirecc.va.gov/cih-visn2/Documents/Provider_Education_Handouts/Asthma_Information_Sheet_for_BHPs_Version_3.pdf
351,Astma bij kinderen (M24),https://richtlijnen.nhg.org/files/2020-12/specifieke_zoekstrategie_m24.pdf
352,Astma bij volwassenen (M27),https://link.springer.com/content/pdf/10.1007/978-90-313-6614-9_14.pdf
353,Atención domiciliaria al paciente en situación terminal en la Comunidad Autónoma del País Vasco (Informe nº: Osteba D-07-01),
354,"Atmung, Atemunterstützung und Beatmung bei akuter und chronischer Querschnittlähmung. S2k-LL (Paraplegie)",https://register.awmf.org/assets/guidelines/179-011m_S2k_Atmung-Atemunterstuetzung-Beatmung-bei-akuter-und-chronischer-Querschnittlaehmung_2022-11.pdf
355,ATOMs – Adjustable Transobturator Male System. Dispositivo para incontinencia de orina (Informe nº: Osteba E-17-03),https://www.euskadi.eus/contenidos/informacion/2017_osteba_publicacion/es_def/adjuntos/E-17-03.pdf
356,Atooppinen ekseema,https://www.duodecimlehti.fi/xmedia/duo/duo17843.pdf
357,Atopic eczema in under 12s: diagnosis and management (CG57),http://www.nottinghameczema.org.uk/documents/wetwrapping19.pdf
358,Atopische Dermatitis (AD) [Neurodermitis; atopisches Ekzem]. S3-LL (DDG),https://derma.de/fileadmin/derma/1_derma.de_WebRoot/Aerzte/Leitlinien/013-027l_S3_Atopische-Dermatitis-AD-Neurodermitis-atopisches-Ekzem_2023-07_1_01.pdf
359,"Atraumatische Femurkopfnekrose des Erwachsenen. S3-LL (DGOOC),  Деректива S3 Асептический некроз головки бедра",
360,Atrial fibrillation: diagnosis and management (NG196),https://www.ncbi.nlm.nih.gov/books/NBK571339/bin/niceng196er2_bm1.pdf
361,Atrioventrikuläre Septumdefekte (AVSD). S2k-LL (DGPK),https://www.dgpk.org/wp-content/uploads/2019_11_27_LL-AVSD._total_final.li_.pdf
362,Atriumfibrilleren (M79),https://link.springer.com/content/pdf/10.1007/978-90-313-6614-9_4.pdf
363,Atrophie multisystématisée,https://www.orpha.net/pdfs/data/patho/Pub/fr/AtrophieMultisystematisee-FRfrPub8744v01.pdf
364,Attention deficit hyperactivity disorder: diagnosis and management (NG87),https://www.nursinginpractice.com/wp-content/uploads/2020/04/NG87_ADHD.pdf
365,Augenärztliche Screening-Untersuchung von Frühgeborenen. S2k-LL (GNPI),https://gnpi.de/wp-content/uploads/2022/03/024-010l_S2k_Augenaerztliche_Screening-Untersuchung_Fruehgeborene_2020-07.pdf
366,Australasian Bronchiolitis Guideline: 2023 Update,https://www.crd.york.ac.uk/PROSPEROFILES/8d54d26d85dcebb213295deab2041473.pdf
367,Australian and New Zealand Living Clinical Guidelines for Stroke Management,https://files.magicapp.org/guideline/ab46fd84-96a5-4fc1-bea2-939397fff4ac/published_guideline_7638-9_2.pdf
368,Australian Dietary Guidelines (2013) (N 55),https://www.eatforhealth.gov.au/sites/default/files/2022-09/n55_australian_dietary_guidelines.pdf
369,Australian Guidelines for the Prevention and Control of Infection in Healthcare (2019),https://www.jnjmedtech.com/system/files/pdf/134844-200316%20ANZ%20One%20Pager%20SSI%20Guidlines%20Summary.pdf
370,"Australian Guidelines for the Prevention and Treatment of Acute Stress Disorder, Posttraumatic Stress Disorder and Complex Posttraumatic Stress Disorder",https://aci.health.nsw.gov.au/__data/assets/pdf_file/0004/212971/Australian-guidelines-treatment-acute-stress-posttraumatic-disorder.pdf
371,Australian guidelines on the treatment of acute stress disorder and posttraumatic stress disorder,https://aci.health.nsw.gov.au/__data/assets/pdf_file/0005/212972/Australian-guidelines-treatment-acute-stress-posttraumatic-disorder-summary.pdf
372,Australian Immunisation Handbook,https://doh.getquickmail.com/stockpdfs/1108-doh-immunisation-handbook-10th.pdf
373,Australian Living Guidelines for the Management of Respiratory Distress Syndrome (RDS),https://www.health.qld.gov.au/__data/assets/pdf_file/0012/141150/g-cpap.pdf
374,Australian Motor Neurone Disease (MND) Guideline,https://mndsapathway.com.au/assets/Uploads/Elements/FileList/MND-A5-Brochure-16pp-Final-Art.pdf
375,Australian Pregnancy Care Guidelines 2018 Edition,https://poliklinika-harni.hr/images/uploads/295/smjernice-za-prenatalnu-skrb-ranzcog.pdf
376,Autism spectrum disorder in adults: diagnosis and management (CG142),https://www.ncbi.nlm.nih.gov/books/NBK554918/bin/nicecg142guid_qs1.pdf
377,"Autism spectrum disorder in under 19s: recognition, referral and diagnosis (CG128)",
378,Autism spectrum disorder in under 19s: support and management (CG170),https://docs.bvsalud.org/biblioref/2022/02/1357583/autism-spectrum-disorder-in-under-19s-support-and-management-p_ujnhqcv.pdf
379,Autisme et autres TED: diagnostic et évaluation chez l'adulte. Recommandation pour la pratique clinique,https://handicap.gouv.fr/IMG/pdf/recommandations_pour_la_pratique_professionnelle_fedpsychiatrie.pdf
380,Autisme et autres troubles envahissants du développement: interventions éducatives et thérapeutiques coordonnées chez l’enfant et l’adolescent. Consensus formalisé,https://www.sfp-apa.fr/assets/fichiers/blog/382/09r18_recommandations_gl.pdf
381,Autismikirjon häiriö,https://www.kaypahoito.fi/xmedia/khp/khp00137.pdf
382,"Autismus-Spektrum-Störungen im Kindes-, Jugend- und Erwachsenenalter, Teil 1: Diagnostik. S3-LL (DGKJP)",
383,"Autismus-Spektrum-Störungen im Kindes-, Jugend- und Erwachsenenalter. Teil 2: Therapie. S3-LL (DGKJP)",https://register.awmf.org/assets/guidelines/028-047m_S3_Autismus-Spektrum-Stoerungen-Kindes-Jugend-Erwachsenenalter-Therapie_2021-04_4.pdf
384,Autoimmune Enzephalitiden. S2k-LL (DGN),https://pandasnetwork.org/wp-content/uploads/2018/10/Autoimmune_encephalitis.pdf
385,Autologe Fetttransplantation. S2k-LL (DGPRÄC),https://www.dgpraec.de/wp-content/uploads/2018/03/S2k_Leitlinie_Fetttransplantation.pdf
386,Autotests de dépistage du VIH,https://fr.oraquick.com/media/wysiwyg/OQHIVST_CE_IFU_-_French.pdf
387,Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen. S3-LL (DGRh),https://register.awmf.org/assets/guidelines/060-003k_S3_Axiale-Spondyloarthritis-Morbus-Bechterew-Fruehformen-2019-10-abgelaufen.pdf
388,"Babies, children and young people's experience of healthcare (NG204)",https://www.ncbi.nlm.nih.gov/books/NBK574946/bin/niceng204guid_pathway1.pdf
389,Bakterielle Infektionen bei Neugeborenen. S2k-LL (GNPI),https://gnpi.de/wp-content/uploads/2021/01/024-008l_S2k_Bakterielle_Infektionen_Neugeborene_2019-02.pdf
390,Bakterielle Vaginose. S2k-LL (DGGG),https://www.aerzteblatt.de/pdf/di/120/20/m347.pdf
391,Bariatric and Metabolic Surgery in Adults,https://www.thelancet.com/pdfs/journals/lanhl/PIIS2666-7568(25)00091-1.pdf
392,Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management (NG231),https://www.ncbi.nlm.nih.gov/books/NBK595311/bin/niceng231er6-appb-et1.pdf
393,Basaalcelcarcinoom. National evidence-based guideline,https://c.answersincme.com/programs/160202705/resources/nmsc.pdf
394,Basal Insulin Initiation and Dose Titration in Adults with Type 2 Diabetes: an Asia-Pacific Clinical Practice Guideline,
395,"Basalzellkarzinom der Haut. S2k-LL (DKG, DDG))",https://opendata.uni-halle.de/bitstream/1981185920/120126/1/J%20Deutsche%20Derma%20Gesell%20-%202024%20-%20Lang%20-%20S2k%E2%80%90Leitlinie%20Basalzellkarzinom%20der%20Haut%20Aktualisierung%202023.pdf
396,Bedplassen (M59),https://www.cbip.be/PDFREP/GGRWS/fr/10.%20Systeme%20nerveux.pdf
397,Bedwetting in under 19s (CG111),https://www.peduro.org.tr/wp-content/uploads/2024/05/bedwetting-in-under-19s.pdf
398,Beentumoren. National consensus-based guideline,https://richtlijnendatabase.nl/gerelateerde_documenten/file/22077/1/IKNL%20richtlijn%20Beentumoren.pdf
399,"Begutachtung bei psychischen und psychosomatischen Störungen. S2k-LL (DGPM, DGNB, DGPPN)",https://www.dgpraec.de/wp-content/uploads/2021/04/094-001l_S2k_Allgemeine_Grundlagen_der_medizinischen_Begutachtung_2019-04.pdf
400,Begutachtung nach gedecktem Schädel-Hirntrauma im Erwachsenenalter. S2k-LL (DGNB),https://dgnb-ev.de/ploxmedia/_1_/35ff0a083141d9133411b2a953135804/Leitlinie+SHT+2023+2.1.pdf
401,"Begutachtung psychischer und psychosomatischer Erkrankungen. S2k-LL (DGPM, DKPM)",https://www.aerzteblatt.de/pdf/116/33/m553.pdf
402,Behandlung akuter perioperativer und posttraumatischer Schmerzen. S3-LL (DIVS),https://beckassets.blob.core.windows.net/product/readingsample/128343/9783769105834_excerpt_001.pdf
403,Behandlung Cannabisbezogener Störungen. S3-LL (DG-Sucht),https://www.dgppn.de/_Resources/Persistent/7d9713f1d9ec137d874c2cb2b51b0408303d2054/076-005l_S3_Behandlung-Cannabisbezogener-Stoerungen_2025-12.pdf
404,Behandlung der Narkolepsie bei Erwachsenen und Kindern. S2k-LL (DGN),https://register.awmf.org/assets/guidelines/030_D_Ges_fuer_Neurologie/030-056a3_S2k_Behandlung-Narkolepsie-Erwachsene-Kinder_2025-12.pdf
405,Behandlung der neonatelen Asphyxie unter besonderer Berücksichtigung der therapeutischen Hypothermie. S2k-LL (GNPÜI),https://gnpi.de/wp-content/uploads/2020/07/024-023l_S2k_Behandlung_der_neonatalen_Aphyxie_unter_besonderer_Beruecksichtigung_der_therapeutischen_Hypothermie_2013-06.pdf
406,Behandlung der Polymyalgia rheumatica. S3-LL (DGRh),
407,Behandlung der Thorakalen Aortendissektion Typ A. S3-LL (DGTHG),https://register.awmf.org/assets/guidelines/011-018l_S2k_Behandlung-der-thorakalen-Aortendissektion-Typ-A_2021-02_1.pdf
408,Behandlung thermischer Verletzungen des Erwachsenen. S2k-LL (DGV),https://verbrennungsmedizin.de/files/dgv_files/pdf/leitlinien/044-001l_S2k_Thermische__Verletzungen_Erwachsene_2018-10.pdf
409,Behandlung von akuten und chronischen Erkrankungen der thorakalen Aorta; Fokus: Aortenbogen. S2k-LL (DGTHG),https://register.awmf.org/assets/guidelines/011-023l_S2k_Behandlung-akute-chronische-Erkrankungen-der-thorakalen-Aorta-Fokus-Aortenbogen_2023-03.pdf
410,Behandlung von Angststörungen. S3-LL (DGPM),https://register.awmf.org/assets/guidelines/051-028k_S3_Behandlung-von-Angststoerungen_2021-06.pdf
411,Behandlung von depressiven Störungen bei Kindern und Jugendlichen. S3-LL (DGKJP),https://www.aerzteblatt.de/pdf/pp/13/1/s34.pdf
412,Behandlung von erwachsenen Nierentransplantations-Patienten. S2k-LL (DGfN),https://www.thieme-connect.com/products/ejournals/pdf/10.1055/a-0873-4658.pdf
413,"Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie. S3-LL (PEG, DGP, DGI)",https://www.thieme-connect.com/products/ejournals/pdf/10.1055/a-1497-0693.pdf
414,Behandlung von spontanen intrazerebralen Blutungen. S2e-LL (DGN),https://www.dgn.org/wp-content/uploads/2021/06/030002_LL_Intrazerebrale-Blutungen_-2021_6.1.pdf
415,Behandlung von spontanen intrazerebralen Blutungen. S2k-LL (DGN),https://www.dgn.org/wp-content/uploads/2021/06/030002_LL_Intrazerebrale-Blutungen_-2021_6.1.pdf
416,Behandlung von virusinduzierten obstruktiven Atembeschwerden im Säuglingsalter und Kleinkindalter (Bronchiolitis/obstruktive Bronchitis). S2k-LL (GPP),
417,Behandlungsleitlinien und Behandlungsstrategien für den Einsatz in klinischen Krisen- und Katastrophenmedizin. S2k-LL (DGOU),https://register.awmf.org/assets/guidelines/001-043l_S2k_Katastrophenmedizinische-praehospitale-Behandlungsleitlinie_2023-10.pdf
418,Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline,http://www.ericzhouphd.com/uploads/1/6/6/5/16652960/journal_of_clinical_sleep_medicine_2021__2_.pdf
419,Behaviour change: digital and mobile health interventions (NG183),https://docs.bvsalud.org/biblioref/2021/04/1179109/behaviour-change-digital-and-mobile-health-interventions-pdf-6_rGX5oUH.pdf
420,Behaviour change: general approaches (PH6),https://assets.publishing.service.gov.uk/media/5bb21dd2e5274a3e0d7af9e0/Improving_Peoples_Health_Behavioural_Strategy.pdf
421,Behaviour change: individual approaches (PH49),https://www.drugsandalcohol.ie/21170/1/Behaviour_change_individual_approaches.pdf
422,Behoud ovariële functie na kankerbehande. National consensus-based guideline,https://www.nvog.nl/wp-content/uploads/2022/07/NTOG_2022_2_DEF-LR.pdf
423,Beikost. S3-LL (DGKJ),https://archiv.dgaki.de/wp-content/uploads/2023/08/Kopp-22-S3-Leitlinie-Allergiepraevention.pdf
424,Belastungsinkontinenz der Frau. S2e-LL (DGGG),https://register.awmf.org/assets/guidelines/015-091l_S2k_Harninkontinenz-der-Frau_2022-03.pdf
425,Beratung zur Vitamin D Substitution. S3-LL (DEGAM),https://register.awmf.org/assets/guidelines/053-024l_S3_Hausaerztliche-Risikoberatung-zur-kardiovaskulaeren-Praevention_2025-11.pdf
426,Beroerte (M103),https://richtlijnen.nhg.org/files/2020-01/specifieke_zoekstrategie_brt_m103.pdf
427,"Berufliche Hautmittel: Hautschutz, Hautpflege und Hautreinigung zur Prävention von Handekzemen. S2k-LL (DDG, DGAUM)",https://www.researchgate.net/profile/Manige_Fartasch/publication/277336871_S1-Leitlinie_Berufliche_Hautmittel_Hautschutz_Hautpflege_und_Hautreinigung_ICD_10_L23_L24_-_Kurzversion/links/56694e2b08ae8d6928fcdd4d/S1-Leitlinie-Berufliche-Hautmittel-Hautschutz-Hautpflege-und-Hautreinigung-ICD-10-L23-L24-Kurzversion.pdf
428,Besonderheiten der Überwachung bei künstlicher Ernährung. S3-LL (DGEM),https://www.dgem.de/sites/default/files/PDFs/Leitlinien/S3-Leitlinien/073-021l_S3_K%C3%BCnstliche_Ern%C3%A4hrung_ambulant_2014-04.pdf
429,Betreuung von Neugeborenen diabetischer Mütter. S2k-LL (GNPI),
430,Betreuung von Neugeborenen in der Geburtsklinik. S2k-LL (GNPI),https://gnpi.de/wp-content/uploads/2022/03/024-005l_S2k_Betreuung-von-Neugeborenen-in-der-Geburtsklinik_2022-01.pdf
431,Bewegungsförderung und Bewegungstherapie in der pädiatrischen Onkologie. S2k-LL (GPOH),https://www.gpoh.de/e45/e69/e486/Pressemitteilung_NeueS2k_Leitlinie025_036_BewegungsfoerderungundBewegungstherapiederpaediatrischenOnkologie_istonline.pdf
432,"Bewegungstherapie bei onkologischen Erkrankungen. S3-LL (Leitlinienprogramm Onkologie der AWMF, DKG und DKH)",https://register.awmf.org/assets/guidelines/025-036l_S2k_Bewegungsfoerderung-Bewegungstherapie-in-der-p%C3%A4diatrischen_Onkologie_2021-10.pdf
433,Bewertung von Risikofaktoren für das Auftreten des Offenwinkelglaukoms. S2e-LL (DOG),https://dog.org/wp-content/uploads/sites/11/2009/09/045-015l_S2e_Bewertung_Risikofaktoren_fuer_Auftreten_Offenwinkelglaukom_2020-11V2.pdf
434,Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer,https://www.melbournebreastcancersurgery.com.au/wp-content/themes/ypo-theme/pdf/biomarkers-for-adjuvant-endocrine-and-chemotherapy-in-early-stage-breast-cancer-asco-guidelines-2022.pdf
435,Biomarkers for Systemic Therapy in Metastatic Breast Cancer,
436,Bipolar disorder: assessment and management (CG185),https://www.ncbi.nlm.nih.gov/books/NBK602489/bin/nicecg185er1-appa-et1.pdf
437,Birt-Hogg-Dubé Syndroom (BHD). National consensus-based guidline,https://kce.fgov.be/sites/default/files/2021-11/KCE_243_oncogenetic_testing_Neurofibromatosis_Report_0.pdf
438,Blaasinstillatie. National evidence-based guideline,https://iknl.nl/getmedia/7514867b-4481-4235-81c6-27dc8902c843/samenvattingskaart-richtlijn-blaasinstillatie.pdf
439,Bladder cancer. National consensus-based nutrition guideline,https://about.ebsco.com/sites/g/files/nabnos191/files/acquiadam-assets/Nutrition-Reference-Center-Care-Sheet-Bladder-Cancer-Diet.pdf
440,Bladder cancer: an assessment of international practice guidelines,https://collegeoncologie.be/wp-content/uploads/2021/09/Fiche_Guideline-Bladder_2015_EN.pdf
441,Bladder cancer: diagnosis and management (NG2),
442,Bladdercarcinoma (english version),https://www.poijaya.org/wp-content/uploads/2021/08/bladder.pdf
443,Blauwdruk Kanker en Werk. National evidence-based guideline,https://www.targetatwork.nl/wp-content/uploads/2018/08/BLAUWDRUK_KankerWerk.pdf
444,Blood transfusion (NG24),https://www.transfusionguidelines.org/document-library/documents/nice-blood-transfusion-guideline/download-file/NICE%20tx.%20guideline.pdf
445,Bon usage des agents antiplaquettaires. Recommandations de bonne pratique,https://www.bayer.com/sites/default/files/2020-11/Recommandation%20bon%20usage%20des%20agents%20antiplaquettaires.pdf
446,Bonding bei Früh- und Reifgeborenen. S2k-LL (DGPM),https://www.dghwi.de/wp-content/uploads/2020/07/2021_03_19_LL_Langfassung.pdf
447,Bonding bei Früh- und Reifgeborenen. S2k-LL (DGPM),https://www.dghwi.de/wp-content/uploads/2020/07/2021_03_19_LL_Langfassung.pdf
448,Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline,
449,Bone Marrow Synoptic Reporting for Hematologic Neoplasms: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center,
450,Borderline ovariumtumoren. National consensus-based guideline,https://www.jogcr.com/article_697084_245de0cefef58819a6abeb6915a29516.pdf
451,Borderline personality disorder (BPD) (CG78),https://www.choiceforum.org/docs/bpd.pdf
452,Borderline-Persönlichkeitsstörung. S3-LL (DGPPN),https://register.awmf.org/assets/guidelines/038-015l_S3_Borderline-Persoenlichkeitsst%C3%B6rungen_2022-11.pdf
453,Borstkanker (M07),https://richtlijnen.nhg.org/files/2020-02/zoekstrategie_mca_m07.pdf
454,Botmetastasen. National evidence-based guideline,https://repository.ubn.ru.nl/bitstream/handle/2066/187343/187343.pdf
455,Brachytherapy for Patients With Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update,https://www.blueshieldca.com/content/dam/bsca/en/provider/docs/2023/August/PRV_BrachLocal_ProstateCA.pdf
456,Bradykarde Herzrhythmusstörungen im Kindes- und Jugendalter sowie bei jungen Erwachsenen mit angeborenen Herzfehlern (EMAH). S2k-LL (DGPK),https://www.dgpk.org/wp-content/uploads/2019_09_04_LL-Bradykardie_final.pdf
457,Brain injury rehabilitation in adults (SIGN CPG 130),https://www.sign.ac.uk/media/1068/sign130.pdf
458,Brain tumours (primary) and brain metastases in over 16s (NG99),https://www.northernireland.gov.uk/sites/default/files/publications/health/hsc-sqsd-nice-ng99-25-18_0.pdf
459,"Brain tumours, National consensus-based nutrition guideline",
460,Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update,https://www.theibcnetwork.org/wp-content/uploads/2012/11/JCO-2012-Khatcheressian-JCO.2012.45.9859.pdf
461,"Breast cancer in women: diagnosis, treatment and follow-up",https://kce.fgov.be/sites/default/files/2021-11/KCE_143_Breast_cancer_0.pdf
462,Breast Cancer Reconstruction Surgery (Immediate and Delayed) Across Ontario: Patient Indications and Appropriate Surgical Options,https://pdfs.semanticscholar.org/520f/1995ba454c5b5f4531ee54417796d90b8f0b.pdf
463,Breast cancer. National consensus-based guideline nutrition,https://www.bccancer.bc.ca/nutrition-site/Documents/Patient%20Education/a_nutrition_guide_for_women_with_breast_cancer.pdf
464,Breast Screening for Survivors of Breast Cancer,https://www.nccn.org/patients/guidelines/content/PDF/breastcancerscreening-patient.pdf
465,"Breastfeeding - Promoting and Supporting the Initiation, Exclusivity, and Continuation of Breastfeeding in Newborns, Infants and Young Children, Third Edition",
466,Breastfeeding programs in acute and primary healthcare settings (Best Practice 15(3)),https://www.cdph.ca.gov/Programs/CFH/DWICSN/CDPH%20Document%20Library/HealthCareProviders/Breastfeeding-Pocket-Guide.pdf
467,Bridging. S3-LL (DEGAM),https://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-Praxisempfehlungen/Zahn%C3%A4rztliche%20chirurgische%20Behandlung/%C3%B6ffentlich/083-018_DEGAM%20LL%20Zahn%20Chirugie%20Praxisempfehlung_06-03-20.pdf
468,British guideline on the management of asthma (SIGN CPG 158),https://static1.squarespace.com/static/6119163ed2da9f50704d2399/t/618d76eae8b43f303b816c96/1636660970978/SIGN+Guideline+Summary+Asthma+in+Children.pdf
469,"Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing (NG117)",
470,Bronchiolitis in children: diagnosis and management (NG9),https://www.ncbi.nlm.nih.gov/books/NBK573296/bin/niceng9er1-appd-et1.pdf
471,Brustschmerz - DEGAM-Leitlinie für die primärärztliche Versorgung. S3-LL (DEGAM),https://register.awmf.org/assets/guidelines/053-023l_S3_Brustschmerz%E2%80%93primaeraerztliche-Versorgung_2025-07.pdf
472,"Bruxismus, Diagnostik und Therapie. S3-LL (DGZMK)",https://tandedoc.de/pdf/tandedoc-einblick-in-wissenschaftliche-leitlinien_kiefergymnastik.pdf
473,Brystkræft – fysisk træning under kemoterapi for brystkræft,https://www.dmcg.dk/siteassets/kliniske-retningslinjer/opdelt-paa-dmcg/brystcancer/dbcg_fys_tra_kemo_v2.0_admgod_191224.pdf
474,Buikpijn bij kinderen (M100),https://richtlijnen.nhg.org/files/2020-01/Totstandkoming%20NHG-Standaard%20Buikpijn%20bij%20kinderen.pdf
475,CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leucoencephalopathy). Guide ALD,https://orphandiseasecenter.squarespace.com/s/CADASIL-95hx.pdf
476,Caesarean birth (NG192),https://www.ncbi.nlm.nih.gov/books/NBK569604/bin/niceng192er2-appd-et1.pdf
477,Calidad de vida del paciente con ictus y de su cuidador. Pronóstico y resultados del tratamiento rehabilitador (Informe nº: Osteba D-13-06),https://www.euskadi.eus/contenidos/informacion/2013_osteba_publicacion/es_def/adjuntos/Informe%20D-13-06.pdf
478,Cancer broncho-pulmonaires. Guide du parcours de soins,http://cdn2.splf.fr/wp-content/uploads/2022/03/guide_bpco_actu_2019_vf.pdf
479,Cancer colorectal. Guide ALD,https://www.has-sante.fr/upload/docs/application/pdf/2012-03/ald_30__guide_ccr_web.pdf
480,Cancer de l'estomac. Guide ALD,https://ressources-aura.fr/wp-content/uploads/2019/03/GUIALDEST11.pdf
481,Cancer de l'oesophage. Guide ALD,https://ressources-aura.fr/wp-content/uploads/2019/03/GUIALDOES11.pdf
482,Cancer de la prostate. Guide ALD,https://ressources-aura.fr/wp-content/uploads/2019/04/GUIALDPROSMD12.pdf
483,Cancer du testicule. Guide ALD,https://www.laboratoires-maymat.fr/wp-content/uploads/2018/10/ald_30_lap_cancer_du_testicule_web.pdf
484,Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over (NG36),
485,Cancer rehabilitation (engish version),https://patient-institute.org/uploads/3/4/7/4/34744109/stockwell_-rehabed.pdf
486,Cancer survivorship care (english version),https://www.nccn.org/patients/guidelines/content/PDF/survivorship-crl-patient.pdf
487,Cánceres de intervalo en el programa de detección precoz del cáncer de mama (Informe nº: Osteba D-07-07),
488,Canine-Assisted Activities (CAAs) for older people residing in long term care (Best Practice 15(13)),
489,Cannabis or Cannabinoids for the Management of Chronic Noncancer Pain: Best Practice Advice From the American College of Physicians,
490,Cannabis-based medicinal products (NG144),https://nclhealthandcare.org.uk/wp-content/uploads/2023/09/4_Cannabis_position_statement.pdf
491,CAP-NSH Uniform Labeling of Blocks and Slides in Surgical Pathology,https://documents.cap.org/documents/uniform-labeling-infographic.pdf
492,Características mínimas de un programa de rehabilitación cardiaca en la Comunidad Autónoma del País Vasco (Informe n°: Osteba D-03-02),https://www.euskadi.eus/contenidos/informacion/2003_osteba_publicacion/es_def/adjuntos/2003/d_03-02_rehabilitacion_cardiaca.pdf
493,Carbohydrate intake for adults and children: WHO guideline,https://www.sochob.cl/web1/wp-content/uploads/2023/07/Carbohydrate-intake-for-adults-and-children-WHO-guideline.pdf
494,Cardiac arrhythmias in coronary heart disease (SIGN CPG 152),https://www.sign.ac.uk/media/1089/sign152.pdf
495,Cardiac rehabilitation  (SIGN CPG 150),https://www.sign.ac.uk/assets/pat150.pdf
496,Cardiomyopathie hypertrophique. Guide ALD,https://www.sfcardio.fr/wp-content/uploads/2024/10/recommandations-cardiomyopathie-hypertrophique.pdf
497,Cardiovasculair risicomanagement (M84),https://jn.nutrition.org/cms/10.3945/jn.110.124735/attachment/cfce22c5-071c-4f1e-a3e3-9571f6ac8084/mmc2-sup2-supinfo.pdf
498,Cardiovascular disease prevention  (PH25),https://www.actiononsalt.org.uk/media/action-on-salt/NICE-Consultation-FINAL.pdf
499,Cardiovascular disease: identifying and supporting people most at risk of dying early (PH15),
500,"Cardiovascular disease: risk assessment and reduction, including lipid modification (CG181)",https://www.ncbi.nlm.nih.gov/books/NBK592515/bin/methods-pdf-13065969997.pdf
501,Care and support of people growing older with learning disabilities (NG96),
502,Care of deteriorating patients (SIGN CPG 139),https://www.sign.ac.uk/assets/sign139.pdf
503,Care of deteriorating patients (SIGN CPG 167),https://www.sign.ac.uk/media/2091/sign-167-care-of-deteriorating-patients.pdf
504,Care of dying adults in the last days of life (NG31),https://docs.bvsalud.org/biblioref/2021/05/1223825/care-of-dying-adults-in-the-last-days-of-life-pdf-1837387324357.pdf
505,Care of Patients With Liver Disease During the COVID-19 Pandemic: EASL-ESCMID Position Paper,https://easl.eu/wp-content/uploads/2020/04/Pressrelease_EASL-ESCMID_PositionPaper_Covidliver_2April2020.pdf
506,Caregiver burden of terminally ill adults in the home setting (Best Practice 15(6)),
507,Caregiving experiences of families living with persons with schizophrenia (Best Practice 18(6)),https://www.diva-portal.org/smash/get/diva2:1771699/FULLTEXT01.pdf
508,Catálogo de Guías de Práctica Clínica en el Sistema Nacional de Salud,
509,Cataracts in adults: management (NG77),
510,CCO Thyroid Cancer Guideline: An Endorsement of the 2015 American Thyroid Association Management of the 2015 ATA Management Guideline for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer.,http://medi-guide.meditool.cn/ymtpdf/A6C8E1B6-7817-63DB-3FBE-FCF83D7E6807.pdf
511,Celiac Disease (CD). Evidence Based Nutrition Practice Guideline,https://www.andeal.org/files/files/Celiac/27_CD_Full_Methods-wTables_2021.pdf
512,Cellulitis and erysipelas: antimicrobial prescribing (NG141),http://dickyricky.com/Medicine/Guidelines/NICE/NG141%20Cellulitis%20and%20erysipelas%20-%20antimicrobial%20prescribing%20-%20visual%20summary.pdf
513,Central Venous Catheter Care for the Patient With Cancer: American Society of Clinical Oncology Clinical Practice Guideline,http://www.gavecelt.it/nuovo/sites/default/files/uploads/asco_guidelines_2013.pdf
514,Cerebral palsy in adults (NG119),https://www.ncbi.nlm.nih.gov/books/NBK578080/bin/chbm2.pdf
515,Cerebral palsy in under 25s: assessment and management (NG62),https://www.pandasa.org/data/PDF/NIce-guidelines-for-cerebral-palsy-care.pdf
516,Certificat médical initial concernant une personne victime de violences. Recommandation pour la pratique clinique,https://arretonslesviolences.gouv.fr/sites/default/files/2025-05/M%C3%A9decin.e.s_%C3%A9crits_professionnels.pdf
517,Cervical Cancer Screening for Individuals at Average Risk: 2020 Guideline Update from the American Cancer Society,https://www.asccp.org/wp-content/uploads/2026/01/Practice-Advisory-ACS-Guidelines-Updated-12-19.25.pdf
518,Cervicale intra-epitheliale neoplasie (CIN). National consensus-based guideline,https://screening.iarc.fr/doc/9789241506779_eng.pdf
519,Cervixcarcinoom. National evidence-based guideline,https://www2.tri-kobe.org/nccn/guideline/gynecological/english/cervical.pdf
520,"CFTR-Modulatortherapie bei Mukoviszidose. S3-LL (DGP, GPP)",https://www.thieme-connect.com/products/ejournals/pdf/10.1055/a-2182-1907.pdf
521,Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges (NG11),https://www.positivehandling.co.uk/wp-content/uploads/2016/02/NG11-Guidance-20150529-.pdf
522,Changing Practice: Appraising Systematic Reviews (Best Practice 4(1Suppl.1)),https://pdfs.semanticscholar.org/432e/77585e0759ae1fd6d12733221199981a2283.pdf
523,Changing Practice: Introduction to Systematic Reviews (Best Practice 5(1Suppl.1)),https://www.imicams.ac.cn/webpages/education/files/%E7%B3%BB%E7%BB%9F%E8%AF%84%E4%BB%B7%E5%8F%8A%E5%85%B6%E6%B5%81%E7%A8%8B2018.04.19%EF%BC%88%E5%9F%B9%E8%AE%AD%E8%AF%BE%E4%BB%B6%EF%BC%89.pdf
524,Check-list de sortie d'hospitalisation supérieure à 24h,https://www.omedit-idf.fr/wp-content/uploads/2016/02/HAS.pdf
525,Chemo- and Targeted Therapy for Patients With HER2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline,
526,Chemo- and Targeted Therapy for Women with HER2 Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline,
527,Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor–Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update,https://cda-amc.ca/sites/default/files/DRR/2025/PC0401_Enhertu_Draft_Clinical_Pharmacoeconomic.pdf
528,Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline,https://www.cancercareontario.ca/sites/ccocancercare/files/guidelines/full/pebc5-7v3f.pdf
529,Chest pain of recent onset: assessment and diagnosis (CG95),https://heeoe.hee.nhs.uk/sites/default/files/chest_pain_of_recent_onset_nice_2010.pdf
530,Child abuse and neglect (NG76),https://register.awmf.org/assets/guidelines/027_D_Ges_fuer_Kinderheilkunde_und_Jugendmedizin/027-069me_S3_Child_Protection_Guideline_2019-08.pdf
531,Child maltreatment: when to suspect maltreatment in under 18s (CG89),
532,Childhood Immunisation,https://www.health.ny.gov/prevention/immunization/docs/child_schedule.pdf
533,Children and young people exposed prenatally to alcohol (SIGN CPG 156),https://www.sign.ac.uk/media/1120/sign156_search_narrative.pdf
534,"Children’s attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care (NG26)",
535,Children’s experiences of postoperative pain management (Best Practice 17(7)),https://www.theseus.fi/bitstream/10024/896053/2/Sirma%2C%20Joy.pdf
536,Chirurgie der Adipositas. S3-LL (DGAV),https://www.allianzadipositasschweiz.ch/AllianzAdipositasSchweiz/fileadmin/3_Veranstaltungen/Annual_Meeting_2024/02_The_german_S3_guidelines_on_bariatric_surgery_past__present_and_future_.pdf
537,"Chirurgische Maßnahmen bei Geschlechtsinkongruenz. S2k (DGU, DGPRÄC)",https://www.researchgate.net/profile/Dominik-Gross/publication/329970001_Geschlechtsinkongruenz_Geschlechtsdysphorie_und_Trans-Gesundheit_S3-Leitlinie_zur_Diagnostik_Beratung_und_Behandlung/links/5c26415e299bf12be39f1bc6/Geschlechtsinkongruenz-Geschlechtsdysphorie-und-Trans-Gesundheit-S3-Leitlinie-zur-Diagnostik-Beratung-und-Behandlung.pdf
538,Cholestase im Neugeborenenalter. S2k-LL (GPGE),https://register.awmf.org/assets/guidelines/068-015l_S2k_Cholestase-im-Neugeborenenalter_2025-09-abgelaufen.pdf
539,Cholesteatom. S2k-LL (DGHNO),https://scispace.com/pdf/seltene-erkrankungen-des-mittelohres-und-der-lateralen-29kbfvsuzt.pdf
540,Chorea / Morbus Huntington. S2k-LL (DGN),https://register.awmf.org/assets/guidelines/030-028l_S2k_Chorea_Morbus_Huntington_2023-01.pdf
541,Chronic Complications of Diabetes Mellitus,https://www.sciencedirect.com/science/article/pii/S0029646522028377/pdf?md5=94c99b442803858ae1e3df8f548d8b7c&pid=1-s2.0-S0029646522028377-main.pdf
542,Chronic Heart Failure,https://www.accp.com/docs/bookstore/psap/p7b05.sample01.pdf
543,Chronic heart failure in adults: diagnosis and management (NG106),
544,Chronic kidney disease  delaying progression and reducing cardiovascular complications,https://www.ukkidney.org/sites/default/files/documents/UK%20RPG%20CKD%20Delaying%20progression%20leaflet%202025_compressed.pdf
545,Chronic kidney disease  early detection,https://www.kidney.org/sites/default/files/CKD-Early-Detection-and-Management.pdf
546,Chronic Kidney Disease (CKD). Evidence Based Nutrition Practice Guideline,https://www.andeal.org/files/files/CKD/CKD2020_Comparison_Table_20200820.pdf
547,Chronic kidney disease (stage 4 or 5): management of hyperphosphataemia (CG157),https://www.ncbi.nlm.nih.gov/books/NBK551826/bin/nicecg157surv_AppendixA1.pdf
548,Chronic kidney disease: assessment and management (NG203),https://prescqipp.info/media/5981/281-part-1-chronic-kidney-disease-ckd-in-adults-20.pdf
549,Chronic leukemia. National nutrition consensus-based nutrition guideline,https://leukemiarf.org/wp-content/uploads/2023/05/Nutrition-and-Leukemia-5.8.23.pdf
550,Clinical Practice Guideline of Korean Medicine for Rheumatoid Arthritis,
551,Clinical practice guideline on Perioperative Care in Major Abdominal Surgery,https://www.guiasalud.es/wp-content/uploads/2018/12/GPC_555_CMA_IACS_compl_en.pdf
552,Clinical Practice Guideline on the Management of Patients with Rheumatoid Arthritis,https://providers.bluekc.com/Content/themes/base/PDF/ClinicalGuidelines/RheumatoidArthritis_CPGL.pdf
553,Clinical Practice Guideline:  Improving Nasal Form and Function after Rhinoplasty,https://www.rcot.org/2021/pdf/Clinical%20Practice%20Guideline-%20Improving%20Nasal%20Form%20and%20Function%20after%20Rhinoplasty.pdf
554,Clinical Practice Guideline:  Surgical Management of Rhinosinusitis,https://sborl.es/wp-content/uploads/2016/02/AmAc-GPC-sinusitis-adulto.pdf
555,Clinical Practice Guideline: Acute Otitis Externa,https://shastahealth.org/sites/default/files/2024-01/acute_otitis_externa.pdf
556,Clinical Practice Guideline: Adult Sinusitis (Update),http://antimicrob.net/wp-content/uploads/2015-Amer.-Academy-Otolaryngology_Adult-Sinusitis-Guidelines.pdf
557,Clinical Practice Guideline: Age Related Hearing Loss,https://www.entnet.org/wp-content/uploads/2024/04/CPG-ARHL-PatientHandout-Impact.pdf
558,Clinical Practice Guideline: Allergic Rhinitis,https://www.aafp.org/pubs/afp/issues/2015/1115/p942.pdf
559,Clinical Practice Guideline: Bell's Palsy,https://mfch.cz/wp-content/uploads/2017/04/ngc-10075.pdf
560,Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update),https://hmlfunctionalcare.com/wp-content/uploads/2021/06/Clinical-Practice-Guidelines.pdf
561,Clinical Practice Guideline: Hoarseness (Dysphonia) Update,https://www.rcot.org/2021/pdf/Clinical%20Practice%20Guideline-%20Hoarseness%20(Dysphonia)%20(Update).pdf
562,Clinical Practice Guideline: Immunotherapy for Inhalant Allergy,
563,Clinical Practice Guideline: Improving Voice Outcomes after Thyroid Surgery,https://www.entsurgeons.us/storage/app/media/aao-news6-2013.pdf
564,Clinical Practice Guideline: Ménière's Disease,https://journals.sagepub.com/cms/asset/acf34278-8e12-44fe-90ee-be005b54ed80/otoj_162_2s.ed_board.pdf
565,Clinical Practice Guideline: Nosebleed (Epistaxis),
566,Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations,https://medicalxpress.com/pdf536940640.pdf
567,Clinical Practice Guideline: Otitis Media with Effusion (Update),https://www.rcot.org/2021/pdf/ClinicalPracticeGuideline-OtitisMediawithEffusion(Update)-27-06-59.pdf
568,Clinical Practice Guideline: Sudden Hearing Loss (Update),
569,Clinical Practice Guideline: Tinnitus,https://www.rcot.org/2021/pdf/CPG-Tinnitus03-10-2016.pdf
570,Clinical Practice Guideline: Tonsillectomy in Children (Update),https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/aao-guidelines-tonsillectomy-2019.pdf
571,Clinical Practice Guideline: Tympanostomy Tubes in Children (Update),https://www.odu.edu/sites/default/files/documents/Tympanostomy_Tubes_in_Children.pdf
572,Clinical practice guidelines for influenza,https://storagehub.homnya.com/cmsimage/allegati/allegato1726472726.pdf
573,Clinical practice guidelines for keratinocyte cancer,https://cancerwa.asn.au/assets/public/2025/11/Clinical-Melanoma-Guide-for-GPs.pdf
574,Clinical Practice Guidelines for Surveillance Colonoscopy,https://www.colonprep.com.au/wp-content/uploads/2017/05/NHMRC_colonoscopy_guideline_120314.pdf
575,Clinical Practice Guidelines for The Diagnosis and Treatment of Diffuse Glioma-Related Epilepsy: 2025 update,https://medtion-image.medtion.com/uploads/1/file/public/202512/20251225175827_1x2p9ho3od.pdf
576,"Clinical practice guidelines for the prevention, early detection and management of colorectal cancer",https://extranet.who.int/ncdccs/Data/AUS_D1_cp106_clinical_practice_guidelines_prevention_early_detection_management....pdf
577,Clinical practice guidelines for the use of recombinant and plasma-derived factor VIII and factor IX products,https://www.haemophilia.org.au/HFA/media/Documents/Haemophilia/Bleeding%20Registry/Evidence-based-clinical-practice-guidelines-June2006.pdf
578,Clinical Practice in a Digital Health Environment,https://hl-prod-ca-oc-download.s3-ca-central-1.amazonaws.com/CNA/2f975e7e-4a40-45ca-863c-5ebf0a138d5e/UploadedImages/documents/policy-advocacy/CNA-Position-Statement_Nursing-Practice-in-Digitally-Enabled-Care-Environments_E.pdf
579,Clinical Utility of Multigene Profiling Assays in Invasive Early-Stage Breast Cancer,https://www.cancercareontario.ca/sites/ccocancercare/files/guidelines/summary/pebcMOTAC-4v2s.pdf
580,"Clinical Utility of Positron Emission Tomography in the Diagnosis, Staging and Management of Sarcoidosis",
581,Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline,https://www.auanet.org/documents/Guidelines/PDF/clinical-guidance/Clinically-Localized-Prostate-Cancer.pdf
582,Clostridioides difficile infection: antimicrobial prescribing (NG199),
583,Cochlea-Implantat Versorgung. S2k-LL (DGHNO),https://register.awmf.org/assets/guidelines/017-071l_S2k_Cochlea-Implantat-Versorgung-zentral-auditorische-Implantate_2020-12-abgelaufen.pdf
584,"Coeliac disease: recognition, assessment and management (NG20)",https://www.nursinginpractice.com/wp-content/uploads/2020/04/NG20-Coeliac-Disease.pdf
585,Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings (CG120),
586,Coexisting severe mental illness and substance misuse: community health and social care services (NG58),
587,Colitis ulcerosa. S3-LL (DGVS),https://register.awmf.org/assets/guidelines/021-009l_S3_Colitis-ulcerosa_2025-11.pdf
588,Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies,https://documents.cap.org/documents/thoracic-summary-recommendations.pdf
589,"Colon Cancer :Diagnosis, Treatment and Follow-Up",https://kce.fgov.be/sites/default/files/2021-11/KCE_218_Colon_cancer.pdf
590,Colonoscopy for Diagnostic Evaluation and Interventions to Prevent Recurrence After Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians,https://www.acponline.org/sites/default/files/acp-policy-library/guidelines/colonoscopy_for_diagnostic_evaluation_interventions_to_prevent_recurrence_diverticulitis_2022.pdf
591,Colorectaalcarcinoom,https://richtlijnen.nhg.org/files/2020-05/colorectaalcarcinoom.pdf
592,Colorectal cancer (NG151),https://www.thelancet.com/pdfs/journals/lanonc/PIIS1470-2045(22)00256-X.pdf
593,"Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas (CG118)",
594,Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society,
595,Colorectal Cancer Screening in Average Risk Populations: Evidence Summary,https://scispace.com/pdf/colorectal-cancer-screening-in-average-risk-populations-3g0hpqesv1.pdf
596,Colorectal cancer. National nutrition consensus-based guideline,https://www.wcrf.org/wp-content/uploads/2024/10/Colorectal-cancer-report.pdf
597,Colorectale levermetastasen. National evidence-based guideline,https://kce.fgov.be/sites/default/files/2021-11/d20061027355_0.pdf
598,Comment améliorer la sortie de l'hôpital et favoriser le maintien à domicile des patients adultes relevant de soins palliatifs ?,https://igas.gouv.fr/sites/igas/files/files-spip/pdf/2016-064R_.pdf
599,Comment organiser la sortie des patients hospitalisés pour insuffisance cardiaque ?,https://programme.europa-organisation.com/slides/programme_cnch-2017/17-20171123_1400_Auditorium_DAMY_Thibaud_1111_(208)/DAMY_Thibaud_20171123_1400_Auditorium_wmk.pdf
600,Comment réduire les hospitalisations non programmées des résidents des Ehpad,https://www.fhf.fr/sites/default/files/documents/Rapport%20Mati%C3%A8res%20Grises%20-%20Objectif%20Grand%20Age%20-%20%C3%A9viter%20l%27h%C3%B4pital.pdf
601,Comment réduire les risques associés à la création d’un pneumopéritoine en chirurgie digestive ?,http://www.fcvd.fr/wp-content/uploads/2017/10/REC_PNEUMOP%C3%89RITOINE.pdf
602,Common anemias in adults,https://www.isbtweb.org/static/f69e633c-ae47-4512-bef3cec2b9e2aaca/The-Assessment-and-Management-of-Common-Anaemias-In-Adults-1.pdf
603,Common mental health problems: identification and pathways to care (CG123),https://oklahoma.gov/content/dam/ok/en/odmhsas/documents/a0001/common-mh-care-pathways.pdf
604,Community engagement: improving health and wellbeing and reducing health inequalities (NG44),https://docs.bvsalud.org/biblioref/2021/05/1223808/community-engagement-improving-health-and-wellbeing-and-reduci_cqkPzQi.pdf
605,Community pharmacies: promoting health and wellbeing (NG102),
606,Comparison of PET/CT and PET/MR Imaging in Oncology,https://cdn.iuc.edu.tr/FileHandler2.ashx?f=05_mkl-02.002_aldahouksezdi.pdf
607,Comparison of PET/CT and PET/MR Imaging in Oncology,https://cdn.iuc.edu.tr/FileHandler2.ashx?f=05_mkl-02.002_aldahouksezdi.pdf
608,Complementaire zorg. National consensus-based guideline,https://www.diva-portal.org/smash/get/diva2:1089201/FULLTEXT01.pdf
609,Complex interactive factors which determine carers' experiences of seeking help for relatives with first- episode psychosis (Best Practice 18(10)),
610,Conditions du développement de la chimiothérapie en hospitalisation à domicile,https://d8miq7k9f04rm.cloudfront.net/uploads/1696050017_b7b57b2063889bdd414b.pdf
611,Conduite à tenir après le traitement d'urgence d'une suspicion d'anaphylaxie. Fiche mémo,https://www.sfdermato.org/upload/recommandations/anaphylaxie-fiche-memo-b8333297cd7d67b41486aa4a7f3a9850.pdf
612,Conduite à tenir en médecine de premier recours devant un enfant ou un adolescent susceptible d’avoir un trouble déficit de l’attention avec ou sans hyperactivité,
613,Confidencialidad de la historia clínica. Análisis de la situación actual y áreas de mejora en el uso y manejo de la misma (Informe nº: Osteba D-09-03),
614,Congress of Neurological Surgeons Systematic Review and Evidence-based Guidelines for Perioperative Spine: Preoperative Nutritional Assessment,
615,Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Perioperative Spine: Preoperative Opioid Evaluation,
616,Congress of Neurological Surgeons Systematic Review and Evidence-based Guidelines for Perioperative Spine: Preoperative Osteoporosis Assessment,
617,Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Perioperative Spine: Preoperative Pulmonary Evaluation and Optimization,
618,Congress of Neurological Surgeons Systematic Review and Evidence-based Guidelines for Perioperative Spine: Preoperative Surgical Risk Assessment,
619,CONGRESS OF NEUROLOGICAL SURGEONS SYSTEMATIC REVIEW AND EVIDENCE-BASED GUIDELINES FOR THE ROLE OF IMAGING FOR PATIENTS WITH FUNCTIONING PITUITARY ADENOMAS,
620,CONGRESS OF NEUROLOGICAL SURGEONS SYSTEMATIC REVIEW AND EVIDENCE-BASED GUIDELINES FOR THE ROLE OF MEDICAL MANAGEMENT FOR PATIENTS WITH FUNCTIONING PITUITARY ADENOMAS,
621,CONGRESS OF NEUROLOGICAL SURGEONS SYSTEMATIC REVIEW AND EVIDENCE-BASED GUIDELINES FOR THE ROLE OF SURGERY FOR PATIENTS WITH FUNCTIONING PITUITARY ADENOMAS,
622,CONGRESS OF NEUROLOGICAL SURGEONS SYSTEMATIC REVIEW AND EVIDENCE-BASED GUIDELINES ON THE ROLE OF RADIOSURGERY FOR PATIENTS WITH FUNCTIONING PITUITARY ADENOMAS,
623,Consejo Genético en anomalías congénitas en la Comunidad Autónoma del País Vasco (Informe nº: Osteba D-08-06),https://www.euskadi.eus/contenidos/informacion/2008_osteba_publicacion/es_def/adjuntos/D_08_06%20consejo%20genetico.pdf
624,Consejo genético en el cáncer de mama y de colon (Informe nº: Osteba D-07-06),https://www.euskadi.eus/contenidos/informacion/2007_osteba_publicacion/es_def/adjuntos/d_07-06_consejo_genetic.pdf
625,"Consensus Document for the Diagnosis of Prosthetic Joint Infections: A Joint Paper by the EANM, EBJIS, and ESR (With ESCMID Endorsement)",
626,"Consensus Statement on Effective Communication of Urgent Diagnoses and Significant, Unexpected Diagnoses in Surgical Pathology and Cytopathology From the College of American Pathologists and Association of Directors of Anatomic and Surgical Pathology",http://www.girardslaw.com/library/Pathologists_Consensus_Statement_2013.pdf
627,Consensus-based organizational guideline for the planning and delivery of spine stereotactic body radiotherapy treatment in Ontario,
628,Consolidated guidelines on differentiated HIV testing services,https://irp.cdn-website.com/85632419/files/uploaded/WHO.pdf
629,"Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach",
630,"Consolidated guidelines on HIV testing services, 2019",https://www.aidsdatahub.org/sites/default/files/resource/who-consolidated-guidelines-hiv-testing-services-2019-2020.pdf
631,"Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations",https://www.hst.org.za/publications/NonHST%20Publications/9789240052390-eng.pdf
632,Constipation (english version),https://gikids.org/wp-content/uploads/2020/03/Constipation-all-English.pdf
633,Constipation in children and young people: diagnosis and management (CG99),https://hub.careinspectorate.com/media/1482/constipation-in-children-and-young-people.pdf
634,Contaminantes procedentes del tratamiento de las aguas de consumo en la Comunidad Autónoma del País Vasco: Evaluación del riesgo y las alternativas de tratamiento (Informe nº: Osteba D/12/01),
635,"Continuous versus Intermittent Chemotherapy Strategies in Inoperable, Advanced Colorectal Cancer",https://pdfs.semanticscholar.org/39fb/32fa8aeb7864b7a3737b7a56d5caeff9d165.pdf
636,Contraception : prescriptions et conseils aux femmes,http://www.avortementancic.net/IMG/pdf/1e_maj_contraception_prescription-conseil-femmes-060215.pdf
637,Contraception chez la femme adulte en âge de procréer (hors post-partum et post-IVG),https://sante.gouv.fr/IMG/pdf/15_05_13_DP_ASS_contraception.pdf
638,Contraception chez la femme après une interruption volontaire de grossesse (IVG),https://www.jle.com/download/met-299199-22079-contraception_chez_la_femme_apres_une_interruption_volontaire_de_grossesse_ivg_-g.pdf
639,Contraception chez la femme en post-partum,https://oldmduq.fmoq.org/Media/66631/089-097Doc0900.pdf
640,Contraception d’urgence : dispensation en officine,https://dumas.ccsd.cnrs.fr/dumas-01291610v1/file/Pharmacie_2016_Lobry.pdf
641,Contraception hormonale orale : dispensation en officine,https://uspo.fr/wp-content/uploads/2014/01/contraception_transdermique_v3.pdf
642,Contraception: Fiches mémo,http://www.avortementancic.net/IMG/pdf/1e_maj_contraception_prescription-conseil-femmes-060215.pdf
643,Contraception chez l’adolescente,https://www.medecinesciences.org/articles/medsci/pdf/2021/08/msc200585.pdf
644,Contraceptive services for under 25s (PH51),https://assets.publishing.service.gov.uk/media/6412fa41d3bf7f79d7b78f5d/Integrated-sexual-health-service-specification-2023.pdf
645,Control de Calidad en Radioterapia de Intensidad Modulada (Informe nº: Osteba D-08-04),https://www.euskadi.eus/contenidos/informacion/2008_osteba_publicacion/es_def/adjuntos/D_08_04%20radioterapia%20de%20intensidad%20modulada.pdf
646,Controlled drugs: safe use and management (NG46),https://www.bmj.com/content/bmj/353/bmj.i2137.full.pdf
647,Coopération entre anesthésistes-réanimateurs et chirurgiens : mieux travailler en équipe,http://www.fcvd.fr/wp-content/uploads/2017/10/REC_COOP%C3%89RATION_MAR-CHIR-1.pdf
648,COPD (M26),https://wa-provider.kaiserpermanente.org/static/pdf/public/guidelines/copd.pdf
649,COPD – Nationale VersorgungsLeitlinie (NVL),https://digab.de/wp-content/uploads/2021/09/copd-2aufl-vers1.pdf
650,Cough (acute): antimicrobial prescribing (NG120),https://www.health-ni.gov.uk/sites/default/files/publications/health/NG120%20-%20Cough%20Acute%20-%20%20antimicrobial%20prescribing.pdf
651,COVID-19 (M111),https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200510covid-19-sitrep-111.pdf
652,COVID-19 : usage optimal des traitements pharmacologiques,https://www.sfndt.org/sites/www.sfndt.org/files/medias/documents/ANSM_point-sur-lutilisation-des-traitements-contre-le-covid-19-disponibles-en-acces-precoce_fe%CC%81vrier%202023.pdf
653,COVID-19 guideline: Management of the long-term effects of COVID-19 (SIGN CPG 161),
654,COVID-19 rapid guideline: delivery of systemic anticancer treatments (NG161),https://www.ncbi.nlm.nih.gov/books/NBK566889/bin/niceng161guid_bm1.pdf
655,COVID-19 rapid guideline: haematopoietic stem cell transplantation (NG164),
656,COVID-19 rapid guideline: managing COVID-19 (NG191),https://sostelemedicina.ucv.ve/documentos/manuales/Directriz%20rapida%20COVID-19_manejo%20de%20COVID-19.pdf
657,COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NG188),https://www.ncbi.nlm.nih.gov/books/NBK608070/bin/niceng188methods-chapter-2-pdf-479082189212.pdf
658,COVID-19 rapid guideline: vaccine-induced immune thrombocytopenia and thrombosis (VITT) (NG200),https://b-s-h.org.uk/media/20075/guidance-version-22-20210903.pdf
659,COVID-19 rapid guideline: vitamin D (NG187),https://www.fairfieldhome.co.uk/wp-content/uploads/2021/01/COVID-19-rapid-guideline-vitamin-D.pdf
660,Cowden syndroom (2.0),https://medlineplus.gov/download/genetics/condition/cowden-syndrome.pdf
661,CPOE in the Outpatient Oncology Setting,https://pdfs.semanticscholar.org/1d80/f0b9f5477f6023c5ec41b037061cbc4e73f8.pdf
662,Cribado prenatal del Sindrome de Down (Informe nº: Osteba D-07-04),https://observatoriosaludmujeres.sanidad.gob.es/saludSexualReproductiva/saludReproductiva/buenasPracticas/BBPP2015/docs/BBPP_PARTO_Cantabria_2.pdf
663,Cribado prenatal para la detección del síndrome de Down mediante el análisis de ADN fetal en sangre materna (Informe nº: Osteba E-16-05),
664,Crio-ablación en la fibrilación auricular con catéter Arctic-Front (Informe nº: Osteba E-14-14),https://www.euskadi.eus/contenidos/informacion/2014_osteba_publicacion/es_def/adjuntos/crioabla_fibriauri.pdf
665,Crisis Intervention for Adults Using a Trauma-Informed Approach: Initial Four Weeks of Management Third Edition,
666,Critères d'éligibilité des patients à un hébergement à proximité d'un établissement de santé,https://sante.gouv.fr/IMG/pdf/rapport_parlement_hotels_hospitaliers.pdf
667,Criteria for appropriate use of FDG-PET in breast cancer,https://assr.regione.emilia-romagna.it/pubblicazioni/dossier/doss207/@@download/publicationFile/doss207.pdf
668,Criteria for appropriate use of FDG-PET in esophageal cancer,https://assr.regione.emilia-romagna.it/pubblicazioni/dossier/doss209/@@download/publicationFile/doss209.pdf
669,Critical Illness. Evidence-Based Nutrition Practice Guideline,https://www.andeal.org/vault/pqnew109.pdf
670,Crohn’s disease: management (NG129),
671,Cryopreservatie van ovariumweefsel. National evidence-based guideline,https://www.ntvg.nl/system/files/publications/2008124520001a.pdf
672,Cryopreservatie van zaadcellen bij oncologiepatiënten. Regional consensus-based guideline (IKR),
673,CSPEN中国成人脓毒症患者营养治疗指南,https://www.nhsa.gov.cn/attach/Ypsn2025/YPSW202500285/YPSW202500285(ppt).pdf
674,Current Care Guidelines - Programme Information,https://studentebookhub.com/wp-content/uploads/2024/preview/9781264277681.pdf
675,Cutaneous melanoma (SIGN CPG 146),https://www.sign.ac.uk/media/1082/sign146.pdf
676,Cystic fibrosis: diagnosis and management (NG78),https://www.telemedecine-360.com/wp-content/uploads/2019/03/2017-NICE-Cystic-fibrosis-diagnosis-and-management.pdf
677,Cystinose. S3-LL (GPN),https://register.awmf.org/assets/guidelines/166-006l_S3_Cystinose_2025-06.pdf
678,"Cystite aiguë simple, à risque de complication ou récidivante, de la femme",https://www.revuebiologiemedicale.fr/images/Infos_bio/339_INFOBIO_HAS_CYSTITE_AIGUE.pdf
679,Cystite chez la femme (Guide de pratique clinique),https://ebpnet.be/sites/default/files/2023-11/WOREL%20GPC%20Cystite%20chez%20la%20femme%20FR%20-%20decembre%202016.pdf
680,Cystitis bij de vrouw (Richtlijn),https://www.huisartsnu.be/sites/default/files/images/stories/huisartsnuarchief/H30_4_2_cystitis_lezersreactie.pdf
681,Dangerosité psychiatrique: étude et évaluation des facteurs de risque de violence hétéro-agressive chez les personnes ayant des troubles schizophréniques ou des troubles de l'humeur. Audition publique,
682,De overgang (M73),https://link.springer.com/content/pdf/10.1007/978-90-313-6614-9_40.pdf
683,Decision making and mental capacity (NG108),http://dickyricky.com/Medicine/Guidelines/NICE/NG108%20Decision-making%20and%20mental%20capacity.pdf
684,Decubitus (M70),https://link.springer.com/content/pdf/10.1007/978-90-313-6614-9_54.pdf
685,Déficit en mévalonate kinase (MKD),https://scispace.com/pdf/mevalonate-kinase-deficiency-current-perspectives-mq91kckmfm.pdf
686,Defining Breakthrough Invasive Fungal infection-Position Paper of the Mycoses Study Group Education and Research Consortium and the European Confederation of Medical Mycology,
687,Définition des critères de réalisation des interventions de chirurgie bariatrique chez les moins de 18 ans,https://www.sfpediatrie.com/sites/www.sfpediatrie.com/files/medias/documents/criteres_eligibilite_chir_bariatrique.pdf
688,"Definition, Pathophysiologie, Diagnostik und Therapie der intestinalen Motilitätsstörung. S3-LL (DGVS)",
689,"Definition, Pathophysiologie, Diagnostik und Therapie des Fibromyalgiesyndroms. S3-LL (Deutsche Schmerzgesellschaft)",https://fibromyalgie-graz.com/wp-content/uploads/2015/09/04.-Leitlinien-Fibromyalgie-Langfassung.pdf
690,"Definition, Pathophysiologie, Diagnostik und Therapie des Reizdarmsyndroms. S3-LL (DGVS)",
691,Definitive and Adjuvant Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline,
692,Deformitäten der Brust bei Frauen und Männern. S2k-LL (DGGG),https://derma.de/fileadmin/derma/1_derma.de_WebRoot/DDG/Arbeitskreise/AK_Andrologie/AK_Andrologie_Aktivitaeten_2025_derma_de_F.pdf
693,Dégénérescence maculaire liée à l'âge: prise en charge diagnostique et thérapeutique. Recommandation pour la pratique clinique,https://couf.fr/wp-content/uploads/2024/11/Chapitre-15_2021.pdf
694,Dehydratie en vochttoediening. National consensus-based guideline,https://palliaweb.nl/getmedia/82a2be23-870e-470a-a2c7-286b5bea5e9f/16095-Dehydratie-en-vochttoediening-20251217100353.pdf
695,Délétion 22q11,https://www.orpha.net/pdfs/data/patho/Pub/fr/Deletion22q11-FRfrPub126v01.pdf
696,"Deletion- und Duplikationssyndrom 22q11.2 im Kindes-, Jugend- und Erwachsenenalter. S3-LL (DGKJP)",https://www.dgspj.de/wp-content/uploads/qualitaetssicherung-leitlinien-liste-03-2025.pdf
697,Delier (M77),https://ruger-docs.s3.amazonaws.com/_manuals/m77MarkII.pdf
698,Delier. National consensus-based guideline,https://bmjopen.bmj.com/content/bmjopen/7/3/e013809.full.pdf
699,"Delir im höheren Lebensalter - Eine transsektoral umsetzbare, interdisziplinär-interprofessionelle Leitlinie zu Delir-Prävention, -Diagnostik und –Therapie beim alten Menschen",
700,Delirium (english version),https://www.uhcw.nhs.uk/download/clientfiles/files/Patient%20Information%20Leaflets/Medicine/Care%20of%20the%20Elderly/Delirium.pdf
701,"Délirium chez les personnes âgées à l’urgence : prévention, évaluation et prise en charge",https://aiiuq.qc.ca/wp-content/uploads/2020/11/NOVEMBRE-RevueAIIUQ-d%C3%A9lirium.pdf
702,"Delirium, Dementia, and Depression in Older Adults: Assessment and Care",https://rnao.ca/sites/rnao-ca/files/Delirium_dementia_and_depression_in_older_adults_LTC_case_study_and_discussion_guide.pdf
703,"Delirium: prevention, diagnosis and management (CG103)",http://medi-guide.meditool.cn/ymtpdf/42BA655E-6D44-EEE5-BA3F-A10A35936886.pdf
704,Délivrance de l'information à la personne sur son état de santé. Recommandation pour la pratique clinique,https://www.has-sante.fr/upload/docs/application/pdf/2012-06/recommandations_-_delivrance_de_linformation_a_la_personne_sur_son_etat_de_sante.pdf
705,Démarche d’assurance qualité des pratiques professionnelles en matière de dépistage combiné de la trisomie 21,https://static.cnsf.asso.fr/wp-content/uploads/2017/11/cnsf_Recommandations-HAS-trisomie-21-mai-2016.pdf
706,"Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onset (NG16)",
707,"Dementia: assessment, management and support for people living with dementia and their carers (NG97)",
708,Dementia: which non-pharmacological interventions ?,https://aspe.hhs.gov/sites/default/files/private/pdf/103546/Mtg7-Handout2.pdf
709,Dementie (M21),https://link.springer.com/content/pdf/10.1007/978-90-313-6614-9_27.pdf
710,Dementie. National consensus-based guideline,http://www.24hmb.com/voimages/web_image/upload/file/20140615/28811402828802749.pdf
711,"Demenzen - Living Guideline. S3-LL (DGPPN, DGN)",https://www.dgppn.de/_Resources/Persistent/eaaf635dfd245f9f18f194574f66f560f075a3e1/S3-Leitlinie_Demenzen_Leitlinienreport_2025-02-28_1741687370810.pdf
712,Dental checks: intervals between oral health reviews (CG19),
713,Dental interventions to prevent caries in children (SIGN CPG 138),https://www.scottishdental.nhs.scot/wp-content/uploads/2014/04/SIGN138.pdf
714,Dentale digitale Volumentomographie. S2k-LL (DGZMK),https://register.awmf.org/assets/guidelines/083-005l_S2k_Dentale-digitale-Volumentomographie-DVT_2023-02_1.pdf
715,"Dentale Implantate bei Patienten mit Immundefizienz. S3-LL (DG Paro, DGZMK)",
716,Dépistage du diabète de type 2 et évaluation du risque cardiovasculaire,https://www.revmed.ch/view/605615/4746606/RMS_22_1480.pdf
717,Dépistage du tabagisme et prévention des maladies liées au tabac,https://www.has-sante.fr/upload/docs/application/pdf/2016-06/referentiel_tabac.pdf
718,Dépistage et prévention du cancer colorectal. Recommandation en santé publique,https://www.mast-group.com/media/14129/depistage_et_prevention.pdf
719,Dépistage et prévention du cancer du col de l'utérus. Recommandation en santé publique,https://repere.re/wp-content/uploads/CANCER_DU_COL.pdf
720,Dépistage et prévention du cancer du sein,https://www.has-sante.fr/upload/docs/application/pdf/2015-04/refces_k_du_sein_vf.pdf
721,Depressie (M44),https://research.vu.nl/ws/files/130068995/E%20%20Krijnen-de%20Bruin%20-%20thesis.pdf
722,Depressie. National consensus-based guideline,https://ccsmh.ca/wp-content/uploads/2016/03/NatlGuideline_Depression.pdf
723,Depressio,https://www.nimh.nih.gov/sites/default/files/health/publications/depression/depression.pdf
724,"Dépression de l'adolescent: repérage, diagnostic et prise en charge initiale. Recommandation pour la pratique clinique",https://publications.msss.gouv.qc.ca/msss/fichiers/2021/21-914-18W.pdf
725,Depression in adolescents and young adults,https://publications.aap.org/pediatrics/article-pdf/138/6/e20161878/914312/peds_20161878.pdf
726,Depression in adults with a chronic physical health problem: recognition and management (CG91),
727,Depression in adults: treatment and management (NG222),https://mot.southyorkshire.icb.nhs.uk/sheffield/files/Sheffield%20Guideline%20Depression%20in%20adults%20-%20treatment%20and%20management%20protocol.pdf
728,Depression in children and young people: identification and management (NG134),https://www.ncbi.nlm.nih.gov/books/NBK547251/bin/niceng134_pathway1.pdf
729,Der isolierte Ventrikelseptumdefekt. S2k-LL (DGPK),https://www.dgpk.org/wp-content/uploads/2019_11_27_VSDnachFulda20.9.2019.final_.li_.pdf
730,Dermatomycosen (M64),https://link.springer.com/content/pdf/10.1007/978-90-313-6614-9_56.pdf
731,Dermatomyosite de l’enfant et de l’adulte,https://www.sfdermato.org/upload/recommandations/pnds-dermatomyosite-de-lenfant-et-de-ladulte-9933eb945ad8f83b5c8887a317d5f453.pdf
732,Desarrollo de protocolos de búsqueda bibliográfica de la literatura adaptándolos a los diferentes productos de evaluación (Informe nº: Osteba E-08-03),https://www.euskadi.eus/contenidos/informacion/2008_osteba_publicacion/es_def/adjuntos/e_08_03_protocolos.pdf
733,Desarrollo del Conjunto de Datos Básicos de la Asistencia Ambulatoria Especializada (CDB-AAE) de Osakidetza. Experiencia piloto en tres hospitales (Informe nº: Osteba D11/05),https://www.euskadi.eus/contenidos/informacion/2011_osteba_publicacion/es_def/adjuntos/D-11-05%20Asistecia%20ambulatoria%20especializada.pdf
734,Desarrollo y evaluación de herramientas para la seguridad del paciente que puedan ser incorporadas en la gestión de procesos asistenciales (Informe nº: Osteba D-08-03),https://www.euskadi.eus/contenidos/informacion/2008_osteba_publicacion/es_def/adjuntos/D_08_03_herra_seguri.pdf
735,Desarrollo y pilotaje de un programa colaborativo multidisciplinar para la atención integral de pacientes diagnosticados de insuficiencia cardíaca (IC) PROMIC (Informe nº: Osteba D-14-01),
736,Descripción de la metodología de elaboración-adaptación-actualización empleada en la guía de práctica clínica sobre asma de la Comunidad Autónoma del País Vasco (Informe nº: Osteba D-05-03),https://www.euskadi.eus/informacion/metodos-y-formacion/web01-a3ikeost/es/adjuntos/d_05_03_adaptacion_guia_asma.pdf
737,Desfibrilador subcutáneo (Informe nº: Osteba E-14-15),https://www.euskadi.eus/contenidos/informacion/2014_osteba_publicacion/es_def/adjuntos/desfibri_subcut.pdf
738,Desigualdades sociales en la salud perinatal en la CAPV (Informe nº: Osteba D-07-05),https://www.izenpe.eus/contenidos/informacion/2007_osteba_publicacion/es_def/adjuntos/d_07-05_inform_Desisoc.pdf
739,Detecteren behoefte psychosociale zorg. National evidence-based guideline,https://www.venvn.nl/media/2ocnee0g/detecteren-behoefte-psychosociale-zorg.pdf
740,"Deutsch-Österreichische Leitlinien zur antiretroviralen Therapie der HIV-1-Infektion. S2k-LL (DAIG, INSTAND)",https://www.fast-trackcities.org/sites/default/files/Deutsch%20Osterreichische%20Leitlinien%20zur%20antiretroviralen%20Therapie%20der%20HIV%201%20Infektion%20(2017).pdf
741,Developing and Sustaining Effective Staffing and Workload Practices,https://rnao.ca/sites/rnao-ca/files/bpg/Staffing_and_Workload_Practices_2017.pdf
742,"Developing and Sustaining Interprofessional Health Care: Optimizing patients/clients, organizational, and system outcomes",https://rnao.ca/sites/rnao-ca/files/DevelopingAndSustainingBPG.pdf
743,Developing and Sustaining Nursing Leadership,https://rnao.ca/sites/rnao-ca/files/LEADERSHIP_16.5_x_8.5_WEB_0.pdf
744,Developing and updating local formularies (MPG1),https://www.ukmi.nhs.uk/noncms/conferencedb2019/documents/presentations/posters/Preece%20D%20Medicines%20Advisory%20Service%20Formulary%20%20UKMI%20PDS%202019.pdf
745,Development of international guidelines by Tuina practitioners for specific acupoints of paediatrics Tuina (2022 version),
746,Developmental follow-up of children and young people born preterm (NG72),https://www.infantjournal.co.uk/pdf/inf_080_pme.pdf
747,Diabeetikon jalkaongelmat,https://www.duodecimlehti.fi/xmedia/duo/duo17036.pdf
748,Diabeettinen retinopatia,https://diabetesjournals.org/care/article-pdf/27/10/2540/562075/zdc01004002540.pdf
749,DIABETE ET GROSSESSE : DE LA PRECONCEPTION AU POSTNATAL,https://www.revmed.ch/view/412788/3611990/RMS_653_1143.pdf
750,Diabeteksen munuaistauti,https://www.kaypahoito.fi/xmedia/khp/khp00070.pdf
751,Diabetes & Psyche. S3-LL (DDG),https://www.diabetes-psychologie.de/downloads/German_guideline_psychosocial_issues_and_diabetes.pdf
752,Diabetes (type 1 and type 2) in children and young people: diagnosis and management (NG18),https://www.ncbi.nlm.nih.gov/books/NBK592512/pdf/Bookshelf_NBK592512.pdf
753,Diabetes in der Schwangerschaft. S2e-LL (DDG),https://register.awmf.org/assets/guidelines/057-023m_S2e_Diabetes_und_Schwangerschaft_2022-01.pdf
754,Diabetes in pregnancy: management from preconception to the postnatal period (NG3),https://cdn.asp.events/CLIENT_CloserSt_D86EA381_5056_B739_5482D50A1A831DDD/sites/DPC2020/media/libraries/presentation/Pregnancy-in-Primary-Care---diabetes-risk-factors-&-assessment.pdf
755,Diabetes Mellitus (DM) Type 1 and 2. Evidence-based Nutrition Practice Guideline,https://www.andeal.org/vault/2440/editor/File/Franz_et_al_2008.pdf
756,Diabetes mellitus in pregnancy,https://www.e-dmj.org/upload/pdf/dmj-2021-0335.pdf
757,Diabetes mellitus type 2 (M01),https://richtlijnen.nhg.org/files/2020-01/zoekstrategie_dm2_versie_2018.pdf
758,"Diabetes und Parodontitis. S2k (DGZMK, DG Paro, DDG)",https://epaper.zwp-online.info/epaper/sim/prj/2025/prj0225/Neue-Leitlinie_18.pdf
759,Diabetes und Straßenverkehr. S2e-LL (DDG),https://www.ddg.info/fileadmin/user_upload/05_Behandlung/01_Leitlinien/Evidenzbasierte_Leitlinien/2025/250522_Leitlinie_Strassenverkehr.pdf
760,Diabetes. Schäden an der Netzhaut: Vorbeugen und behandeln. PatientenLeitlinie zur Nationalen VersorgungsLeitlinie,https://www.ddg.info/fileadmin/user_upload/05_Behandlung/01_Leitlinien/dm-netzhautkomplikationen-2aufl-vers2-pll.pdf
761,Diabetic foot problems: prevention and management (NG19),https://wileymicrositebuilder.com/practicaldiabetes/wp-content/uploads/sites/29/2016/04/New-NICE-guidelines-on-diabetic-foot-disease-prevention-and-management.pdf
762,"Diabetic foot ulcers: Prevention, assessment and management",https://sobest.com.br/wp-content/uploads/2025/05/Diabetic-foot-ulcers.pdf
763,Diabetic retinopathy: management and monitoring (NG242),https://www.ncbi.nlm.nih.gov/books/NBK607258/bin/niceng242er9-appf-et1.pdf
764,Diagnose der Mukoviszidose. S2k-LL (GPP),https://register.awmf.org/assets/guidelines/026-023m_S2k_Diagnose_der_Mukoviszidose_2023-11.pdf
765,Diagnose und nicht interventionelle Therapie neuropathischer Schmerzen. S2k-LL (DGN),https://register.awmf.org/assets/guidelines/030-114l_S2k_Diagnose-nicht-interventionelle-Therapie-neuropathischer-Schmerzen_2023-07-abgelaufen.pdf
766,Diagnose und Therapie der Bienen- und Wespengiftallergie. S2k-LL (DGAKI),https://register.awmf.org/assets/guidelines/061-020m_S2k_Diagnose-Therapie-Bienengiftallergie-Wespengiftallergie_2024-08.pdf
767,"Diagnose und Therapie der Multiplen Sklerose, Neuromyelitis Optica Spektrum und MOG-IgG-assoziierte Erkrankungen - Living Guideline. S2k-LL (DGN, DGGG)",https://dnvp9c1uo2095.cloudfront.net/cms-content/030050_living_Guideline_MS_V7.1_240105_1704444034393.pdf
768,Diagnose und Therapie des Guillain-Barré Syndroms im Kindes- und Jugendalter (ICD-10: G61.0). S3-LL (GNP),https://register.awmf.org/assets/guidelines/022-008p_S3_Guillain-Barre_Syndrom_2019-03_01.pdf
769,Diagnose und Therapie neuropathischer Schmerzen. S2k-LL (DGN),https://www.dgn.org/wp-content/uploads/2013/01/030114_LL_Neuropathische_Schmerzen_2019.pdf
770,Diagnose und Therapie von Glomerulonephritiden. S3-LL (DGfN),https://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-S3-Leitlinien/053-048_Versorgung%20von%20Patienten%20mit%20nicht-dialysepflichtiger%20Niereninsuffizienz%20in%20der%20Hausarztpraxis/oeffentlich-2024/2024-11-25_01vsf22011_ckdup_anlage_1_langversion.pdf
771,Diagnose von Thrombozytenfunktionsstörungen - Thrombozytopathien . S2k-LL (GTH),https://gth-online.org/wp-content/uploads/2020/08/086-003l_S2k_Diagnostik_Thrombozytenfunktionsstoerungen_Thrombozytopathien_2018-09.pdf
772,Diagnosestellung und medikamentöse Therapie der Psoriasis Arthritis. S3-LL (DGRh),https://register.awmf.org/assets/guidelines/013-001l_S3_Therapie-Psoriasis-vulgaris_2025-08.pdf
773,Diagnosing and managing disseminated histoplamsosis among people living with HIV,https://www.sahivsoc.org/Files/9789275122495_eng.pdf
774,Diagnosis and Management of Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians,https://www.acponline.org/sites/default/files/acp-policy-library/guidelines/diagnosis_and_management_of_acute_left-sided_colonic_diverticulitis_2022.pdf
775,Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline,https://unige.iris.cineca.it/bitstream/11567/950265/1/20Ullmann%20AJ%20et%20al.pdf
776,Diagnosis and Management of Asthma in Adults,https://medstaff.chsbuffalo.org/wp-content/uploads/2017/08/Review-Diagnosis-and-Management-of-Asthma-in-Adults.pdf
777,Diagnosis and Management of Asthma in Children,https://www.aimhitn.org/s/Diagnosis-and-Management-of-Asthma-in-Children.pdf
778,Diagnosis and Management of Autism Spectrum Disorder,https://e-century.us/files/ijcem/14/9/ijcem0124999.pdf
779,Diagnosis and Management of Chronic Myeloproliferative Disorder,https://alliedhealth.lsuhsc.edu/ClinicalLaboratory/PowerPoint%20for%20CLPC/Fall%202016/Foley%20mpdisclassrev16rev4%20CLPC%20B&W.pdf
780,Diagnosis and management of colorectal cancer (SIGN CPG 126),https://www.sign.ac.uk/media/1064/sign126.pdf
781,Diagnosis and management of epilepsy in adults (SIGN CPG 143),https://www.sign.ac.uk/media/1079/sign143_2018.pdf
782,Diagnosis and Management of Generalized Anxiety Disorder in Adults,https://www.accp.com/docs/bookstore/acsap/a17b2_sample.pdf
783,Diagnosis and management of gonorrhoea and syphilis,https://kce.fgov.be/sites/default/files/2023-10/KCE_371S_Diagnosis_and_Management_Gonorrhoea_Syphilis_Supplement.pdf
784,Diagnosis and management of gonorrhoea and syphilis,https://kce.fgov.be/sites/default/files/2023-10/KCE_371S_Diagnosis_and_Management_Gonorrhoea_Syphilis_Supplement.pdf
785,Diagnosis and management of psoriasis and psoriatic arthritis in adults (SIGN CPG 121),https://www.sign.ac.uk/assets/qrg121.pdf
786,Diagnosis and Management of Sepsis,https://www.aafp.org/pubs/afp/issues/2020/0401/p409.pdf
787,Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline,
788,Diagnosis and Management of the Common Cold in Adults and Children,https://www.cdc.gov/common-cold/media/pdfs/2024/04/CommonCold_fact_sheet_508.pdf
789,Diagnosis and treatment of varicose veins in the legs,https://kce.fgov.be/sites/default/files/2021-11/kce_164c_varicose_veins.pdf
790,Diagnosis of Acute Gout: A Clinical Practice Guideline From the American College of Physicians,https://www.ser.es/wp-content/uploads/2018/06/Diagnosis-of-acute-Gout.pdf
791,Diagnosis of Obstructive Sleep Apnea in Adults: A Clinical Practice Guideline From the American College of Physicians,https://www.acponline.org/sites/default/files/acp-policy-library/guidelines/diagnose_obstructive_sleep_apnea_2014.pdf
792,"Diagnosis, Management & Prevention of Infective Endocarditis","https://mymahtas2.moh.gov.my/files/Prevention,%20Diagnosis%20&%20Management%20of%20Infective%20Endocarditis.pdf"
793,"Diagnosis, treatment, follow-up and referral of infections with Chlamydia trachomatis (CT) in primary care",https://professionals.wrha.mb.ca/old/extranet/publichealth/files/services/healthy-sexuality/8.1Chlamydiaguideline.pdf
794,Diagnostic et traitement de la sclérose en plaque de l'enfant,https://afpa.org/content/uploads/2017/10/pnds_-_sclerose_en_plaques_de_lenfant.pdf
795,Diagnóstico de la Diabetes Mellitus Gestacional: evaluación de los nuevos criterios IADPSG (Informe nº: Osteba E-14-21),https://www.euskadi.eus/contenidos/informacion/2014_osteba_publicacion/es_def/adjuntos/E-14-21.pdf
796,Diagnóstico preimplantacional de portadores de cromosoma X frágil y otros trastornos hereditarios en técnicas de fecundación artificial  (Informe nº: Osteba D-05-01),https://www.euskadi.eus/contenidos/informacion/2005_osteba_publicacion/es_def/adjuntos/2005/d_05-01_diagnostico_genetico_preimplantacional.pdf
797,Diagnóstico y consumo de fármacos para la enfermedad de Alzheimer en el País Vasco (Informe nº: Osteba EKU I12-03),https://www.euskadi.eus/contenidos/informacion/2012_osteba_publicacion/es_def/adjuntos/eku_12_03_farm_alzhei.pdf
798,"Diagnostik auf Vorliegen eines primären Immundefekts - Abklärung von Infektionsanfälligkeit, Immundysregulation und weiteren Symptomen von primären Immundefekten. S2k-LL (API)",
799,Diagnostik bei Verdacht auf eine Betalaktamantibiotika-Überempfindlichkeit. S2k-LL (DGAKI),https://www.fennerlabor.de/wp-content/uploads/2023/11/Betalaktam.pdf
800,Diagnostik der Idiopathischen Lungenfibrose. S2k-LL (DGP),https://www.bayerisches-aerzteblatt.de/fileadmin/aerzteblatt/ausgaben/2017/10/einzelpdf/BAB_10_2017_480_485.pdf
801,Diagnostik des Wachstumshormonmangels im Kindes- und Jugendalter. S2e-LL (DGKED),https://core.ac.uk/download/pdf/187228572.pdf
802,Diagnostik und antientzündliche Therapie der Uveitis bei juveniler idiopathischer Arthritis. S2k-LL (DOG),https://register.awmf.org/assets/guidelines/045-012m_S2k_Diagnostik-antientzuendliche-Therapie-Uveitis-juveniler-idiopathischer-Arthritis_2021-06-verlaengert.pdf
803,"Diagnostik und Begutachtung asbestbedingter Berufskrankheiten. S2k-LL (DGAUM, DGP)",https://www.thieme-connect.com/products/ejournals/pdf/10.1055/s-0031-1292047.pdf
804,Diagnostik und Begutachtung der Berufskrankheit Nr. 4101 Quarzstaublungenerkrankung (Silikose) der Berufskrankheitenverordnung . S2k-LL (DGP),https://www.dguv.de/medien/ipa/publikationen/ipa-journale/ipa-journale2025/dokumente/ipa_j_03-25_am-aktuell.pdf
805,Diagnostik und Behandlung bei der Lese- und/oder Rechtschreibstörung. S3-LL (DGKJP),https://www.bvl-legasthenie.de/images/static/pdfs/Leitlinien/LF_Leitlinie.pdf
806,Diagnostik und Behandlung der Rechenstörung. S3-LL (DGKJP),https://www.dgspj.de/wp-content/uploads/qualitaetssicherung-leitlinien-liste-03-2025.pdf
807,Diagnostik und Behandlung des Bruxismus. S3-LL (DGZMK),https://tandedoc.de/pdf/tandedoc-einblick-in-wissenschaftliche-leitlinien_kiefergymnastik.pdf
808,Diagnostik und Behandlung von akuten Folgen psychischer Traumatisierung. S2k-LL (DeGPT),https://www.zep-hh.de/files/zep/pdf/S2-Leitlinie%20Diagnostik%20und%20BEhandlung%20von%20akuten%20Folgen%20psychischer%20Traumatisierung.pdf
809,Diagnostik und Behandlung von Zwangsstörungen im Kindes- und Jugendalter. S3-LL (DGKJP),https://register.awmf.org/assets/guidelines/028-007l_S3_Zwangsstoerungen_Kindes-_und_Jugendalter_2021-06.pdf
810,Diagnostik und Intervention bei Bindungsstörungen im Kindes- und Jugendalter (reaktive Bindungsstörung und soziale Bindungsstörung mit Enthemmung). S2k-LL (DGKJP),
811,Diagnostik und Management der Fetalen Anämie. S2e-LL (DEGUM),https://www.thieme-connect.com/products/ejournals/pdf/10.1055/a-2535-0528.pdf
812,"Diagnostik und Management des oralen Lichen planus. S2k-LL (DGZMK, DDG)",
813,"Diagnostik und Management von Vorläuferläsionen des oralen Plattenepithelkarzinoms in der Zahn-, Mund- und Kieferheilkunde",
814,"Diagnostik und Management von Vorläuferläsionen des oralen Plattenepithelkarzinoms in der Zahn-, Mund- und Kieferheilkunde. S2k-LL (DGMKG)",
815,"Diagnostik und Therapie bei Fieber ohne Fokus während der Granulozytopenie (Kinderonkologie).2k-LL (DGPI, GPOH, DGKJ)",https://www.gpoh.de/sites/gpoh/content/e6/e14/e207/e276178/048-014l_S2k_Diagnostik-Therapie-Fieber-ohne-Fokus_-Granulozytopenie-Kinderonkologie_2024-03_ger.pdf
816,Diagnostik und Therapie Bipolarer Störungen.S3-LL (DGPPN),https://link.springer.com/content/pdf/10.1007/978-3-662-61153-1.pdf
817,Diagnostik und Therapie der Adoleszentenkyphose (Morbus Scheuermann) bei Kindern und Jugendlichen. S2k (DWG),https://register.awmf.org/assets/guidelines/151-003l_S2k_Diagnostik-Therapie-Adoleszentenkyphose-Morbus-Scheuermann-Kinder-Jugendliche_2025-01.pdf
818,"Diagnostik und Therapie der akuten Querschnittlähmung. S3-LL (DGN, DMGP)",https://register.awmf.org/assets/guidelines/030-070l_S3_Diagnostik-Therapie-akuten-Querschnittlaehmung_2025-04.pdf
819,Diagnostik und Therapie der Alopecia areataS3-LL (DDG),https://link.springer.com/content/pdf/10.1007/s44368-025-00013-8.pdf
820,Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden (AAV). S3-LL (DGRh),https://www.dgrh.de/fileadmin/user_upload/06_finden/presse/pressemitteilungen/pdf/2024/Pressemitteilung_14_2024.pdf
821,Diagnostik und Therapie der Ehlers-Danlos-Syndrome. S2k-LL (,https://ehlers-danlos-organisation.de/images/edsorg/informaterial/vortrage/BA%20Vanessa%20Wawroschek.pdf
822,Diagnostik und Therapie der Endometriose. S2k-LL (DGGG),https://www.euroendocert.de/de/wp-content/uploads/2016/07/015-045l_S2k_Diagnostik_Therapie_Endometriose_2013-10.pdf
823,Diagnostik und Therapie der epidermalen Nekrolyse (Stevens-Johnson-Syndrom und toxisch epidermale Nekrolyse) SJS-TEN. S3-LL (DDG),
824,"Diagnostik und Therapie der Essstörungen. S3-LL (DGPM, DKPM)",https://higherlogicdownload.s3.amazonaws.com/AEDWEB/27a3b69a-8aae-45b2-a04c-2a078d02145d/UploadedImages/Resources/German_ED_diagnosis_and_treatment.pdf
825,Diagnostik und Therapie der Exogen-allergischen Alveolitis (EAA). S2k-LL (DGP),https://register.awmf.org/assets/guidelines/020-036l_S2k_Diagnostik-Therapie-der-exogen-allergischen-Alveolitis-EAA_2024-07.pdf
826,Diagnostik und Therapie der Gicht. S3-LL (DGRh),https://www.akdae.de/fileadmin/user_upload/akdae/Arzneimitteltherapie/AVP/Artikel/2025-01/005.pdf
827,Diagnostik und Therapie der hepatorenalen Tyrosinämie (Tyrosinämie Typ 1). S3-LL (DGKJ),https://register.awmf.org/assets/guidelines/027-003l_S2k_Diagnostik-Therapie-der-hepatorenalen-Tyrosinaemie_-Typ-1__2022-12.pdf
828,Diagnostik und Therapie der Ichthyosen. S2k-LL (DDG),https://register.awmf.org/assets/guidelines/013-043l_S1_Ichtyosen_2017-05-abgelaufen.pdf
829,Diagnostik und Therapie der Interstitiellen Cystitis (IC/BPS). S2k-LL (DGU),https://register.awmf.org/assets/guidelines/043-050k_S2k_Diagnostik-Therapie-Interstitielle-Zystitis-IC-BPS_2026-01.pdf
830,Diagnostik und Therapie der Kohlenmonoxidvergiftung. S2k-LL (DIVI),https://www.deutschesgesundheitsportal.de/wp-content/uploads/pdfs/neue-s2k-leitlinie-diagnostik-und-therapie-der-kohlenmonoxidvergiftung-ist-online.pdf
831,Diagnostik und Therapie der Lymphödeme. S2k-LL (GDL),https://register.awmf.org/assets/guidelines/058-001m_S2k_Diagnostik_und_Therapie_der_Lymphoedeme_2019-07-abgelaufen.pdf
832,Diagnostik und Therapie der neurogenen Blasenentleerungsstörungen bei Patienten mit Meningomyelocele. S2k-LL (DGU),https://register.awmf.org/assets/guidelines/043-047l_S2k_neurogene_Blasenfunktionsst%C3%B6rungen_spinale_Dysraphie_2019-08-abgelaufen.pdf
833,Diagnostik und Therapie der neurogenen Blasenfunktionsstörungen bei Kindern und Jugendlichen mit spinaler Dysraphie. S2k-LL (DGU),https://register.awmf.org/assets/guidelines/043-047l_S2k_neurogene_Blasenfunktionsst%C3%B6rungen_spinale_Dysraphie_2019-08-abgelaufen.pdf
834,"Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus. S3-LL (Leitlinienprogramm Onkologie von AWMF, DKG und DKH)",https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Oesophaguskarzinom/Version_3/LL_%C3%96sophaguskarzinom_Kurzversion_3.1.pdf
835,Diagnostik und Therapie der sekundären Eisenüberladung bei Patienten mit angeborenen Anämien. S2k-LL (GPOH),https://register.awmf.org/assets/guidelines/025-029l_S2k_Diagnostik-Therapie-der-sekundaeren-Eisenueberladung-bei-Patienten-mit-angeborenen-Anaemien_2022-03_1.pdf
836,Diagnostik und Therapie der Skabies. S3-LL (DDG),https://www.paediatrische-dermatologie.de/uploads/pdf/LL/013-052k_S1_Skabies-Diagnostik-Therapie_2016-12_01.pdf
837,"Diagnostik und Therapie der Spondylodiszitis. S2k-LL (DWG, DGOOC)",https://register.awmf.org/assets/guidelines/151-001m_S2k_Diagnostik-Therapie-Spondylodiszitis_2025-09-abgelaufen.pdf
838,Diagnostik und Therapie der unilateralen spastischen Zerebralparese / LL-uCP. S3-LL (DGSPJ),https://www.dgspj.de/wp-content/uploads/qualitaetssicherung-leitlinien-liste-03-2025.pdf
839,Diagnostik und Therapie der Varikose. S3-LL (DGP),https://register.awmf.org/assets/guidelines/037-018l_S2k_Varikose_Diagnostik-Therapie_2019-07-abgelaufen.pdf
840,Diagnostik und Therapie der Venenthrombose und der Lungenembolie. S2-LL (DGA),https://www.gefaesschirurgieberlin.de/wp-content/uploads/2018/01/Phlebothrombose-AWMF-Leitlinie-.pdf
841,Diagnostik und Therapie der zirkumskripten Sklerodermie. S2k-LL (DDG),https://derma.de/fileadmin/derma/1_derma.de_WebRoot/Aerzte/Leitlinien/013-066l_S2k_zirkumskripte_Sklerodermie_2014-07_01.pdf
842,Diagnostik und Therapie des Adulten Still-Syndroms. S2e-LL (DGRh),https://www.dgrh.de/fileadmin/user_upload/06_finden/presse/pressemitteilungen/pdf/2025/Pressemitteilung__03_2025.pdf
843,"Diagnostik und Therapie des akuten, idiopathischen sensorineuralen Hörverlustes (Hörsturz). S2k-LL (DGHNO-KHC)",
844,Diagnostik und Therapie des Benignen Prostatasyndroms (BPS). S2e-LL (DGU),https://register.awmf.org/assets/guidelines/043-034l_S2e_Diagnostik_Therapie_benignes_Prostatasyndrom_2023-04.pdf
845,Diagnostik und Therapie des chronischen Pruritus. S2k-LL (DDG),https://derma.de/fileadmin/derma/1_derma.de_WebRoot/Aerzte/Leitlinien/013-048l_S2k_Chronischer_Pruritus_2017-01.pdf
846,"Diagnostik und Therapie des Hepatozellulären Karzinoms und biliärer Karzinome - Living Guideline. S3-LL (Leitlinienprogramm Onkologie der AWMF, DKG und DKH)",https://register.awmf.org/assets/guidelines/032-053OLk_S3_Diagnostik-Therapie-Hepatozellulaeres-Karzinom-biliaere-Karzinome_2025-06.pdf
847,"Diagnostik und Therapie des Karpaltunnelsyndroms. S3-LL (DGH, DGNC)",https://register.awmf.org/assets/guidelines/005-003l_S3_Diagnostik-Therapie-Karpaltunnelsyndrom-KTS_2022-04_01.pdf
848,"Diagnostik und Therapie des Kubitaltunnelsyndroms. S3-LL (DGH, DGNC, DGN, DGOOC)",https://www.dgpraec.de/wp-content/uploads/2022/01/005-009l_S3_Kubitaltunnelsyndrom-Diagnostik-Therapie_2018-02.pdf
849,Diagnostik und Therapie des kutanen Lupus erythematodes. S2k-LL (DDG),https://derma.de/fileadmin/derma/1_derma.de_WebRoot/Aerzte/Leitlinien/013-060l_S2k_Kutaner_Lupus_erythematodes_2020-06.pdf
850,Diagnostik und Therapie des Morbus Crohn. S3-LL (DGVS),https://www.pathologie-dueren.de/media/11476/s3_morbus_crohn_diagnostik_therapie_2014.pdf
851,Diagnostik und Therapie des Pemphigus vulgaris / foliaceus und des bullösen Pemphigoids. S2k-LL (DDG),https://derma.de/fileadmin/derma/1_derma.de_WebRoot/Aerzte/Leitlinien/013-071l_S2k_Pemphigus_vulgaris_und_bulloeser_Pempghigoid_2014-12-verlaengert.pdf
852,Diagnostik und Therapie des polyzystischen Ovarsyndroms (PCOS). S2k-LL (DGE),https://register.awmf.org/assets/guidelines/089-004k_S2k_Diagnostik-Therapie-polyzystisches-Ovarsyndrom-PCOS_2025-08.pdf
853,Diagnostik und Therapie des Schleimhautpemphigoids. S2k-LL (DDG),https://freidok.uni-freiburg.de/files/231459/YqIMTZWxxx6kexmK/J+Deutsche+Derma+Gesell+-+2022+-+Hofmann+-+S2k-Leitlinie+zur+Diagnostik+und+Therapie+des+Schleimhautpemphigoids.pdf
854,"Diagnostik und Therapie des Schnarchens des Erwachsenen. S3-LL (DGHNO, DGMKG, DGZSM)",https://register.awmf.org/assets/guidelines/017-068k_S3_Diagnostik_Therapie_Schnarchen_Erwachsene_2019-8-abgelaufen.pdf
855,Diagnostik und Therapie des Ulcus cruris venosum. S2k-LL (DGP),https://register.awmf.org/assets/guidelines/037-009l_S2k_Diagnostik-Therapie-Ulcus-cruris-venosum__2024-01_1.pdf
856,Diagnostik und Therapie des Zoster und der Postzosterneuralgie. S2k-LL (DDG),https://register.awmf.org/assets/guidelines/013-023l_S2k_Diagnostik-Therapie-Zoster-Postzosterneuralgie_2020-09-abgelaufen.pdf
857,Diagnostik und Therapie klinisch hormoninaktiver Hypophysentumoren. S2k-LL (DGE),https://www.endokrinologie.net/files/download/089-002l_S2k_Diagnostik-Therapie-hormonaktiver-Hypophsenadenome_2020-02.pdf
858,Diagnostik und Therapie myasthener Syndrome. S2k-LL (DGN),https://register.awmf.org/assets/guidelines/030-087l_S2k_Diagnostik-Therapie-myasthener-Syndrome_2025-01.pdf
859,Diagnostik und Therapie osteoporotischer thorakolumbaler Wirbelfrakturen. S2k-LL (DGOU),https://register.awmf.org/assets/guidelines/187-063l_S2k_Diagnostik-Therapie-osteoporotischer-thorakolumbaler-Wirbelfrakturen_2025-08.pdf
860,"Diagnostik und Therapie peripherer Nerventumoren. S2e-LL (DGNC, DGPRÄC, DGH)",https://register.awmf.org/assets/guidelines/008-024l_S2k_Diagnostik-Therapie-peripherer-Nerventumoren_2022-12.pdf
861,Diagnostik und Therapie von Aufmerksamkeitsstörungen bei neurologischen Erkrankungen im Erwachsenenalter. S2e-LL (DGN),https://www.thieme-connect.de/products/ebooks/pdf/10.1055/b-0034-37876.pdf
862,Diagnostik und Therapie von benignen Erkrankungen der Gebärmutter. S3-LL (DGGG),https://hologiced.com/wp-content/uploads/2018/08/guidelines-dggg.pdf
863,Diagnostik und Therapie von erwachsenen Patienten mit Husten. S3-LL (DGP),https://www.lunge-allergie.de/images/downloads/DGP-Leitlinie%20Diagnostik%20und%20Therapie%20von%20erwachsenen%20Patienten%20mit%20akutem%20und%20chronischen%20Husten.pdf
864,Diagnostik und Therapie von Frauen mit wiederholten Spontanaborten. S2k-LL (DGGG),https://www.thieme-connect.com/products/ejournals/pdf/10.1055/a-1895-9940.pdf
865,Diagnostik und Therapie von Gallensteinen. S3-LL (DGVS),https://scispace.com/pdf/s3-guidelines-for-diagnosis-and-treatment-of-gallstones-dg081ql73x.pdf
866,Diagnostik und Therapie von Harnstoffzyklusstörungen. S3-LL (DGKJ),https://register.awmf.org/assets/guidelines/027-006m_S3_Diagnostik-Therapie-Harnstoffzyklusstoerungen_2018-06-abgelaufen.pdf
867,Diagnostik und Therapie von Hyperlipidämien bei Kindern und Jugendlichen. S3-LL (DGKJ),https://www.aerzteblatt.de/pdf/121/14/a936.pdf
868,"Diagnostik und Therapie von Long COVID im Kinders- und Jugendalter. S2k-LL (DGKJ, DGPI)",https://www.dgspj.de/wp-content/uploads/qualitaetssicherung-leitlinien-liste-03-2025.pdf
869,Diagnostik und Therapie von Neglect und andere Störungen der Raumkognition. S2k-LL (DGN),https://register.awmf.org/assets/guidelines/030-126l_S2k_Diagnostik-Therapie-Neglect-andere-Stoerungen-der-Raumkognition_2023-03.pdf
870,Diagnostik und Therapie von Patienten mit Kraniosynostosen. S2k-LL (DGMKG),https://register.awmf.org/assets/guidelines/007-108m_Diagnostik-Therapie-Patienten-mit-Kraniosynostosen_2023-10.pdf
871,"Diagnostik und Therapie von Speicheldrüsentumoren des Kopfes. S3-LL (Leitlinienprogramm Onkologie von AWMF, DKH und DKG)",https://register.awmf.org/assets/guidelines/007-102OLl_S3_Diagnostik-Therapie-Speicheldruesentumoren-des-Kopfes_2025-08.pdf
872,Diagnostik und Therapie von Spontanpneumothorax und postinterventionellem Pneumothorax. S3-LL (DGT),https://register.awmf.org/assets/guidelines/010_Thoraxchirurgie/010-007es_S3_Spontanpneumothorax-postinterventioneller-Pneumothorax-Diagnostik-Therapie_2018-03-abgelaufen.pdf
873,Diagnostik und Therapie von Spontanpneumthorax und postinterventionellem Pneumothorax. S3-LL (DGT),https://register.awmf.org/assets/guidelines/010_Thoraxchirurgie/010-007es_S3_Spontanpneumothorax-postinterventioneller-Pneumothorax-Diagnostik-Therapie_2018-03-abgelaufen.pdf
874,Diagnostik und Therapie von Störungen der Stimmfunktion. S2k-LL (DGP),https://register.awmf.org/assets/guidelines/049-008m_S2k_Diagnostik-Therapie-Stoerungen-der-Stimmfunktion-Dysphonien_2023-01.pdf
875,Diagnostik und Therapie vor einer assistierten reproduktionsmedizinischen Behandlung (ART). S2k-LL (DGGG),
876,"Diagnostik und Therapieoptionen von Aphthen und aphtoiden Läsionen der Mund- und Rachenschleimhaut. S2k-LL (DGMKG, DGZMK)",
877,Diagnostik von Sprachentwicklungsstörungen (SES) unter Berücksichtigung umschriebener Sprachentwicklungsstörungen (USES). S3-LL (DGPP),https://api.pageplace.de/preview/DT0400.9783653021462_A31441596/preview-9783653021462_A31441596.pdf
878,"Diagnostik, idealer Behandlungszeitpunkt und Management verlagerter und retinierter Eckzähne. (DGZMK, DGKFO)",https://register.awmf.org/assets/guidelines/083-050p1_S2k_KFO_Diagnostik_2025-11.pdf
879,"Diagnostik, idealer Behandlungszeitpunkt und Management verlagerter und retinierter Eckzähne. S2k-LL (DGZMK)",https://www.quintessence-publishing.com/downloads/cmf_2023_03_s2k_guideline.pdf
880,"Diagnostik, Prävention und Therapie der Tuberkulose im Kindes- und Jugendalter. S2k-LL (DGPI)",
881,"Diagnostik, Therapie und Management der Glutarazidurie Typ 1 (Synonym: Glutaryl-CoA-Dehydrogenase-Defizienz). S3-LL (DGKJ)",https://register.awmf.org/assets/guidelines/027-018l_S3_Diagnostik-Therapie-Management-der-Glutarazidurie-Typ-1_2022-05.pdf
882,"Diagnostik, Therapie und Management von Methylmalonazidämien und Propionazidämie. S3-LL (DGKJ)",https://register.awmf.org/assets/guidelines/027-067l_S3_Diagnostik-Therapie-Management-Methylmalonazidaemien-Propionazidaemien_2025-04.pdf
883,"Diagnostik, Therapie und Metaphylaxe der Urolithiasis. S2k-LL (DGU)",https://www.deutschesgesundheitsportal.de/wp-content/uploads/pdfs/dgu-aktualisiert-s2k-leitlinie-diagnostik-therapie-und-metaphylaxe-der-urolithiasis.pdf
884,"Diagnostik, Therapie und Nachsorge der akuten Extremitätenischämie. S3-LL (DGG)",https://register.awmf.org/assets/guidelines/065-003l_S3_Diagnostik-Therapie-Nachsorge-periphere-arterielle-Verschlusskrankheit_2024-11_2.pdf
885,"Diagnostik, Therapie und Nachsorge der extracraniellen Carotisstenose. S3-LL (DGG)",https://register.awmf.org/assets/guidelines/004-028l_extracranielle-Carotisstenose-Diagnostik-Therapie-Nachsorge_2025-02-abgelaufen.pdf
886,"Diagnostik, Therapie und Nachsorge der Keimzelltumoren des Hodens. S3-LL (Leitlinienprogramm Onkologie von AWMF, DKG und DKH)",
887,"Diagnostik, Therapie und Nachsorge der Patientin mit Vulvakarzinom und seiner Vorstufen. S3-LL (Leitlinienprogramm Onkologie von AWMF, DKG und DKH)",https://derma.de/fileadmin/derma/1_derma.de_WebRoot/Aerzte/Leitlinien/015-059k_S2k_Vulvakarzinom_und_Vorstufen_Diagnostik_Therapie_2016-11.pdf
888,"Diagnostik, Therapie und Nachsorge der Patientin mit Zervixkarzinom. S3-LL (Leitlinienprogramm Onkologie von AWMF, DKG und DKH)",https://register.awmf.org/assets/guidelines/032-033OLl_S3_Diagnostik_Therapie_Nachsorge_Zervixkarzinom_2022-03.pdf
889,"Diagnostik, Therapie und Nachsorge der thrombotisch thrombozytopenischen Purpura (TTP). S3-LL (GTH)",https://register.awmf.org/assets/guidelines/086-007l_S3_Diagnostik-Therapie-Nachsorge-der-thrombotisch-thrombozytopenischen-Purpura-TTP_2025-10.pdf
890,"Diagnostik, Therapie und Nachsorge des Hodgkin Lymphoms bei erwachsenen Patienten. S3-LL (Leitlinienprogramm Onkologie von AWMF, DKG und DKH)",https://register.awmf.org/assets/guidelines/018-029OLl_S3_Hodgkin-Lymphom_Erwachsene_Diagnostik_Therapie_Nachsorge_2022-10.pdf
891,"Diagnostik, Therapie und Nachsorge des Larynxkarzinoms. S3-LL (Leitlinienprogramm Onkologie von AWMF, DKG und DKH)",
892,"Diagnostik, Therapie und Nachsorge des Melanoms. S3-LL (LeitlinienprogrammsOnkologie der AWMF, DKG und DKH)",
893,"Diagnostik, Therapie und Nachsorge des Nierenzellkarzinoms. S3-LL  (Leitlinienprogramm Onkologie von AWMF, DKG und DKH)",https://register.awmf.org/assets/guidelines/043-017OLl_S3_Diagnostik-Therapie-Nachsorge-Nierenzellkarzinom_2024-10.pdf
894,"Diagnostik, Therapie und Nachsorge des Oro- und Hypopharynxkarzinoms. S3-LL (Leitlinienprogramm Onkologie der AWMF, DKG und DKH)",
895,"Diagnostik, Therapie und Nachsorge des Peniskarzinoms. S3-LL (Leitlinienprogramm Onkologie der AWMF, DKG und DKH)",https://register.awmf.org/assets/guidelines/043-042OLl_S3_Peniskarzinom_2025-09-abgelaufen.pdf
896,"Diagnostik, Therapie und Nachsorge des Vaginalkarzinoms. S2k-LL (DGGG, DKG)",https://register.awmf.org/assets/guidelines/032_D_Krebsgesellschaft/032-042d_S2k_Vaginalkarzinom-Vorstufen-Diagnostik-Therapie-Nachsorge_2019-03.pdf
897,"Diagnostik, Therapie und Nachsorge für erwachsene Patient*innen mit einem diffusen großzelligen B-Zell-Lymphom und verwandten Entitäten. S3-LL ( Leitlinienprogramm Onkologie der AWMF, DKG und DKH)",https://register.awmf.org/assets/guidelines/018-038OLl_Diagnostik-Therapie-Nachsorge-erwachsene-PatientIinnen-diffusen-grosszelligen-B-Zell-Lymphom-verwandten-Entitaeten-DLBC-2022-10.pdf
898,"Diagnostik, Therapie und Nachsorge für Patienten mit einem follikulären Lymphom. S3-LL (Leitlinienprogramm Onkologie der AWMF, DKG und DKH)",https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Follikulaeres_Lymphom/LL_Foll_Lymphom_Langversion_1.0.pdf
899,"Diagnostik, Therapie und Nachsorge für Patienten mit einer chronisch lymphatischen Leukämie. S3-LL  (Leitlinienprogramm Onkologie von AWMF, DKG und DKH)",https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/CLL/Version_2/LL_CLL_Kurzversion_2.0.pdf
900,"Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren. S3-LL (Leitlinienprogramm Onkologie von AWMF, DKG und DKH)",https://www.ago-online.de/fileadmin/ago-online/downloads/_leitlinien/kommission_ovar/Diakit_S3_Ovar_OL.pdf
901,"Diagnostik, Therapie und Nachsorge von low-grade muzinösen Neoplasien der Appendix (LAMN). S2k-LL (DGAV)",https://register.awmf.org/assets/guidelines/088-012k_S2k_Diagnostik_Therapie_Nachsorge_low-grade_muzinoese_Neoplasien_Appendix_2025-02.pdf
902,"Diagnostik, Therapie und Rehabilitation von Patientinnen und Patienten mit schwerer Beeinträchtigung der Persönlichkeitsfunktionen. S3-LL (DGPT)",https://register.awmf.org/assets/guidelines/134-001k_S3_Diagnostik-Therapie-Rehabilitation-PatientInnen-schwere-Beeintraechtigung-Persoenlichkeitsfunktionen-LL-SBPF_2025-02.pdf
903,"Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Alter. S2k-LL (DDG)",https://pdfs.semanticscholar.org/7092/d00bed3ad74d5ec743ded3c965bf4106aff9.pdf
904,"Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter. S3-LL (DDG)",https://scispace.com/pdf/diagnostik-therapie-und-verlaufskontrolle-des-diabetes-2aou31vy45.pdf
905,"Diagnostik, Therapie und Versorgung der durch Phenylalaninhydroxylasemangel bedingte Hyperphenylalaninämie/Phenylketonurie. S3-LL (DGKJ)",
906,Diarree. National consensus-based guideline,http://www.pemdatabase.org/2001_An_evidence_and_consensus_based_guideline_for_acute_diarrhoea.pdf
907,Diarrhoea and vomiting caused by gastroenteritis in under 5s: diagnosis and management (CG84),
908,"Die Behandlung periimplantärer Infektionen an Zahnimplantaten. S3-LL (DGZMK, DGI)",http://gesundes-implantat.de/cms/wp-content/uploads/2016/09/S3-Leitlinie_Beh-periimpl-Infekti-Zahnimpl_2016-09-06.pdf
909,"Die Behandlung von Parodontitis - Stadium IV. S3-LL (DGZMK, DGParo, DGI, DGKFO, DGPro)",https://www.kzvnr.de/fileadmin/user_upload/PDF/Zahnaerzteseite/Parodontitis_PAR/Prof._Jepsen_zur_Parodontitis_aus_RZB_06_2021.pdf
910,"Die Behandlung von Parodontitis Stadium I bis III - Die deutsche Implementierung der S3-Leitlinie „Treatment of Stage I–III Periodontitis“ der European Federation of Periodontology (EFP). S3-LL (DGParo, DGZMK)",https://labor-koblenz.de/wp-content/uploads/2024/11/083-043l_S3_Behandlung-von-Parodontitis-Stadium-I-III_2021-02_2.pdf
911,Die Fetale und Neonatale Allo-immune Thrombozytopenie (FNAIT): Diagnostik und Management. S2e-LL (DEGUM),
912,Die kongenitale Choanalatresie - Diagnostik und Management. S2k-LL (DGHNOKCH),
913,Die Sectio caesarea. S3-LL (DGGG),https://www.dggg.de/fileadmin/data/Presse/Pressemitteilungen/2024/FAQ_Sectio/FAQ_zur_Sectio_final.pdf
914,Die überaktive Blase (ÜAB). S2k-LL (DGGG),https://www.kup.at/kup/pdf/7955.pdf
915,Die vaginale Geburt am Termin. S3-LL (DGGG),https://www.dggg.de/fileadmin/data/Presse/Pressemitteilungen/2021/Erste_S3-Leitlinie_zur_vaginalen_Geburt_am_Termin_veroeffentlicht/Gemeinsame_PM_S3_LL_Vaginale_Geburt_am_Termin.pdf
916,Diepe veneuze trombose en longembolie (M86),https://www.ntvg.nl/icmje/A8657/geertjan-geersing.pdf
917,Diepe veneuze trombose en longembolie. National consensus-based guideline,https://sfera.unife.it/bitstream/11392/2410176/1/vWINter%20Supplement%20main%20document.pdf
918,Dietary and Pharmacologic Management to Prevent Recurrent Nephrolithiasis in Adults: A Clinical Practice Guideline From the American College of Physicians,https://www.acponline.org/sites/default/files/acp-policy-library/guidelines/dietary_pharmacologic_management_nephrolithiasis_2014.pdf
919,Differentialdiagnose der hereditären und erworbenen Neuropathien im Kindes- und Jugendalter. S2k-LL (GNP),https://register.awmf.org/assets/guidelines/022-027k_S2k_Differentialdiagnose-erworbene-hereditaere-Neuropathie-Kinder-Jugendliche_2021-07_1.pdf
920,"Dilatation der oberen Harnwege: Diagnostik, Management und Therapie bei Nierenbeckendilatation / Ureteropelviner Stenose. S3-LL (DGU)",
921,"Direkte Kompositrestaurationen an bleibenden Zähnen im Front- und Seitenzahnbereich. S3-LL (DGZMK, DGZ)",https://www.zahnaerzte-in-sachsen.de/fileadmin/Publikationen/LZKS/IZZ/DOKUMENTE/ZBS/2025/ZBS_06-2025_Fruehjahrstagung.pdf
922,"Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and education (NG213)",
923,Disclosure of Interests and Management of Conflicts of Interest in Clinical Guidelines and Guidance Statements: Methods From the Clinical Guidelines Committee of the American College of Physicians,https://www.acponline.org/sites/default/files/acp-policy-library/guidelines/disclosure_of_interests_and_management_of_conflict_of_interest_2019.pdf
924,"Diseño de un protocolo de interacción entre atención primaria y hospital, para mejorar la detección precoz y el seguimiento de los pacientes con esclerosis multiple (Informe nº: Osteba D-13-09)",https://www.euskadi.eus/contenidos/informacion/2013_osteba_publicacion/es_def/adjuntos/D_13_09%20esclerosis%20multiple.pdf
925,Diseño y plan de implementación de la telemedicina en áreas clínicas específicas: telemonitorización y teledermatología. Evaluación de puesta en marcha y costes (Informe nº: Osteba E-10-03),https://www.euskadi.eus/contenidos/informacion/2010_osteba_publicacion/es_def/adjuntos/e_10_03_dis_plan.pdf
926,Diseño y Validación de una herramienta de cribado para la Evaluación de Impacto en Salud de las políticas autonómicas (Informe nº: Osteba D-16-01),https://www.sanidad.gob.es/areas/promocionPrevencion/promoSaludEquidad/equidadYDesigualdad/docs/Herramienta_Cribado.pdf
927,Disorders of Lipid Metabolism (DLM). Evidence-Based Nutrition Practice Guideline,https://www.andeal.org/vault/pq97.pdf
928,Distale Femurfrakturen S2e-LL (DGOU),https://register.awmf.org/assets/guidelines/187-041l_S2e_Distale-Femurfrakturen_2025-02.pdf
929,Distale Femurfrakturen. S2e-LL (DGOU),https://register.awmf.org/assets/guidelines/187-041l_S2e_Distale-Femurfrakturen_2025-02.pdf
930,Distale Humerusfrakturen. S2e-LL (DGOU),https://ota.org/sites/files/2018-08/U05-Distal%20Humerus%20Fractures.pdf
931,Distale Radiusfraktur. S2e-LL (DGOU),https://register.awmf.org/assets/guidelines/187_Orthop%C3%A4die_und_Unfallchirurgie/187-019le_S2e_Distal-radius-fracture-of-the-adult__2022-10.pdf
932,Diverticular disease: diagnosis and management (NG147),https://www.ncbi.nlm.nih.gov/books/NBK558081/bin/bm1.pdf
933,Diverticulitis (M99),https://www.handouts.ca/pdfs/Diverticulitiscombined.pdf
934,DKG Guidelines can be found by following the link Open Publication link below,https://www.dkgnj.org/uploads/2/2/3/1/22313516/guidelines_for_chapter_leaders_9-25-2019.pdf
935,Domestic violence and abuse: multi-agency working (PH50),
936,Donación en asistolia controlada y no controlada con perfusión regional normotérmica o hipotérmica basada en oxigenación de membrana extracorpórea para trasplantes renales y hepáticos (Informe nº: Osteba E-19-02),https://docs.bvsalud.org/biblioref/2024/11/1579149/osteba_donacion-en-asistolia.pdf
937,Donation of residual biological samples and consent given for secondary use (Best Practice 15(9)),https://www.dla.mil/Portals/104/Documents/J7Acquisition/DLAD.pdf
938,Donor milk banks: service operation (CG93),https://www.childrenshealthireland.ie/documents/3185/Breastfeeding-_Guideline_for_the_Provision_of_Pasteurised_Donor_Breast_Milk_Nov_25.pdf
939,Dossier de liaison d’urgence (DLU),https://pepite-depot.univ-lille.fr/LIBRE/Th_Medecine/2023/2023ULILM173.pdf
940,Drug allergy: diagnosis and management (CG183),https://www.ncbi.nlm.nih.gov/books/NBK563974/bin/nicecg134guid_qs1.pdf
941,Drug misuse in over 16s: opioid detoxification (CG52),https://atca.com.au/wp-content/uploads/2021/12/drug-misuse-management-in-over-16s-drug-misuse-management-in-over-16s-overview.pdf
942,Drug misuse in over 16s: psychosocial interventions (CG51),
943,Drug misuse prevention: targeted interventions (NG64),https://www.drugsandalcohol.ie/28749/1/NICE-drug-misuse-prevention.pdf
944,Duizeligheid (M75),
945,Dyslipidemiat,https://biomedres.us/pdfs/BJSTR.MS.ID.006869.pdf
946,Duration of Oxaliplatin-containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline,
947,Dysplasie fibreuse des os. Guide ALD,https://www.has-sante.fr/upload/docs/application/pdf/2022-07/pnds_dysplasie_fibreuse2022_vdef_has.pdf
948,Durchführung des Epikutantests mit Kontakt-Allergenen. S3-LL (DDG),http://dkg.ivdk.org/dok/Pub_315_deutsch.pdf
949,Dyspnoe en hoesten. National consensus-based guideline,https://www.researchgate.net/profile/Niels_Chavannes/publication/46687076_NHG_standaard_COPD/links/02e7e51f790b2d6b0e000000/NHG-standaard-COPD.pdf
950,Durchführung und Dokumentation des intraoperativen neurophysiologischen Monitorings (IONM). S3-LL (DGNC),
951,Dyspnoea (english version),https://indiachest.org/wp-content/uploads/2016/07/Dyspnea_dipesh_2010.pdf
952,Dwarslaesie. National consensus-based guideline,https://www.vkgl.nl/images/links/Richtlijnen_en_protocollen/Dutch_national_consensus-based_guideline_for_the_disclosure_of_incidental_findings_during_clinical_genetic_diagnostic_testing_version2.pdf
953,EAES Rapid Guideline: Complete mesocolic excision for right-sided colon cancer,
954,"Dysgnathiechirurgie. S3-LL (DGMKG, DGZMK)",https://register.awmf.org/assets/guidelines/007_D_Ges_f_Mund-_Kiefer-_und_Gesichtschirurgie/007-089eng_S3_Implant-treatment-for-oral-rehabilitation-in-connection-with-head-neck-radiation_2023-11.pdf
955,EAES Rapid Guideline: Management of complicated diverticulitis,
956,"EAES rapid guideline: Systematic review, meta-analysis, GRADE assessment and evidence-informed recommendations on the management of cholecystitis",
957,EAES rapid recommendation update 2025: TaTME for rectal cancer – with ESCP and ESGAR participation,https://eaes.eu/wp-content/uploads/2025/02/EAES-rapid-recommendation-update-protocol_-TaTME-for-rectal-cancer.pdf
958,"EAN consensus review on prevention, diagnosis and management of tick-borne encephalitis",http://www.diva-portal.org/smash/get/diva2:1947204/FULLTEXT01.pdf
959,EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic,
960,"EAN guideline on palliative care of people with severe, progressive multiple sclerosis",
961,"EAN guideline on palliative care of people with severe, progressive multiple sclerosis",
962,EAN guidelines on central neurostimulation therapy in chronic pain conditions,
963,EAN guidelines on central neurostimulation therapy in chronic pain conditions,
964,EAN-ESCMID guidelines on the diagnosis and management of encephalitis in adults caused by infection,https://www.encephalitis.info/wp-content/uploads/2023/11/Management-of-Viral-Encephalitis-in-Adults.pdf
965,EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke,https://publications.ersnet.org/content/erj/55/4/1901104/DC2/embed/inline-supplementary-material-2.pdf
966,EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke,https://publications.ersnet.org/content/erj/55/4/1901104/DC2/embed/inline-supplementary-material-2.pdf
967,Early and locally advanced breast cancer: diagnosis and management (NG101),https://www.ncbi.nlm.nih.gov/books/NBK601996/bin/niceng101er14-appd-et1.pdf
968,"Early childhood pacifier use in relation to breastfeeding, SIDS, infection and dental malocclusion (Best Practice 9(3))",
969,Early Detection for Colorectal Cancer: ASCO Resource-Stratified Guideline,
970,Early Management of Head Injury in Adults,https://aci.health.nsw.gov.au/__data/assets/pdf_file/0003/195150/NSW-Health-Initial-management-closed-head-injuries-full.pdf
971,Eating disorders (SIGN CPG 146),https://www.sign.ac.uk/media/1987/sign-164-eating-disorders-v2.pdf
972,Eating disorders: recognition and treatment (NG69),https://www.adolescenciasema.org/ficheros/articulosparaprofesionales/documentos/Neurologiaysaludmental/comportamiento%20alimentario/TCA%20guia%20NICE%20mayo%202017.pdf
973,"Ebstein Anomalie der Trikuspidalklappe im Kindes-, Jugend- und jungen Erwachsenenalter (EMAH-Patienten). S2k-LL (DGPK)",https://register.awmf.org/assets/guidelines/023-041l_S2k_Ebstein-Anomalie-der-Trikuspidalklappe_2022-01.pdf
974,Écoulement urétral : mesures diagnostiques et traitement pharmacologique,
975,Ectopic pregnancy and miscarriage: diagnosis and initial management (NG126),https://files.medelement.com/uploads/materials/ad9c4208257757f4057265baf7bf8d24.pdf
976,ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis,
977,ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis,
978,Eczeem (M37),https://huidhuis.nl/wp-content/uploads/2021/12/m37_NHG-Standaard-Eczeem.pdf
979,Educational interventions for mental health consumers receiving psychotropic medication  (Best Practice 10(4)),
980,Educational interventions to promote oral hypoglycaemic adherence in adults with Type 2 diabetes (Best Practice 15(11)),
981,Educational interventions to raise men’s awareness of bladder and bowel health (Best Practice 15(4)),
982,Efectividad clínica y coste-efectividad de la telemonitorización no-invasiva en pacientes con insuficiencia cardíaca (Informe nº: Osteba E-17-11),https://www.euskadi.eus/contenidos/informacion/2017_osteba_publicacion/es_def/adjuntos/E-17-11.pdf
983,Efectividad de la ventilación mecánica no invasiva para el tratamiento de la insuficiencia respiratoria en pacientes con esclerosis lateral amiotrófica (Informe nº: Osteba E-17-01),https://www.euskadi.eus/contenidos/informacion/2017_osteba_publicacion/es_def/adjuntos/E-17-01.pdf
984,"Efectividad, seguridad e indicaciones de la tecnología radiológica de supresión de hueso para la detección de cáncer de pulmón (Informe nº: Osteba E-18-06)",https://redets.sanidad.gob.es/documentos/Supresion_de_Hueso_Osteba.pdf
985,Effective communication between registered nurses and adult oncology patients in inpatient settings (Best Practice 15(1)),
986,Effective dietary interventions for overweight and obese children  (Best Practice 11(1)),https://espace.library.uq.edu.au/view/UQ:026a796/UQ026a796_OA.pdf
987,Effective Teaching Strategies and Methods for Cancer Patient Education,
988,Effective Use of Advanced Practice Nurses in the Delivery of Adult Cancer Services in Ontario,
989,Effectiveness and Safety of Influenza Vaccination During Pregnancy (Best Practice 18(13)),https://www.thelancet.com/pdfs/journals/eclinm/PIIS2589-5370(20)30266-2.pdf
990,Effectiveness of a pelvic floor muscle exercise program on urinary incontinence following childbirth (Best Practice 9(2)),https://pdfs.semanticscholar.org/8194/d587b5003d17d67ade388c9b03c635b15995.pdf
991,Effectiveness of Different Types of Care for the Peritoneal Dialysis Catheter Exit Site (Best Practice 18(9)),
992,Effectiveness of interventions for undernourished older inpatients in the hospital setting (Best Practice 11(2)),
993,Effectiveness of music listening in reducing depressive symptoms in adults (Best Practice 15(12)),
994,Effectiveness of non-pharmacological pain management in relieving chronic pain for children and adolescents (Best Practice 14(17)),
995,Effectiveness of Nurse Practitioners in residential aged care facilities (Best Practice 14(19)),
996,Effectiveness of parent-centred interventions for the prevention and treatment of childhood overweight and obesity in community settings (Best Practice 18(3)),
997,Efficience de la télémédicine: état des lieux de la littérature internationale et cadre d'évaluation. Évaluation médico-économique,https://www.has-sante.fr/upload/docs/application/pdf/2013-07/efficience_tlm_vf_2013-07-18_14-48-38_743.pdf
998,EFNS guideline on diagnosis and management of limb girdle muscular dystrophies,
999,EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force,https://www.polioplace.org/sites/default/files/files/pph22-4p6.pdf
1000,EFNS guideline on mild traumatic brain injury: report of an EFNS task force,
1001,EFNS guideline on neuroimaging in acute stroke. Report of an EFNS task force,
1002,EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force,
1003,EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force,https://www.medicaid.nv.gov/Downloads/provider/Anti-Migraine_Agents_Misc_2021-07.pdf
1004,EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults,
1005,EFNS guideline on the management of status epilepticus,
1006,EFNS guideline on the management of status epilepticus in adults,https://www.bucksformulary.nhs.uk/docs/Guideline_595FM.pdf
1007,EFNS guideline on the treatment of cerebral venous and sinus thrombosis,https://www.portailvasculaire.fr/sites/default/files/docs/saposnik-et-al-2024-diagnosis-and-management-of-cerebral-venous-thrombosis-a-scientific-statement-from-the-american.pdf
1008,EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients,https://www.portailvasculaire.fr/sites/default/files/docs/saposnik-et-al-2024-diagnosis-and-management-of-cerebral-venous-thrombosis-a-scientific-statement-from-the-american.pdf
1009,EFNS guideline on the treatment of tension-type headache – Report of an EFNS task force,https://mrimedical.net/wp-content/uploads/2018/08/3-EFNS-guideline-on-the-treatment-of-tension-type-headache-report-of-an-EFNS-task-force.-Eur-J-Neurol.-Bendtsen-L-Evers-S-Linde-M-2010.pdf
1010,EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses,
1011,"EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy",https://www.cmaj.ca/highwire/filestream/58918/field_highwire_adjunct_files/0/five-wernicke-1-at.pdf
1012,EFNS guidelines for the diagnosis and management of Alzheimer’s disease,http://www.24hmb.com/voimages/web_image/upload/file/20140615/28811402828802749.pdf
1013,"EFNS guidelines for the molecular diagnosis of neurogenetic disorders: motoneuron, peripheral nerve and muscle disorders",
1014,EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases,https://scispace.com/pdf/efns-guidelines-for-the-use-of-intravenous-immunoglobulin-in-mzluccxo0u.pdf
1015,EFNS guidelines on cognitive rehabilitation: report of an EFNS task force,
1016,EFNS Guidelines on cognitive rehabilitation: report of an EFNS Task Force,
1017,EFNS guidelines on diagnosis and management of neuromyelitis optica,https://www.ema.europa.eu/en/documents/presentation/presentation-neuromyelitis-optica-there-standard-care-eliezer-katz_en.pdf
1018,EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force,
1019,EFNS guidelines on diagnosis and treatment of primary dystonias,https://www.ern-rnd.eu/wp-content/uploads/2019/10/ERN-RND-Affirmed-Guideline-diagnosis-and-treatment-of-primary-dystonias_reference_final.pdf
1020,EFNS guidelines on disease-specific CSF investigations,
1021,EFNS guidelines on management of narcolepsy,https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0460_08-23-2011.pdf
1022,EFNS guidelines on management of neurological problems in liver transplantation,
1023,EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep,https://parkinsonizm.ru/wp-content/uploads/2022/10/EFNS_guideline_2006_restless_legs_syndrome_and_periodic_limb_movement_disorder_in_sleep.pdf
1024,EFNS guidelines on neuropathic pain assessment: revised 2009,https://www.orofacialpain.org.uk/downloads/Neuropathic%20pain/linked%20papers%20Ne%20Pain/Cruccu_et_al_2010_revised_EFNS_guidelines_on_NP_assessment[1].pdf
1025,EFNS guidelines on neurostimulation therapy for neuropathic pain,https://www.neuromodulation.com/assets/Members_only/fact_sheet_neuropathic_memb.pdf
1026,EFNS guidelines on pharmacological treatment of neuropathic pain,https://www.neuromuskularni-sekce.cz/res/file/archiv/Guidelines-Neuropathic-pain-EFNS-2006.pdf
1027,EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force,https://iris.unito.it/retrieve/handle/2318/2069710/1841746/Eur%20J%20Neurol%202024%20-%20Van%20Damme%20-%20European%20Academy%20of%20Neurology%20EAN%20guideline%20on%20the%20management%20of%20amyotrophic.pdf
1028,EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis,https://www.neuromuskularni-sekce.cz/res/file/aktuality/EFNS%20Guide-neuroboreliosis.pdf
1029,EFNS guidelines on the diagnosis and management of orthostatic hypotension,
1030,EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia,https://www.researchgate.net/profile/Corrado_Angelini/publication/337862085_EFNS_guidelines_on_the_diagnostic_approach_to_pauci-_or_asymptomatic_hyperCKemia/links/5e6ccb5e458515e5557a049b/EFNS-guidelines-on-the-diagnostic-approach-to-pauci-or-asymptomatic-hyperCKemia.pdf
1031,EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias,https://parkinsonizm.ru/wp-content/uploads/2022/10/EFNS_guideline_2010_molecular_diagnosis_of_ataxias_and_spastic_paraplegias.pdf
1032,"EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias",https://www.bcbsm.com/amslibs/content/dam/public/mpr/mprsearch/pdf/2037301.pdf
1033,EFNS guidelines on the molecular diagnosis of mitochondrial disorders,https://secure.highmark.com/ldap/medicalpolicy/wpa-highmark/attachment-references/L-197-002.pdf
1034,"EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington’s disease, Parkinson’s disease and dystonias",
1035,EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision,https://www.orofacialpain.org.uk/downloads/Neuropathic%20pain/linked%20papers%20Ne%20Pain/Cruccu_et_al_2010_revised_EFNS_guidelines_on_NP_assessment[1].pdf
1036,EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases,
1037,EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis,
1038,EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy,
1039,EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy,
1040,EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives,
1041,EFNS task force on molecular diagnosis of neurologic disorders Guidelines for the molecular diagnosis of inherited neurologic diseases First of two parts,https://parkinsonizm.ru/wp-content/uploads/2022/09/EFNS_guideline_2001_molecular_diagnosis_of_inherited_neurologic_diseases__part_1.pdf
1042,EFNS task force on molecular diagnosis of neurologic disorders Guidelines for the molecular diagnosis of inherited neurologic diseases Second of two parts,
1043,EFNS Task Force on postgraduate neurological training Survey of the current situation of postgraduate neurological training in Europe,https://ibn.idsi.md/sites/default/files/imag_file/1-5_2.pdf
1044,EFNS Task Force on Teaching of Neuroimaging in Neurology Curricula in Europe: present status and recommendations for the future,
1045,EFNS task force – therapy of nystagmus and oscillopsia,http://www.vertigocenter.ch/straumann/reprints/Straube2004.pdf
1046,EFNS task force: the use of neuroimaging in the diagnosis of dementia,https://nervuslimibas.lv/PDF/vadlinijas/4_EFNS%20task%20force%20the%20use%20of%20neuroimaging%20in%20the%20diagnosis%20of%20dementia_2012.pdf
1047,EFNS-ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system,
1048,EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia,http://www.24hmb.com/voimages/web_image/upload/file/20140615/28811402828802749.pdf
1049,EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease,
1050,EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood,
1051,EFNS/ENS Guidelines for the treatment of ocular myasthenia,https://file.medtrib.cn/pdf/f54deb4d-36f3-443f-a241-717d0d23c600/EFNS-ENS%20Guidelines%20for%20the%20treatment%20of%20ocular%20myasthenia.pdf
1052,EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease,https://www.movementdisorders.org/MDS-Files1/MDS-ES/MDS-ES--EFNS/BerardellietalEFNSMDSESene12022.pdf
1053,Ei-alkoholiperäinen rasvamaksatauti,https://www.kaypahoito.fi/xmedia/khp/khp00132.pdf
1054,Einsatz der intraaortalen Ballongegenpulsation in der Herzchirurgie (IABP). S3-LL (DGTHG),https://register.awmf.org/assets/guidelines/011-020m_S3_Einsatz-intraaortale-Ballongegenpulsation-Herzchirurgie-IABP_2024-09.pdf
1055,Einsatz und Behandlung von humaner Milch in Einrichtungen des Gesundheitswesens. S2k-LL (GNPI),https://register.awmf.org/assets/guidelines/024-026l_S2k_Einsatz-Behandlung-humane-Milch-Einrichtungen-Gesundheitswesen_2024-05.pdf
1056,"Einsatz von Exoskeletten im beruflichen Kontext zur Primär-, Sekundär-, und Tertiärprävention von arbeitsassoziierten Muskel-Skelett-Erkrankungen oder -Beschwerden. S2k-LL (DGAUM)",
1057,"Einsatz von Platelet rich Fibrin (PRF) in der dentalen Implantologie. S3-LL (DGZMK, DGI)",https://www.bundestag.de/resource/blob/1057696/WD-8-002-25-pdf.pdf
1058,Einsatz von Schulgesundheitsfachkräften an Schulen. S2k-LL (DGSPJ),https://www.dgspj.de/wp-content/uploads/service-pressemitteilungen-schulgesundheitsfachkraefte-kampagne-dgspj-2023.pdf
1059,"Einwilligung von Menschen mit Demenz in medizinische Maßnahmen. S2k-LL (DGGG, DGPPN, DGN)",https://register.awmf.org/assets/guidelines/108-001l_S2k_Einwilligung_von_Menschen_mit_Demenz_in_medizinische_Ma%C3%9Fnahmen_2024-11-abgelaufen.pdf
1060,Ektooppinen (kohdunulkoinen) raskaus,https://www.theseus.fi/bitstream/10024/171847/2/Rissanen_Eevi_ja_Smahl_Johanna.pdf
1061,Elaboración de Guías de Práctica Clínica en el Sistema Nacional de Salud. Actualización del Manual Metodológico,https://portal.guiasalud.es/wp-content/uploads/2019/01/manual_gpc_completo.pdf
1062,Ellenbogen Erstluxation. S2e-LL (DGU),
1063,Elvytys,https://www.duodecimlehti.fi/xmedia/duo/duo16664.pdf
1064,Elvytys (vastasyntynyt),https://www.kaypahoito.fi/xmedia/hoi/hoi50065f.pdf
1065,Embracing Cultural Diversity in Health Care: Developing Cultural Competence,https://rnao.ca/sites/rnao-ca/files/storage/related/2337_BPG_Embracing_Cultural_Diversity_summary.pdf
1066,Emergency and acute medical care in over 16s: service delivery and organisation (NG94),http://www.dickyricky.com/Medicine/Guidelines/NICE/NG094%20Emergency%20and%20acute%20medical%20care%20service%20delivery.pdf
1067,Empfehlungen für die strukturellen Voraussetzungen der perinatologischen Versorgung in Deutschland. S2k-LL (DGPM),https://register.awmf.org/assets/guidelines/087-001l_S2k_Empfehlungen-strukturelle-Voraussetzungen-perinatologische-Versorgung-Deutschland__2021-04_01.pdf
1068,"Empfehlungen zur Therapie von Patienten mit COVID-19 - Living Guideline. S3-LL (DGIIN, DIVI, DGP)",https://www.bar-frankfurt.de/fileadmin/dateiliste/113-001l_S3_Empfehlungen-zur-Therapie-von-Patienten-mit-COVID-19_2024-01.pdf
1069,Empfehlungen zur Verhinderung lagerungsbedingter Schäden in der operativen Gynäkologie. S2k-LL (DGGG),https://register.awmf.org/assets/guidelines/015-077l_S2k_Verhinderung_Lagerungssch%C3%A4den_Operationen_Gyn%C3%A4kologie_2021-01.pdf
1070,Enabling Aboriginal Health Workers and Non Aboriginal Health Professionals to work collaboratively in the delivery of Health Care to Aboriginal and Torres Strait Islander Australians (Best Practice 18(12)),https://www.mhcc.org.au/wp-content/uploads/2020/07/WwFNP_Resource_v5.pdf
1071,End of life care for adults: service delivery (NG142),https://www.ncbi.nlm.nih.gov/books/NBK558771/bin/bm1.pdf
1072,"End of life care for infants, children and young people with life-limiting conditions: planning and management (NG61)",
1073,Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline,https://www.nvmo.org/wp-content/uploads/2017/11/Rugo-ASCO-guideline-HT-MBC-JCO-2016.pdf
1074,"Endocrine Treatment and Targeted Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer Guideline and Rapid Update",https://www.hhs.texas.gov/sites/default/files/documents/jan-2026-durb-agenda-item03s.pdf
1075,"Endokrinologische Nachsorge nach onkologischen Erkrankungen im Kindes- und Jugendalter. S3-LL (GPOH, DGKED)",https://www.gpoh.de/kinderkrebsinfo/content/e1676/e1738/e1756/e214470/SIOPCNSGCTII_ger.pdf
1076,Endometriosis: diagnosis and management (NG73),https://www.ncbi.nlm.nih.gov/books/NBK604068/bin/niceng73er1-appa-et1.pdf
1077,Endometriumcarcinoom. National evidence-based guideline,https://richtlijnendatabase.nl/uploaded/docs/Oncologie/endometriumcarcinoom/Evidence_tabellen_Vraag6_Endometriumcarcinoom_.pdf
1078,"Endometriumkarzinom. S3-LL (Leitlinienprogramm Onkologie von AWMF, DKG und DKH)",https://register.awmf.org/assets/guidelines/032-034OLl_S3_Endometriumkarzinom_2024-07.pdf
1079,Endorsement of the European Association of Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial  gliomas,
1080,Engaging Clients Who Use Substances,https://rnao.ca/sites/rnao-ca/files/Engaging_Clients_Who_Use_Substances_13_WEB.pdf
1081,Enkelbandletsel (M04),https://richtlijnen.nhg.org/files/2021-10/Totstandkoming%20NHG-Standaard%20Enkelbandletsel.pdf
1082,Ennenaikainen synnytys,https://core.ac.uk/download/pdf/161415963.pdf
1083,"Enuresis und nicht-organische (funktionelle) Harninkontinenz bei Kindern und Jugendlichen. S2k-LL (DGKJP, DGKJ)",https://register.awmf.org/assets/guidelines/028-026l_S2k_Enuresis-und-nicht-organische-funktionelle-Harninkontinenz_2021-12.pdf
1084,Environmental healthcare design strategies and event related anxiety in pediatric patients (Best Practice 16(11)),
1085,Epävakaa persoonallisuus,https://www.kaypahoito.fi/xmedia/khp/khp00074.pdf
1086,epic4: Guidelines for the prevention of healthcare-associated infections,https://www.adcare.no/wp-content/uploads/2024/06/NHS-Guidelines-Preventing-Healthcare-Associated-Infections.pdf
1087,Epicondylitis (M60),https://link.springer.com/content/pdf/10.1007/978-90-313-8460-0_4.pdf
1088,Epicondylopathia radialis humeri. S2k-LL (DGOU),
1089,"Epidemiologie, Diagnostik und Therapie der erektilen Dysfunktion. S3-LL (DGU)",https://dnvp9c1uo2095.cloudfront.net/cms-content/030112_LL_Erektile_Dysfunktion_2018_archiviert_1708602756897.pdf
1090,"Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie. S3-LL (DGP)",https://register.awmf.org/assets/guidelines/020-013l_S3_Epidemiologie-Diagnostik-Therapie-erwachsener-Patienten-nosokomiale-Pneumonie__2024-03.pdf
1091,"Epidemiologie, Diagnostik, Therapie und Nachsorge des Blasenekstrophie-Epispadie Komplex (BEEK). S3-LL (DGU)",https://register.awmf.org/assets/guidelines/043-058m_S3_Epidemiologie-Diagnostik-Therapie-Nachsorge-Blasenekstrophie-Epispadie-Komplex-BEEK_2024-09.pdf
1092,"Epidemiologie, Diagnostik, Therapie, Prävention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei Erwachsenen (HWI). S3-LL (DGU)",https://register.awmf.org/assets/guidelines/043-044k_S3_Epidemiologie-Diagnostik-Therapie-Praevention-Management-Harnwegsinfektionen-Erwachsene-HWI_2024-09.pdf
1093,Épidermolyses bulleuses héréditaires,https://www.sfco-congres.org/articles/sfmbcb/pdf/2017/01/sfco-65-03037.pdf
1094,Epidurale Rückenmarkstimulation zur Therapie chronischer Schmerzen. S3-LL (DGNC),http://research.iscrr.com.au/__data/assets/pdf_file/0004/297796/implantable-pain-therapies-intrathecal-infusions.pdf
1095,Epilepsiat (aikuiset),https://www.kaypahoito.fi/xmedia/khp/khp00083.pdf
1096,Epilepsiat ja kuumekouristukset (lapset),https://www.kaypahoito.fi/xmedia/khp/khp00067.pdf
1097,Epilepsiechirurgie Kindes- und Jugendalter: prächirurgische Diagnostik und Therapie. S2k-LL (GNP),
1098,Epilepsien im Kindes- und Jugendalter: Therapie. S2k-LL (GNP),https://www.dgspj.de/wp-content/uploads/qualitaetssicherung-leitlinien-liste-03-2025.pdf
1099,Epilepsies in children and young people: Investigative procedures and management (SIGN CPG 159),https://www.sign.ac.uk/media/1843/sign-159-qrg.pdf
1100,"Epilepsies in children, young people and adults (NG217)",https://ep.bmj.com/content/early/2023/06/19/archdischild-2022-324427.full.pdf
1101,Epileptinen kohtaus (pitkittynyt),https://www.kaypahoito.fi/xmedia/hoi/hoi50030.pdf
1102,Epitheliaal ovariumcarcinoom. National evidence-based guideline,https://kiyatec.com/wp-content/uploads/2024/01/ovarian-patient.pdf
1103,Erarbeitung von Leitlinien für Diagnostik und Therapie. Methodische Empfehlungen (AWMF),https://www.awmf.org/fileadmin/user_upload/dateien/publikationen_zu_leitlinien/2004.pdf
1104,Erfelijk en familiair ovariumcarcinoom,https://www.huisartsengenetica.nl/sites/default/files/inline-files/BRCA1_2%20geassocieerd%20mamma_ovariumcarcinoom_0.pdf
1105,Erfelijke darmkanker. National evidence-based guideline,https://www.mdl.nl/sites/www.mdl.nl/files/richlijnen/Erfelijke_darmkanker_-_december_2015_def.pdf
1106,Erhöhter TSH-Wert in der Hausarztpraxis. S2k-LL (DEGAM),https://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-S2-Leitlinien/053-046_Erhoehter%20TSH-Wert%20in%20der%20Hausarztpraxis/oeffentlich/S2k%20LL%20TSH%20ver%C3%B6ffentlicht%202023/DEGAM_LL_TSH_2023_Kurz_RZ_010723.pdf
1107,"Ernährung und Ernährungsmedizin in der Onkologie. S3-LL (DGEM, DKG, DGHO)",https://www.dgho.de/arbeitskreise/a-g/ernaehrung-und-stoffwechsel/vorstellung-des-ak-bei-der-jahrestagung/stoffwechsel_hauptprogramm_basel.pdf
1108,Ernährungsempfehlung zur Behandlung des Diabetes mellitus - Empfehlungen zur Proteinzufuhr. S3-LL (DDG),https://www.ddg.info/fileadmin/user_upload/01_Die_DDG/03_Ausschuesse/02_Ernaehrung/2015-057-025l_S3_Diabetes_mellitus_Empfehlungen_Proteinzufuhr_2015-10.pdf
1109,ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia,http://www.bai-care.com/data/upload/file/201803/79dd58ed6ed2679f45b40794e7bd17b1.pdf
1110,"Ersatz fehlender Zähne mit Verbundbrücken. S3-LL (DGZMK, DGI)",https://www.dginet.de/wp-content/uploads/sites/4/2023/01/Leitlinie_Ersatz-fehlender-Zaehne-Verbundbruecken_2019-07_2024-06.pdf
1111,Erster epileptischer Anfall und Epilepsien im Erwachsenenalter. S2k-LL (DGN),https://register.awmf.org/assets/guidelines/030-041l_S2k_Erster-epileptischer-Anfall-Epilepsien-Erwachsenenalter_2023-09.pdf
1112,Ersttrimester Diagnostik und Therapie @ 11-13+6 Schwangerschaftswochen. S2e-LL (DEGUM),https://oegum.at/wp-content/uploads/2025/03/2024-085-002k_S2e_Ersttrimester-Diagnostik-Therapie-Kurzfassung-engl-Teil-2-UiM2024.pdf
1113,ESCMID Clinical Guidelines on the Evaluation and Management of a Reported Antibiotic Allergy,https://padovaid.com/ESCMID.pdf
1114,ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2,https://elibrary.escmid.org/download/16494380023598_ESCMID%20COVID-19%20guidelines_diagnostic%20testing.pdf
1115,ESCMID COVID-19 living guidelines: drug treatment and clinical management,https://dipot.ulb.ac.be/dspace/bitstream/2013/338844/5/lettercmi-rdv7.pdf
1116,ESCMID Generic Competencies in Antimicrobial Prescribing and Stewardship: Towards a European Consensus,
1117,ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients,
1118,ESCMID guideline for the diagnosis and management of Pneumocystis pneumonia,https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-oi/pneumocystis-pneumonia-adult-adolescent-oi.pdf
1119,ESCMID guideline for the diagnosis and treatment of biofilm infections 2014,https://microgendx.com/resources/biofilm-research/ESCMID-guideline-for-the-diagnosis-and-treatment-of-biofilm-infections.pdf
1120,ESCMID guideline on clinician-targeted interventions to optimise treatment for common acute infections in primary care,https://core.ac.uk/download/pdf/196601079.pdf
1121,ESCMID guideline: diagnosis and treatment of acute bacterial meningitis,https://microbius.ru/uploads/document/file/16/diagnosis-and-_.treatment-of-acute-bacterial-meningitis-_escmid_-2016_.pdf
1122,ESCMID Guidelines for management of infectious complications after chimeric antigen receptor T cell therapy and bispecific antibodies for haematological malignancies,https://www.bhs.be/files/Infections.pdf
1123,ESCMID guidelines for management of invasive group A streptococcal infections in adult and paediatric patients,https://www.espid.org/data/files/Guideline%20Sub-Committee/ESPID%20CfG%20Collection%20of%20GAS%20Guidelines%20Dec%202022.pdf
1124,"ESCMID guidelines for the diagnosis, clinical management and follow-up of patients with alveolar echinococcosis",https://publisherspanel.com/api/files/view/1155567.pdf
1125,ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug‐resistant Gram‐negative bacteria in hospitalized patients,
1126,ESCMID guidelines on dosing of antimicrobials in patients with renal impairment with or without RRT,
1127,ESCMID guidelines on infection Control Strategies and Interventions to prevent Ventilator-associated Pneumonia in adult patients,https://publications.ersnet.org/content/erj/50/3/1700582.full.pdf
1128,"ESCMID guidelines on nomenclature, diagnosis and treatment of acute and chronic Q fever",
1129,ESCMID guidelines on selection and duration of antibiotic treatment in infectious aortitis and vascular graft and endograft infections,
1130,ESCMID guidelines on testing for SARS-CoV-2 in asymptomatic individuals to prevent transmission in the health care setting,
1131,ESCMID Guidelines on Vaccination of Adult Solid-Organ Transplant Recipients,https://www.transplant.bc.ca/PublishingImages/transplant-patients/medication-vaccination/vaccination-after-your-transplant/Vaccinations%20for%20Solid%20Organ%20Transplant%20Recipients%20-%2010%2001%202025.pdf
1132,ESCMID rapid guidelines for assessment and management of long COVID,https://elibrary.escmid.org/download/16494379617682_ESCMID%20rapid%20guidelines%20for%20assessment%20and%20management%20of%20long%20COVID.pdf
1133,"ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the Safety of Targeted and Biological Therapies: An Infectious Diseases Perspective (Agents Targeting Lymphoid Cells Surface Antigens [I]: CD19, CD20 and CD52)",
1134,ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Cell surface receptors and associated signaling pathways),
1135,ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the Safety of Targeted and Biological Therapies: An Infectious Diseases Perspective (Intracellular Signaling Pathways: Tyrosine Kinase and mTOR Inhibitors),
1136,ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the Safety of Targeted and Biological Therapies: An Infectious Diseases Perspective (Introduction),
1137,ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the Safety of Targeted and Biological Therapies: An Infectious Diseases Perspective (Soluble Immune Effector Molecules [I]: Anti-Tumor Necrosis Factor-α Agents),
1138,ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children,
1139,ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers,
1140,ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery,https://www.hider.org.tr/kilavuzlar-pdf/uluslararasi/ESCMID%20MDR%20kolonize%20Hastalarda%20perioperatif%20profilaksi%20rehberi.pdf
1141,ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients,
1142,ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients.,
1143,"Establecimiento de estándares, registro y análisis de casos de tratamiento de la colitis ulcerosa mediante sistemas de aféresis (Informe nº: Osteba E-08-05)",https://www.sergas.es/Docs/Avalia-t/Osteba200605.pdf
1144,Estrategias para favorecer y potenciar la Enfermería basada en la evidencia en la Comunidad Autónoma del País Vasco (Informe nº: Osteba D-18-01),https://www.enfermeriacomunitaria.org/web/attachments/article/589/ENFERMERI%CC%81A%20BASADA%20EN%20LA%20EVIDENCIA.pdf
1145,Estrategias terapéuticas en la esquizofrenia refractaria o esquizofrenia resistente a tratamiento (Informe nº: Osteba D/12/04),
1146,Estrategias útiles para la promoción de estilos de vida saludables en Atención Primaria de Salud (Informe nº: Osteba D-08-07),https://www.osakidetza.euskadi.eus/contenidos/informacion/2008_osteba_publicacion/es_def/adjuntos/D_08_07_estilos_vida.pdf
1147,Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update,https://documents.cap.org/documents/erpgr_teaching_powerpoint.pdf
1148,Estudio de casos y controles: La eficacia de la Intervención en la sobrecarga experimentada por familiares de pacientes bipolares (Informe n° D-11-02),
1149,Estudio de costes del programa de detección precoz del cáncer de mama de la Comunidad Autónoma del País Vasco. Revisión sistemática de estudios de evaluación económica del cribado de cáncer de mama (Informe nº: Osteba D/12/03),
1150,Estudio de las prestaciones sanitarias urgentes y emergentes en la Comunidad Autónoma Vasca: Análisis y propuestas de mejora (Informe n°: Osteba D-09-05),https://www.euskadi.eus/contenidos/proyecto_ley/23_pley_xiileg/eu_def/adjuntos/Memoria-CES-ondorengoa.pdf
1151,Estudio de los factores de riesgo de la conducta suicida en pacientes hospitalizados. Análisis de la atención sanitaria (Informe nº: Osteba D-07-02),https://dialnet.unirioja.es/descarga/articulo/8584899.pdf
1152,Estudio de satisfacción de factores de la atención hospitalaria que los familiares de personas fallecidas consideran importantes en la fase final de la vida (Informe nº: Osteba D-06-04),
1153,Estudio multicéntrico para el análisis de la efectividad de la telemedicina en programas de aseguramiento de la calidad de las espirometrías (Informe nº: Osteba E12/03),https://www.euskadi.eus/contenidos/informacion/2012_osteba_publicacion/es_def/adjuntos/e_12_03%20Estudio%20multicentrico%202009_03.pdf
1154,Estudio piloto de identificación y evaluación de tecnologías sanitarias obsoletas a partir de las bases de datos de tecnologías emergentes (Informe nº: Osteba E-14-22),
1155,Estudio sobre la ampliación de la edad de la población diana del programa de detección del cáncer de mama en la CAPV (Informe nº: Osteba D-04-02.,https://www.euskadi.eus/contenidos/informacion/enfermedades_cancer_mama_ampli/es_def/adjuntos/Hoja_Junio2011.pdf
1156,Estudio sobre la utilización de las Guías de Práctica Clínica en Atención Especializada. Exploración de barreras y facilitadores para su implementación (Informe nº: Osteba D-13-08),https://www.euskadi.eus/contenidos/informacion/2013_osteba_publicacion/es_def/adjuntos/Informe%20D-13-08.pdf
1157,État de santé des personnes en situation de prostitution et des travailleurs du sexe et identification des facteurs de vulnérabilité sanitaire,
1158,Etäyhteydellä toteutettava pitkäaikaissairautta sairastavan omahoidon ohjaus,https://www.hotus.fi/wp-content/uploads/2022/12/etaohjaus-hoitosuositus.pdf
1159,Eteisvärinä,https://www.kaypahoito.fi/xmedia/khp/khp00103.pdf
1160,Eturauhassyöpä,https://www.kaypahoito.fi/xmedia/khp/khp00006.pdf
1161,European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO-NMD),https://iris.unito.it/bitstream/2318/2069710/1/Eur%20J%20Neurol%202024%20-%20Van%20Damme%20-%20ALS%20Guidelines%20ene16264-sup-0002-appendixs1.pdf
1162,European Academy of Neurology (EAN)/European Federation of Autonomic Societies (EFAS)/International Neuro-Urology Society (INUS) Guidelines for Practising Neurologists on the Assessment and Treatment of Neurogenic Urinary and Sexual Symptoms (NEUROGED Gui,
1163,European Academy of Neurology guideline on the diagnosis of coma and other disorders of consciousness,
1164,European Academy of Neurology guideline on the management of medication-overuse headache,https://nugs.rs/wp-content/uploads/2014/04/Treatment-of-medication-overuse-headache-guideline-of-the-EFNS-headache-panel-EFNS-guidelines-2011.pdf
1165,European Academy of Neurology guideline on trigeminal neuralgia,https://www.uems-neuroboard.org/web/images/docs/exam/2021/Guideline-Papers/EAN-guideline-trigeminal-neuralgia-Bendtsen2019.pdf
1166,European Academy of Neurology guidelines on the treatment of cluster headache,https://www.uems-neuroboard.org/web/images/docs/exam/2024/papers/06-EAN-guideline-cluster-headache2023.pdf
1167,European Academy of Neurology/Movement Disorder Society - European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies,
1168,European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision,https://www.tnms.com.tw/wp-content/uploads/2022/04/Euro-J-of-Neurology-2021-Van-den-Bergh-European-Academy-of-Neurology-Peripheral-Nerve-Society-guideline-on-diagnosis.pdf
1169,European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome,
1170,European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome,
1171,European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F‐fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus,
1172,European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripher,
1173,European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripher,
1174,European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy*,https://www.neuromuskularni-sekce.cz/res/file/archiv/Guidelines-Management-MMN.pdf
1175,European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of paraproteinaemic demyelinating neuropathies: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Socie,https://www.neuromuskularni-sekce.cz/res/file/archiv/Guidelines-Management-paraproteinemickych-demyelinizacnich-polyneuropatii.pdf
1176,European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Ne,https://www.bcbsil.com/docs/provider/il/standards/cpcp/cpcplab/2026/cpcplab064-1-1-2026.pdf
1177,European guideline and expert statements on the management of narcolepsy in adults and children,
1178,"European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society",https://www.uems-neuroboard.org/web/images/docs/exam/EFNS-guideline_Restless-legs-syndrome.pdf
1179,European physiotherapy benchmark statement,https://www.hv-gesundheitsfachberufe.de/dokumente/Benchmark_Statement_ER_WCPT.pdf
1180,European Physiotherapy Guidelines for Parkinson’s,https://www.parkinsonnet.nl/app/uploads/sites/3/2019/11/eu_guideline_parkinson_guideline_for_pt_s1.pdf
1181,European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases,
1182,European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine),
1183,European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI),
1184,European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists),
1185,European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate disease,
1186,European society of Clinical Microbiology and Infectious Diseases guidelines on diagnosis and treatment of brain abscess in children and adults,
1187,European Society of Clinical Microbiology and Infectious Diseases/European Committee on infection control clinical guidelines on pre-operative decolonization and targeted prophylaxis in patients colonized by multidrug-resistant Gram-positive bacteria b...,
1188,European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults,
1189,European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection,
1190,European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection,
1191,European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment,
1192,European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology,
1193,Euthanasie bij een verlaagd bewustzijn. National consensus-based guideline,https://palliaweb.nl/getmedia/20243dfc-d3f5-4ca8-a4c3-acdc59ec44d2/9047-Euthanasie-bij-een-verlaagd-bewustzijn-20251218100507.pdf
1194,Euthanasie en hulp bij zelfdoding. National consensus-based guideline,https://www.knmp.nl/sites/default/files/2023-04/Richtlijn_Euthanasie_en_hulp_bij_zelfdoding_22-02-2023.pdf
1195,Evaluación de la calidad asistencial en el SNS de los trastornos mentales graves en la infancia. Estudio en Salud Mental Infanto-Juvenil (Informe nº: Osteba E-15-01),https://www.euskadi.eus/contenidos/informacion/2015_osteba_publicacion/es_def/adjuntos/E-15-01.pdf
1196,Evaluación de la calidad del registro de las variables administrativas del CMBD de los hospitales de agudos de Osakidetza-SVS en el año 2005 (Informe nº: Osteba D-08-09),
1197,Evaluación de la efectividad de la detección intraoperatoria del ganglio centinela en tumores sólidos (Informe n°: Osteba D-06-01),https://www.euskadi.eus/contenidos/informacion/2006_osteba_publicacion/es_def/adjuntos/2006/d_06-01_ganglio_centinela.pdf
1198,Evaluación de la efectividad de la intervención psicológica en los primeros episodios psicóticos mediante tratamiento multidisciplinar (Informe nº: Osteba E-14-13),
1199,Evaluación de la eficacia de técnicas psicosociales (rehabilitación cognitiva vs psicoeducación) como tratamiento adicional al tratamiento farmacológico en trastorno bipolar (Informe nº: Osteba D-14-05),
1200,"Evaluación de la evidencia científica sobre la micropigmentación del complejo areola-pezón, requisitos para su adecuada realización y costes (Informe nº: Osteba E-18-02)",https://www.izenpe.eus/contenidos/informacion/2018_osteba_publicacion/es_def/adjuntos/E-18-02.pdf
1201,Evaluación de la implantación de la telemedicina diagnóstica en el ámbito de la dermatología (Informe nº: Osteba E-13-02),https://www.osakidetza.euskadi.eus/contenidos/informacion/osteba_publicaciones/es_osteba/adjuntos/Guia%20Eval%20TELEMEDICINA.pdf
1202,Evaluación de la implementación de guías clínicas en el País Vasco. Ensayo aleatorizado por grupos (Informe nº: Osteba E13/01),https://www.euskadi.eus/contenidos/informacion/2013_osteba_publicacion/es_def/adjuntos/Implementacion%20guias_WEB.PDF
1203,Evaluación de la situación asistencial y recomendaciones terapéuticas en el trastorno por deficit de atención e hiperactividad (Informe nº: Osteba E-10-09),https://www.euskadi.eus/contenidos/informacion/2010_osteba_publicacion/es_def/adjuntos/e_10_09_trast_hiper.pdf
1204,Evaluación de la utilidad e indicación de la biopsia de próstata con fusión de imágenes - resonancia magnética y ecografía transrectal (Informe nº: Osteba E-17-10),https://www.euskadi.eus/contenidos/informacion/2017_osteba_publicacion/es_def/adjuntos/E-17-10.pdf
1205,Evaluación de la utilización de las nuevas herramientas 2.0 y de la web social en las estrategias de difusión y diseminación de las agencias y unidades de Evaluación de Tecnologías Sanitarias (Informe nº. Osteba E-15-03),
1206,Evaluación de la variabilidad e idoneidad en la prescripción de antimicrobianos en atención primaria en la Comunidad Autónoma del País Vasco. Recomendaciones de uso apropiado (Informe nº: Osteba D-00-09),https://www.euskadi.eus/contenidos/informacion/2000_osteba_publicacion/es_def/adjuntos/2000/d_00_09_variabilidad_e_idoneidad_antimicrobianos.pdf
1207,Evaluación de los factores relacionados con el gasto farmacéutico en atención primaria y la calidad de la prescripción en enfermedades crónicas (Informe nº: Osteba D-16-05),https://www.juntadeandalucia.es/export/drupaljda/1337161198telemedicina_diabetes.pdf
1208,"Evaluación de los tiempos de atención del cáncer en las principales localizaciones: colon-recto, pulmón, mama y próstata (Informe nº: Osteba D-16-02)",https://www.nccn.org/patients/guidelines/content/PDF/es_early-prostate.pdf
1209,Evaluación de radioterapia conformada con haces de intensidad modulada. IMRT (Informe nº: Osteba E-14-12),https://www.euskadi.eus/contenidos/informacion/2014_osteba_publicacion/es_def/adjuntos/radioterapiaIMRT.pdf
1210,Evaluación del impacto en la salud del plan de reforma integral de Uretamendi-Betolaza y Circunvalación (Informe nº: Osteba D-09-04),https://www.osakidetza.euskadi.eus/contenidos/informacion/publicaciones_informes_estudio/es_pub/adjuntos/EIS_PRI.pdf
1211,Evaluación del sistema de humidificación de burbuja en la terapia de oxigeno de bajo flujo. Revisión sistemática y analisis de costes (Informe nº: Osteba E-14-04),https://www.euskadi.eus/contenidos/informacion/2014_osteba_publicacion/es_def/adjuntos/humidificacion_burbuja.pdf
1212,Evaluación e impacto de una intervención de telemonitorización en pacientes domiciliarios con insuficiencia cardiaca o broncopatía crónica controlada desde la atención primaria Ensayo clínico aleatorizado. Estudio TELBIL (Informe nº: Osteba E-1...,
1213,Evaluación económica de una intervención de telemonitorización desde la atención primaria en pacientes domiciliarios con insuficiencia cardiaca y/o broncopatía crónica: Análisis coste-efectividad. Estudio TELBIL (Informe nº: Osteba E-13-07),
1214,Evaluación y manejo clínico de las autolesiones en la adolescencia: protocolo basado en la evidencia,
1215,Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion,
1216,Evaluation and management of obstructive sleep apnea in adults hospitalized for medical care: an American Academy of Sleep Medicine clinical practice guideline,
1217,Evaluation of Gastroenteropancreatic Neuroendocrine Tumors and Ki-67,https://e-century.us/files/ijcep/16/9/ijcep0149645.pdf
1218,Evaluation of Minimal Residual Disease in Acute Lymphoblastic Leukemia,https://www.ejgm.co.uk/download/assessment-of-minimal-residual-disease-in-patients-with-b-cell-acute-lymphoblastic-leukemia-using-16837.pdf
1219,Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians,https://clinicalmonster.com/wp-content/uploads/sites/2/2016/06/Evaluation-of-Patients-With-Suspected-Acute-Pulmonary-Embolism-Best-Practice-Advice-From-the-Clinical-Guidelines-Committee-of-the-American-College-of-Physicians.pdf
1220,Evaluation von zahnmedizinischen Leitlinien durch Qualitätszirkel (ELL-QZ),https://www.kvwl.de/fileadmin/user_upload/pdf/Mitglieder/Qualitaetssicherung/Qualitaetszirkel/qz_leitlinie.pdf
1221,Evidence-based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine,https://www.dnd.or.kr/Synapse/Data/PDFData/0196DND/dnd-24-1.pdf
1222,Evidence-Based Clinical Practice Guidelines for  Ankle Sprain in Adults on Traditional Korean Medicine,
1223,Evidence-Based Clinical Practice Guidelines for atopic dermatitis in Traditional Korean Medicine,https://anndermatol.org/Synapse/Data/PDFData/0140AD/ad-37-e21.pdf
1224,Evidence-Based Clinical Practice Guidelines for depression in Adults on Traditional Korean Medicine,http://www-ncbi-nlm-nih-gov-ssl.chlib.schmc.ac.kr/bitstream/2022.oak/3965/2/2024a02732.pdf
1225,Evidence-Based Clinical Practice Guidelines for Idiopathic Facial Paralysus in Adults on Traditional Korean Medicine,
1226,Evidence-Based Clinical Practice Guidelines for lumbar herniated intervertebral disc(HIVD) in Traditional Korean Medicine,
1227,Evidence-Based Clinical Practice Guidelines for Microcystic Adnexal Carcinoma Informed by a Systematic Review,https://jamanetwork.com/journals/jamadermatology/articlepdf/2749819/jamadermatology_2019_cx_190012.pdf
1228,Evidence-Based Clinical Practice Guidelines for Obesity on Traditional Korean Medicine,https://www.sochob.cl/web1/wp-content/uploads/2023/04/Evaluation-and-Treatment-of-Obesity-and-Its-Comorbidities-2022-Update-of-Clinical-Practice-Guidelines-for-Obesity-by-the-Korean-Society-for-the-Study-of-Obesity.pdf
1229,Evidence-Based Clinical Practice Guidelines for Shoulder pain on Traditional Korean Medicine,https://files.magicapp.org/guideline/b7162d32-08f6-4524-8dd7-4775dfb21dfc/files/S%C3%B8g_prot__NKR_skulder_Guidelines_r287819.pdf
1230,"EvidenT-HiP - Evidenzbasierte interdisziplinäre Therapie hüftgelenknaher, pertrochantärer Oberschenkelfrakturen. S3-LL (DGOU)",
1231,Evidenz- und konsensbasierte Indikationskriterien zur Hüfttotalendoprothese bei Coxarthrose (EKIT-Hüfte). S3-LL (DGOU),https://register.awmf.org/assets/guidelines/187-001k_S3_Indikationskriterien_H%C3%BCfttotalendoprothese_bei_Coxarthrose_2021-04.pdf
1232,Évolution des taux de césariennes à terme en France entre 2011 et 2014 et évaluation de l’impact du programme,https://sante.gouv.fr/IMG/pdf/Donnees_quantitatives.pdf
1233,Excess winter deaths and illness and the health risks associated with cold homes (NG6),https://shap.uk.com/wp-content/uploads/2020/02/nice-guidance-ng6.pdf
1234,"Exekutive Dysfunktionen bei neurologischen Erkrankungen, Diagnostik und Therapie. S2e-LL (DGN)",https://register.awmf.org/assets/guidelines/030-125m_S2e__LL_Diagnostik-Therapie-exekutive-Dysfunktionen_2024-12-abgelaufen.pdf
1235,Exercise for People with Cancer,https://www.exerciseismedicine.org/wp-content/uploads/2021/04/exercise-guidelines-cancer-infographic.pdf
1236,"Exokrines Pankreaskarzinom. S3-LL (Leitlinienprogramm Onkologie von AWMF, DKG und DKH)",https://register.awmf.org/assets/guidelines/032-010OLl_Exokrines-Pankreaskarzinom_2025-06.pdf
1237,Expert Consensus on Rapid On-Site Evaluation in Diagnostic Interventional Pulmonology,https://link.springer.com/content/pdf/10.1007/978-981-15-0939-1.pdf
1238,Exploración de barreras y facilitadores para la implementación de guías de práctica clínica: un estudio Delphi (Informe nº: Osteba E-10-05),
1239,Extra-corporeal Photopheresis in the Management of Graft-Versus-Host Disease in Patients who Have Received Allogeneic Blood or Bone Marrow Transplants: Recommendations,https://www.premera.com/medicalpolicies/8.01.36.pdf
1240,"Extrakorporale Photopherese (ECP). S2k-LL (DDG, DKG)",https://register.awmf.org/assets/guidelines/013-072m_S2k_Extrakorporale-Photopherese-ECP_2022-02.pdf
1241,"Extrakorporale Zirkulation (ECLS / ECMO), Einsatz bei Herz- und Kreislaufversagen. S3-LL (DGTHG)",https://www.ai-online.info/images/ai-ausgabe/2021/12-2021/AI_12-2021_Sonderbeitrag_Boeken.pdf
1242,Eye care for intensive care patients (Best Practice 6(1)),https://www.wyccn.org/uploads/6/5/1/9/65199375/crbg_best_practice_ed_tool_eye_care_v3_jan_2024.pdf
1243,Fachärztliche Diagnostik und Therapie von Asthma. S2k-LL (DGP),https://register.awmf.org/assets/guidelines/020-009l_S2k_Fachaerztliche-Diagnostik-Therapie-von-Asthma_2023-07.pdf
1244,Facilitating Client Centred Learning,https://rnao.ca/sites/rnao-ca/files/FCCL_HEFS-_HCP__FINAL.pdf
1245,Faecal incontinence in adults: management (CG49),https://cdn.ps.emap.com/wp-content/uploads/sites/3/2007/09/070710NICE-GUIDANCE-ON-management-of-FAECAL-INCONTINENCE.pdf
1246,Fallot´sche Tetralogie. S2k-LL (DGPK),https://www.dgpk.org/wp-content/uploads/LL_TOF_finale_Version_11-21.pdf
1247,Falls in older people: assessing risk and prevention (CG161),https://docs.bvsalud.org/biblioref/2021/06/1247733/falls-in-older-people-assessing-risk-and-prevention-pdf-35109686728645.pdf
1248,Faltering growth: recognition and management of faltering growth in children (NG75),https://www.childrenshealthireland.ie/documents/1754/Faltering-Growth-References.pdf
1249,Familiair colorectaal carcinoom. National consensus-based guideline,https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/GGPO_Guideline_Colorectal_Cancer_2.1.pdf
1250,Familiair hereditair Pancreascarcinoom,https://link.springer.com/content/pdf/10.1007/978-3-030-62416-3_5525.pdf
1251,Familiair mamma/ovariumcarcinoom. National consensus-based guideline.,
1252,Familiair paraganglioom/glomustumor/feochromocytoom. National consensus-based guideline,https://nanets.net/images/2021/2021_NANETS_Consensus_Guidelines_for_Surveillance_and_Management_of_Metastatic_and_or_Unresectable_Pheochromocytoma_and_Paraganglioma.pdf
1253,Familiair Testiscarcinoom,https://2024.sci-hub.ru/1790/fe9c2feefabbba31f08feee8d45be107/sonneveld1999.pdf
1254,Familiair/hereditair Diffuus Maagcarcinoon,https://www.huisartsengenetica.nl/sites/default/files/inline-files/Hereditair%20diffus%20maagcarcinoom.pdf
1255,Familiair/hereditair maagcarcinoom. National consensus-based guideline,https://repository.ubn.ru.nl/bitstream/handle/2066/178447/178447.pdf
1256,Familiaire Adenomateuze Polyposis (APC),https://www.seom.org/seomcms/images/stories/recursos/sociosyprofs/abstracts/2007/curso_consejo_genetico/blanco_ignacio/ignacio_blanco4.pdf
1257,Familial atypical multiple mole melanoma syndroom. National consensus-based guideline,https://guidelines.carelonmedicalbenefitsmanagement.com/wp-content/uploads/2024/02/PDF-Hereditary-Cancer-Testing-2023-11-05-UC-0324.pdf
1258,"Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer (CG164)",
1259,Familial hypercholesterolaemia: identification and management (CG71),https://pathlabs.rlbuht.nhs.uk/familial-hypercholesterolaemia-identification-and-management.pdf
1260,Familienorientierte Rehabilitation (FOR) bei Herz- und Kreislauferkrankungen im Kindes- und Jugendalter und spezielle Rehabilitation im Jugend- und jungen Erwachsenenalter (JEMAH-Patienten).  S2k-LL (DGPK),https://register.awmf.org/assets/guidelines/023-031l_S2k_Familienorientierte-Rehabilitation_FOR-Herz_und_Kreislauferkrankungen_2018-07-abgelaufen.pdf
1261,Family involvement in decision making for people with dementia in residential aged care (Best Practice 18(2)),
1262,Fear of Cancer Recurrence Guideline,https://hprir.massgeneral.org/wp-content/uploads/2024/04/FCR_Cancer_2024.pdf
1263,Femme enceinte : colonisation urinaire et cystite,https://www.cpias-nouvelle-aquitaine.fr/wp-content/uploads/2023/11/2023-02-07-memo-infections-urinaires-femmes-enceintes.pdf
1264,Femmes enceintes ayant une complication au cours de leur grossesse: transferts en urgence entre les établissements de santé. Recommandation pour la pratique clinique,
1265,"Fertilitätserhalt bei onkologischen Erkrankungen. S2k-LL (DGGG, DGU, DGRM)",https://www.dggg.de/fileadmin/data/Presse/Pressemitteilungen/2025/Leitlinie_Fertilit%C3%A4tserhalt/PM_LL_Fertilit%C3%A4tserhalt_bei_onkolog._Erkrankungen_Okt2025.pdf
1266,Fertility Preservation in Patients with Cancer: American Society of Clinical Oncology Guideline Update,https://oncofertility.msu.edu/wp-content/uploads/2022/04/asco_update.pdf
1267,Fertility problems: assessment and treatment (CG156),https://drseckin.com/wp-content/uploads/2022/04/cg156-assessment-and-treatment-for-people-with-fertility-problems-old.pdf
1268,"Festsitzender Zahnersatz für zahnbegrenzte Lücken. S3-LL (DGZMK, DGPro)",https://www.dgpro.de/sites/default/files/uploads/festsitzender_ze.pdf
1269,Fetal monitoring in labour (NG229),https://www.stgeorges.nhs.uk/wp-content/uploads/2023/05/MAT_FM.pdf
1270,Fetale Alkoholspektrumstörungen (FASD) bei Kindern und Jugendlichen - Diagnostik & Intervention. S3-LL (GNP),
1271,"Fetale Überwachung in der Schwangerschaft (Indikation und Methodik zur fetalen Zustandsdiagnostik im low-risk Kollektiv). S3-LL (DGGG, DEGUM)",https://register.awmf.org/assets/guidelines/015-089l_S3_Fetale-Ueberwachung-in-der-Schwangerschaft_2023-05.pdf
1272,Fetale Wachstumsrestriktion. S2k-LL (DGGG),https://www.thieme-connect.com/products/ejournals/pdf/10.1055/a-2535-0528.pdf
1273,Fever in under 5s: assessment and initial management (NG143),https://ep.bmj.com/content/edpract/107/3/212.full.pdf
1274,Fiebermanagement bei Kindern und Jugendlichen. S3-LL (DGKJ),https://register.awmf.org/assets/guidelines/027-074p1_S3_Fiebermanagement-Kinder-Jugendliche_2025-07.pdf
1275,Fièvre Méditerranéenne Familiale. Guide ALD,https://www.has-sante.fr/upload/docs/application/pdf/2013-02/pnds_-_fievre_mediterraneenne_familiale.pdf
1276,Fiscal policies to promote healthy diets: WHO guideline,https://eurohealthnet.eu/wp-content/uploads/230131_consultation_response_whoguideline_fiscal_policies-_to_promote_healthy_diets.pdf
1277,Fissuren- und Grübchenversiegelung. S3-LL (DGZMK),https://register.awmf.org/assets/guidelines/083-002l_S3_Fissuren-Gruebchenversiegelung_2025-03..pdf
1278,Flu vaccination: increasing uptake (NG103),
1279,Fluor vaginalis (M38),https://mcclimburg-noord.nl/system/ckeditor_assets/attachments/262/20201229_referenties_gynaecologie.pdf
1280,Fluoridierungsmaßnahmen zur Kariesprophylaxe bei Kindern und Jugendlichen. S2k-LL (DGZMK),https://a.storyblok.com/f/262769/x/5a0a1b2f98/ll-basisprophylaxe_11-2016_0.pdf
1281,Focal Tumour Ablation for Renal Cell Carcinoma,https://aacrjournals.org/clincancerres/article-pdf/10/18/6328S/3261577/zdf103040s6328.pdf
1282,Focal Tumour Ablation: Early-stage Primary Lung Cancer and Lung Metastases,https://www.commonwealthcarealliance.org/ri/wp-content/uploads/2024/03/Radiofrequency-Ablation-for-Lung-Cancer_091_12.31.23.pdf
1283,Focal Tumour Ablation: Transarterial Chemoembolization for Hepatocellular Carcinoma,https://www.e-jlc.org/upload/pdf/jlc-2023-05-22.pdf
1284,Focused Guidelines for the Surveillance and Control of Candida Infections in Healthcare Institutions: Addressing Key Clinical Questions,
1285,Folder palliatieve sedatie. National consensus-based guideline,https://www.palliativedrugs.org/download/090916_KNMG_Guideline_for_Palliative_sedation_2009__2_%5B1%5D.pdf
1286,Follow-up after primary therapy for endometrial cancer,http://www.24hmb.com/voimages/web_image//upload/file/20140710/24901404969130577.pdf
1287,Follow-up and Surveillance of Curatively Treated Lung Cancer Patients,https://bpac.org.nz/2021/docs/lung-cancer-surveillance.pdf
1288,Follow-up and Surveillance of Curatively Treated Patients with Lung Cancer,
1289,Follow-up Care and Psychosocial Needs of Survivors of Prostate Cancer,
1290,Follow-up Care for Survivors of Lymphoma who have Received Curative-Intent Treatment,https://scispace.com/pdf/follow-up-care-for-survivors-of-lymphoma-who-have-received-vkvqs00f6i.pdf
1291,"Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement",
1292,"Follow-up Care, Surveillance Protocols and Secondary Prevention Measures for Survivors of Colorectal Cancer",
1293,Follow-up for Cervical Cancer,https://www.thewomens.org.au/images/uploads/fact-sheets/Followup-cervical-cancer-120219.pdf
1294,Food allergy in children and young people (CG116),
1295,Food and Nutrition for Older Adults Promoting Health and Wellness  Recommendations (FNOA),https://www.andeal.org/vault/pqnew111.pdf
1296,Foot assessment in people with diabetes mellitus,https://nursing.ceconnection.com/ovidfiles/00006416-201801000-00005.pdf
1297,Formstörungen der inneren und äußeren Nase (mit funktioneller und/oder ästhetischer Beeinträchtigung). S2k-LL (DGHNO-KHC),
1298,Fractures (complex): assessment and management (NG37),
1299,Fractures (non-complex): assessment and management (NG38),
1300,Fractuurpreventie (M69),https://www.zorginstituutnederland.nl/site/binaries/site-content/collections/documents/2023/05/12/zz-panaxea-rapport-fractuurpreventie-osteoporose/Panaxea-rapport+multidisciplinaire+fractuurpreventie+osteoporose.pdf
1301,Frakturassoziierte Infektion nach Osteosynthese. S2k-LL (DGOU),https://link.springer.com/content/pdf/10.1007/s00104-025-02380-2.pdf
1302,Frakturen des distalen Unterschenkels im Kindesalter. S2k-LL (DGOU),https://register.awmf.org/assets/guidelines/012-026l_S2k_Frakturen_distaler_Unterschenkel_Kinder_2017-11-abgelaufen.pdf
1303,Fraktursonografie. S2e-LL (DEGUM),https://www.iqwig.de/download/d22-02_fraktursonografie-der-oberen-extremitaeten-bei-kindern_da-vorbericht_v1-0.pdf
1304,Framework for clinical guideline development in physiotherapy,
1305,Frische Außenbandruptur des oberen Sprunggelenks. S2k-LL (DGOU),https://uplopen.com/books/9361/files/7b2183bd-7688-461b-b945-f806ef0e7342.pdf
1306,Früher Schwangerschaftsverlust im 1. Trimenon. S2k-LL (DGGG),https://register.awmf.org/assets/guidelines/015-076l_S2k_Frueher-Schwangerschaftsverlust-im-1-Trimenon_2025-01.pdf
1307,"Früherkennung, Diagnose, Therapie und Nachsorge des Harnblasenkarzinoms. S3-LL (Leitlinienprogramm Onkologie von AWMF, DKG und DKH)",https://register.awmf.org/assets/guidelines/032-038OLm_S3_Frueherkennung-Diagnose-Therapie-Nachsorge-Harnblasenkarzinom_2025-04_01.pdf
1308,"Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms. S3-LL (Leitlinienprogramm Onkologie von AWMF, DKG und DKH)",https://register.awmf.org/assets/guidelines/032-045OLm_S3_Frueherkennung-Diagnostik-Therapie-Nachsorge-Mammakarzinom_2026-01.pdf
1309,Frühgeborene an der Grenze der Lebensfähigkeit. S2k-LL (GNPI),https://gnpi.de/wp-content/uploads/2024/01/024-019l_S2k_Fruehgeburt_Grenze_Lebensfaehigkeit_2014.pdf
1310,"Funktionelle (nicht-organische) Obstipation und Stuhlinkontinenz im Kindes- und Jugendalter. S2k-LL (GPGE, DGKJP)",https://register.awmf.org/assets/guidelines/069-019l_S2k_Funktionelle-nicht-organische-Obstipation-Stuhlinkontinenz-im-Kindes-und-Jugendalter_2022-04.pdf
1311,"Funktionelle Körperbeschwerden. S3-LL (DGPM, DKPM)",https://register.awmf.org/assets/guidelines/051-001m_S3_Funktionelle_Koerperbeschwerden_2018-11-abgelaufen.pdf
1312,Gallstone disease: diagnosis and management (CG188),https://www.michaelclarkesurgeon.co.uk/wp-content/uploads/2018/04/CG188_migrated.pdf
1313,Galweg- en galblaascarcinoom,https://www.mdl.nl/sites/www.mdl.nl/files/richlijnen/Galweg-_en_Galblaascarcinoom_definitief_t.b.v._website.pdf
1314,"Gambling-related harms: identification, assessment and management (NG248)",https://www.ncbi.nlm.nih.gov/books/NBK612773/bin/niceng248er3-appa-et1.pdf
1315,Gastric carcinoma (english version),https://sfsurgery.com/wp-content/uploads/2014/06/Gastric-Stomach-Cancer.pdf
1316,Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (CG184),https://www.rouxgroup.org.uk/wp-content/uploads/2021/03/GORD-NICE-2015.pdf
1317,Gastro-oesophageal reflux disease in children and young people: diagnosis and management (NG1),https://docs.bvsalud.org/biblioref/2021/05/1224243/gastrooesophageal-reflux-disease-in-children-and-young-people-_skJWu0t.pdf
1318,Gastrointestinale Blutung. S2k-LL (DGVS),https://aem-online.de/wp-content/uploads/2025/12/Leitlinie_LL-GI-Blutung_16.12.25.pdf
1319,Gastrointestinale Infektionen. S2k-LL (DGVS),https://register.awmf.org/assets/guidelines/021-024m_S2k_Gastrointestinale_Infektionen_2023-11.pdf
1320,Gastrointestinale stroma tumor (GIST). National evidence-based guideline,http://nccndd.qitian-med.tech/nccn-his/%E8%83%83%E8%82%A0%E9%81%93%E9%97%B4%E8%B4%A8%E7%98%A4/%E8%83%83%E8%82%A0%E9%81%93%E9%97%B4%E8%B4%A8%E7%98%A42022.1%E7%89%88.pdf
1321,Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis. S2k-LL (DGVS),https://register.awmf.org/assets/guidelines/021-013l_S2k_Gastrooesophageale-Refluxkrankheit-eosinophile_Oesophagitis_2023-09.pdf
1322,Gebrauch von Präparationen zur äußerlichen Anwendung auf der Haut. S2k-LL (DDG),https://derma.de/fileadmin/derma/1_derma.de_WebRoot/Aerzte/Leitlinien/013-092l_S2k_Praeparationen_lokale_Anwendung_2017-11.pdf
1323,General Nutrition and Dietary treatment . National nutrition consensus-based guideline,https://wecareaboutnutrition.wordpress.com/wp-content/uploads/2016/08/national-guidelines_malnourished-individuals-2015.pdf
1324,Generalised anxiety disorder and panic disorder in adults: management (CG113),https://fmhub.org/wp-content/uploads/2021/08/anxiety-and-panic-disorders.pdf
1325,Generalised anxiety disorder – easing burden and enabling remission,https://isomer-user-content.by.gov.sg/68/85dc8f7b-617d-4ba2-acf4-8e521692d9b6/Generalised%20anxiety%20disorder%20easing%20burden%20and%20enabling%20remission%20references%20(Mar%202025).pdf
1326,Genetische Aortopathien bei Kindern und Jugendlichen. S2k-LL (DGPK),https://www.dgpk.org/wp-content/uploads/DGPK_LL_Kardiomyopathien_Rev-final-Maerz-2024.pdf
1327,Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline,https://pdfs.semanticscholar.org/6a82/a29c672bd1d6641363a0c336a84eac974d03.pdf
1328,Geschlechtsangleichende Hormontherapie bei Geschlechtsinkongruenz im Erwachsenenalter. S2k-LL (DGE),https://www.aerzteblatt.de/pdf/117/43/m725.pdf
1329,"Geschlechtsinkongruenz und Geschlechtsdysphorie im Kindes- und Jugendalter: Diagnostik und Behandlung, S3-LL (DGKJP)",https://www.inlibra.com/10.30820/9783837977585.pdf
1330,"Geschlechtsinkongruenz, Geschlechtsdysphorie und Trans-Gesundheit: Diagnostik, Beratung, Behandlung. S3-LL (DGfS)",
1331,Geschlechtssensible Versorgung für Menschen mit chronischer Nierenkrankheit. S3-LL (DGfN),https://register.awmf.org/assets/guidelines/2025-02_053-048l_S3_Versorgung-PatientInnen-chronische-nicht-nierenersatz-therpapiepflichtige-Nierenkrankheit-Hausarztpraxis_01.pdf
1332,"Gestational diabetes mellitus  an update on screening, diagnosis, and follow-up",https://pdfs.semanticscholar.org/cc89/1f385e176e2bf9e6c4aaed7347db825717ca.pdf
1333,Gestational Diabetes Mellitus (GDM). Evidence Based Nutrition Practice Guideline,http://medi-guide.meditool.cn/ymtpdf/14B18D63-6404-EB24-91C7-B0A6C1007790.pdf
1334,Gestationsbedingte und nicht-gestationsbedingte Trophoblasterkrankungen. S2k-LL (DGGG),https://ago-austria.at/wp-content/uploads/2021/01/032-049l_S2k_Gestationelle_nichtgestationelle_Trophoblasterkrankungen_2016-05.pdf
1335,"Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge. S3-LL (DDG)",https://register.awmf.org/assets/guidelines/057-008l_S3_Gestationsdiabetes-mellitus-GDM-Diagnostik-Therapie-Nachsorge_2019-06-abgelaufen.pdf
1336,Gesundheitliche Aspekte und Gestaltung von Nacht- und Schichtarbeit. S2k-LL (DGAUM),https://register.awmf.org/assets/guidelines/002-030l_S2k_Gesundheitliche-Aspekte-Gestaltung-Nacht-und-Schichtarbeit_2020-03-abgelaufen.pdf
1337,Gevaar bloeding. National consensus-based guideline,https://nvdietist.nl/app/uploads/2021/03/Leukemie-acute.pdf
1338,Gevaar infectie. National consensus-based guideline,https://ncdc.mohfw.gov.in/wp-content/uploads/2025/12/National-Treatment-Guidelines-for-AMU-in-ID-syndromes-2025.pdf
1339,Gichtarthritis - fachärztliche Versorgung. S2e-LL (DGRh),
1340,Glaucoma referral and safe discharge (SIGN CPG 144),https://www.sign.ac.uk/assets/sign144.pdf
1341,Glaucoma: diagnosis and management (NG81),
1342,Glaukooma,https://silmaoptikot.fi/wp-content/uploads/2022/10/Glaukooma.pdf
1343,Gliomas (english version). National consensus-based guideline,https://kiyatec.com/wp-content/uploads/2024/01/brain-gliomas-patient.pdf
1344,Gliome. S2k-LL (DGN),https://dnvp9c1uo2095.cloudfront.net/cms-content/030099l_S2k_Gliome_2014_archiviert_1685021220972.pdf
1345,Gliomen,
1346,GnRH 拮抗剂方案的应用循证临床实践指南（2025版）,
1347,Gonarthrose. S3-LL (DGOU),
1348,Gout  achieving the management goal,
1349,Gout: diagnosis and management (NG219),
1350,Graduated compression stockings for the prevention of post-operative venous thromboembolism (Best Practice 12(4)),
id,title,link
1351,Graduated Compression Stockings for the Prevention of Post-operative Venous Thromboembolism (Best Practice 5(2)),
1352,Group and individual therapy in the treatment of depression (Best Practice 3(2)),
1353,Guía de actuación en el síndrome Prader-Willi (Informe nº: Osteba GPC 17/03),
1354,Guía de Práctica Clínica para el Tratamiento de la Espondiloartritis Axial y la Artritis Psoriásica 2024,
1355,Guía de Práctica Clínica sobre Asma Infantil (Informe nº: Osteba GPC 15/02a),
1356,Guía de Práctica Clínica sobre Cuidados Paliativos en Pediatría,
